Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,40511,0.207313283315716,0.00447505020443469,0.198542184915024,0.216084381716408,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,40275,0.285923004032288,0.0065860389184568,0.273014367752113,0.298831640312463,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,40351,0.345711745898878,0.0037815125528867,0.33829998129522,0.353123510502536,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,40327,0.149094422792845,0.00357566973188496,0.14208611011835,0.15610273546734,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,40484,0.22655388563924,0.00567262997091289,0.21543553089625,0.237672240382229,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,40456,-0.129435008300234,0.00287467060653368,-0.13506936268904,-0.123800653911428,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40223,0.0928351600853661,0.00251019050518651,0.0879151866952006,0.0977551334755317,3.34984434665017e-287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40419,0.144237012841159,0.00395395208647777,0.136487266751663,0.151986758930655,6.36575267016851e-280
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37937,0.232916257084216,0.0064410594825666,0.220291780498386,0.245540733670047,2.25088092252892e-273
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,40304,0.0936948160237488,0.00261708581375451,0.0885653278287899,0.0988243042187076,5.26455916058396e-270
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40484,0.10121493239368,0.00283206886944822,0.0956640774095615,0.106765787377799,3.19697199459933e-269
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,40354,-0.140662594915953,0.00394341021425887,-0.1483916789359,-0.132933510896005,3.728617257537e-268
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,40037,0.197433135762649,0.00578373154695039,0.186097021930626,0.208769249594672,2.30839215559053e-246
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,40347,0.221315262189124,0.00655487437785257,0.208467708408533,0.234162815969715,2.09105754616218e-241
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,40417,0.118437625934054,0.00353528480027057,0.111508467725523,0.125366784142584,7.24537539628899e-238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,38008,-0.18999961476062,0.00572784172849723,-0.201226184548475,-0.178773044972765,4.63614756944943e-232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40484,0.0978451964384157,0.00299832797371459,0.0919684736099351,0.103721919266896,3.24838269495813e-226
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40327,0.0866868724617562,0.00271819942763188,0.0813592015835978,0.0920145433399147,2.22349854208048e-216
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39956,0.149830097115964,0.00472964443906511,0.140559994015396,0.159100200216532,1.81006891837493e-213
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40308,0.14955078068397,0.00477291378256289,0.140195869670146,0.158905691697793,3.71017050582008e-209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,40354,0.160484552155591,0.0051604628317515,0.150370045005358,0.170599059305824,3.5360387221675e-206
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37993,0.113713847588735,0.00365807316841386,0.106544024178644,0.120883670998826,5.47902551832689e-205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40417,-0.0736342747171496,0.00237532760377422,-0.0782899168205471,-0.0689786326137522,6.14417800921619e-205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40300,0.18084536436662,0.00585836451554342,0.169362969916154,0.192327758817085,3.02399405067112e-203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40256,-0.163867370418137,0.0053462315559896,-0.174345984267876,-0.153388756568397,1.79797643381158e-200
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40466,0.167648259716398,0.00549166451672661,0.156884597263613,0.178411922169182,5.36324244148315e-199
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,40223,0.0952896627027543,0.00313259110138041,0.0891497841440487,0.10142954126146,1.50341340992556e-197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40155,0.120465577832477,0.00398998092797187,0.112645215213652,0.128285940451302,1.05607951162317e-194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40037,0.142602354743086,0.004726168800573,0.133339063893963,0.151865645592209,1.9988685607012e-194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FURIN,Furin,40406,0.0880707599786709,0.00292034204589512,0.0823468895687165,0.0937946303886253,2.32126854876091e-194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40398,0.110139451213007,0.00365634572579519,0.102973013590448,0.117305888835565,6.31827957845753e-194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,37567,0.206463521915019,0.00685249739123217,0.193032627028204,0.219894416801834,6.82842823521313e-193
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,40345,0.0816612840249049,0.00279660830458402,0.0761799317479202,0.0871426363018895,1.23964555278601e-182
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37666,-0.076882275245526,0.00265482021650276,-0.0820857228698714,-0.0716788276211806,7.71647957764066e-179
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,39975,0.313041425246491,0.010838712471568,0.291797548802218,0.334285301690765,1.0382161603371e-178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,40371,0.0747383668136884,0.00260573350499644,0.0696311291438954,0.0798456044834814,1.88987793387444e-176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,40414,0.145157051273742,0.00507919154808861,0.135201835839489,0.155112266707996,3.09308965116794e-175
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,37877,0.0883966966029696,0.00312691411102176,0.0822679449453669,0.0945254482605722,7.82811785749714e-171
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40466,0.127555435593564,0.00453852652084838,0.118659923612702,0.136450947574427,1.08654896537849e-169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,37985,0.194490057805562,0.00691911527459245,0.180928591867361,0.208051523743764,5.17671633024851e-169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,40327,0.0574107730214118,0.00206435921313427,0.0533646289636686,0.061456917079155,3.04838724488316e-166
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40300,0.0745636431084716,0.00268496067281053,0.0693011201897629,0.0798261660271802,8.85155176805862e-166
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRN,Agrin,40417,0.0799987282670892,0.00289354690820686,0.0743273763270038,0.0856700802071747,2.18503574799649e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37985,0.174837233856178,0.00632029032818393,0.162449464812937,0.187225002899418,6.78068633890339e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40300,0.209440435021841,0.00766354364042928,0.194419889486599,0.224460980557082,9.85273157256917e-161
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,40409,0.141123985296316,0.00518055069986825,0.130970105924574,0.151277864668057,9.34023091185282e-160
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,40300,0.131026538412317,0.0048328102270211,0.121554230367355,0.140498846457278,2.84526427182233e-158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,40465,0.0471931696947584,0.0017468270282426,0.0437693887194029,0.0506169506701139,3.10046716199629e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,40327,-0.0888013836758854,0.00329054858644523,-0.095250858905318,-0.0823519084464527,7.15514486716118e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,40484,0.0796652338822939,0.00295566913707403,0.0738721223736288,0.085458345390959,1.57109433456132e-156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40354,0.070173774311814,0.00261178590009231,0.0650546739476331,0.075292874675995,1.5067252208868e-155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,40333,-0.106799437979929,0.00397821368752936,-0.114596736807487,-0.0990021391523716,2.68365214444716e-155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39975,0.18687364877837,0.0070166054983248,0.173121102001653,0.200626195555087,7.4858691422329e-153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,37666,0.0672750261447587,0.00252175796899136,0.0623323805255357,0.0722176717639818,9.11395794782536e-153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,40410,0.0784613381088411,0.00298868993533556,0.0726035058355834,0.0843191703820988,9.40967211284595e-149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,40327,-0.0612312311525424,0.00235619651656744,-0.0658493763250146,-0.0566130859800702,7.59895632929424e-146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,40511,0.0771609109496275,0.00299359045439874,0.0712934736590059,0.083028348240249,1.37135335645448e-143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,40140,0.0810285747414347,0.00314967394659998,0.0748552138060987,0.0872019356767706,5.42640953536683e-143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40406,0.0479138663492398,0.00186935001092379,0.0442499403278292,0.0515777923706505,5.04052059950798e-142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,40511,0.0904295826816941,0.00352908325767648,0.0835125794966482,0.09734658586674,5.77159229514992e-142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40039,0.12475428431988,0.00486722451355887,0.115214524273304,0.134294044366455,5.83388310124891e-142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40136,0.332151059182812,0.0129707713947442,0.306728347249113,0.357573771116511,1.00778824910504e-141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40037,0.187627992813716,0.00735852375432121,0.173205286255246,0.202050699372185,1.55085009844261e-140
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40307,0.0452683373585256,0.00178123813366956,0.0417771106165333,0.048759564100518,1.08963504539077e-139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40300,0.23107357203844,0.00918354210701548,0.21307382950869,0.249073314568191,5.07782680656017e-137
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40511,0.170987566570909,0.0067978210992056,0.157663837216466,0.184311295925352,5.75308658001592e-137
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,37666,0.250301163340319,0.00998529507651834,0.230729984990343,0.269872341690295,1.62874143686547e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,40367,0.061133107200081,0.00246166391086026,0.0563082459347949,0.0659579684653671,1.32677291761444e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,40511,0.0570285664603753,0.00229936865610256,0.0525218038944143,0.0615353290263363,2.72657122849954e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,40395,0.0740872400997027,0.00299019349628641,0.0682264608469813,0.079948019352424,5.17584815108758e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40039,0.0951429549716144,0.00383941483751275,0.0876177018900894,0.102668208053139,5.36962634595328e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40511,0.0705464129355454,0.0028506371074511,0.0649591642049412,0.0761336616661495,9.96920859276385e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40406,0.07464691423516,0.00302314649072034,0.0687215471133481,0.0805722813569719,3.91269565493722e-132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40223,-0.129216294158123,0.0052417070372786,-0.139490039951189,-0.118942548365057,1.08686317603903e-131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,40465,0.0721014745954458,0.00292794110584346,0.0663627100279926,0.077840239162899,1.86463158350275e-131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFH,Complement factor H,37296,0.0498629237523481,0.00202666361403186,0.0458906630688456,0.0538351844358505,1.19666303960408e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,40288,0.0866094844439545,0.00353749900149891,0.0796759864010167,0.0935429824868924,5.74073922968185e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40485,0.0449114655292721,0.00183572538480624,0.0413134437750519,0.0485094872834924,8.22081652734009e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40386,0.0493839080286525,0.00202639125948449,0.0454121811600629,0.0533556348972421,7.95612603183321e-129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40187,0.156278889936764,0.00642236731705128,0.143691049995343,0.168866729878184,2.02216912674255e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40058,0.0906091690901394,0.00372603824384325,0.0833061341322066,0.0979122040480722,3.05498536157857e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,40531,0.1122632625806,0.00463432613480645,0.103179983356379,0.121346541804821,2.34087893571605e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,40417,0.143140838867782,0.00591861543001808,0.131540352624947,0.154741325110618,6.10712395888203e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,40448,0.247035449568193,0.0102598915574856,0.226926062115522,0.267144837020865,7.34599284194891e-126
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,40442,0.0782037062958472,0.00325400308093759,0.0718258602572095,0.0845815523344848,2.08157332846558e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,40419,-0.0593421562288191,0.00247071846419497,-0.0641847644186412,-0.054499548038997,2.96350841969978e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,40327,0.0889604988936286,0.00373656624654415,0.081636829050402,0.0962841687368551,3.92661686527095e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40374,0.0620444377205098,0.00261081626174245,0.0569272378474946,0.067161637593525,1.05819560731306e-122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40511,0.0860002834394742,0.00362883483655296,0.0788877671598304,0.093112799719118,4.54502092017531e-122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,40328,0.172063411864009,0.00726222226652837,0.157829456221613,0.186297367506404,5.53170855858808e-122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFI,Complement factor I,38008,0.0418326125495337,0.00176475867082576,0.0383736855547152,0.0452915395443522,9.57282825699842e-122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,40367,0.0372663308258542,0.00157741181791168,0.0341746036627473,0.0403580579889611,2.59137719986179e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,40367,0.0698465948494843,0.00296618715620516,0.0640328680233222,0.0756603216756464,1.51633810908157e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40300,0.163161562517148,0.00694608682256842,0.149547232344914,0.176775892689382,5.77695775675516e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,40511,0.091769249462927,0.00391139214483458,0.0841029208590512,0.0994355780668028,1.02005961924717e-119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,40261,0.0794787369416019,0.00338996705727803,0.072834401509337,0.0861230723738669,1.60313241385041e-119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39975,0.126658783537541,0.00540768732634637,0.116059716377902,0.13725785069718,2.958104225433e-119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,39958,0.122279553267913,0.0052212897351853,0.11204582538695,0.132513281148876,3.15163678180368e-119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,37985,0.186535288932078,0.008010400157067,0.170834904624227,0.202235673239929,1.22642166008994e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,40300,0.187795882895492,0.00808752271051701,0.171944338382878,0.203647427408105,2.55142830566861e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40438,0.0625538282763275,0.00270410727253134,0.0572537780221661,0.0678538785304889,1.7557227941808e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40372,0.0808181800355691,0.00350042594710422,0.0739573451792449,0.0876790148918934,4.87553319794214e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,40336,0.0870757587380325,0.00378086427394448,0.0796652647611014,0.0944862527149637,1.77819813458718e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40531,0.0989921508995073,0.00430719396296753,0.0905500507320909,0.107434251066924,4.89280500238555e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,37637,0.0731713874179156,0.00318527916786289,0.0669282402489044,0.0794145345869269,1.56095597702465e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40336,0.0758054039476541,0.00330918831054431,0.0693193948589873,0.082291413036321,2.75858077949677e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40223,0.064380002416096,0.00281028197766835,0.0588718497398661,0.069888155092326,2.76851029823006e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37589,0.0775616212724533,0.00340433714866874,0.0708891204610626,0.0842341220838441,1.01491381960735e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39975,0.216693689899797,0.00954571576458508,0.19798408700121,0.235403292798383,2.94765015902367e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40275,0.0508871919471592,0.00225280788552045,0.0464716884915391,0.0553026954027793,3.21554725129796e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40531,-0.068573431387716,0.00303892103480411,-0.0745297166159321,-0.0626171461595,5.03005894061305e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,40354,0.0512137255999299,0.00227543139576184,0.0467538800642367,0.0556735711356231,1.86036520648309e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,40199,0.101311495138892,0.00452601635178971,0.0924405030893839,0.1101824871884,2.82098699412558e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,40466,0.0812943367051859,0.00363383820215656,0.0741720138289591,0.0884166595814128,3.49314956165487e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,39238,0.0785404260071816,0.00351083082938104,0.0716591975815948,0.0854216544327684,4.83514010396658e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,40006,0.0605003915045655,0.00271046172239472,0.0551878865286719,0.0658128964804592,1.16568264068187e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFP,Properdin,38008,0.0429561200841075,0.00192443700822214,0.0391842235479922,0.0467280166202229,2.03510171651459e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40327,0.0535157659641097,0.00240579279664743,0.0488004120826808,0.0582311198455387,5.65357802429752e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,37976,0.0535644388529512,0.00240730343566636,0.0488461241190451,0.0582827535868572,9.40668575235219e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37593,0.164881089810705,0.00742105297724137,0.150335825975312,0.179426353646098,2.15785254145426e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MENT,Protein MENT,37666,-0.0423676975328564,0.00191246764284894,-0.0461161341128403,-0.0386192609528725,8.40756170216755e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39975,0.113848747300919,0.0051508474409365,0.103753086316684,0.123944408285155,1.29893087189634e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40531,0.0418168711255029,0.00190314506273615,0.03808670680254,0.0455470354484657,1.87038987429028e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40223,0.142843625061905,0.00650100026258774,0.130101664547233,0.155585585576577,2.00034486362992e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,40485,0.0945447172916479,0.00430674976892555,0.0861034877445539,0.102985946838742,2.88560578793197e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,38008,-0.0534534587532216,0.00243180436461702,-0.058219795307871,-0.0486871221985722,2.98803286418836e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40374,0.0639470203287672,0.00291420304590014,0.058235182358803,0.0696588582987315,3.61820004934972e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37365,0.0617012463622215,0.00281418209546528,0.0561854494551095,0.0672170432693334,1.19990830258031e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,40354,0.114452896121353,0.00523617298701213,0.10418999706681,0.124715795175897,2.22756444571326e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,37985,0.132754512927849,0.00608637637104329,0.120825215240604,0.144683810615094,1.08630450548755e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40391,0.0991564032489609,0.00455611629032296,0.0902264153199279,0.108086391177994,1.65094174572105e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37937,0.0704884529168787,0.00323865500382937,0.0641406891093732,0.0768362167243843,2.97053040520209e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37145,-0.212148289285986,0.00976758700075843,-0.231292759807472,-0.193003818764499,9.824465859277e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40484,0.0543708387155879,0.00251305486527789,0.0494452511796432,0.0592964262515326,2.41840218492261e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,40354,0.0740670791863136,0.00342907009972283,0.0673461017908569,0.0807880565817704,5.25569300521283e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37666,0.0925777138139341,0.00428385619508812,0.0841813556715614,0.100974071956307,8.14712579000849e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39975,0.143424213762306,0.00665626164779419,0.13037794093263,0.156470486591983,1.714804896771e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37557,0.128961131323224,0.00599656244029145,0.117207868940253,0.140714393706195,7.52788138315238e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40531,0.0738662464591911,0.00344077631024927,0.0671223248911025,0.0806101680272797,8.05264091126438e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,40336,0.114779104199007,0.00534626336778907,0.10430042799814,0.125257780399873,8.17879949867905e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,40327,0.106369776663596,0.00497496265970972,0.0966188498505654,0.116120703476627,5.14204762140599e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37785,0.0488816429717858,0.00228463942910752,0.044403749690735,0.0533595362528365,6.93239742737178e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,40354,-0.0684989847436716,0.00320934330314243,-0.0747892976178307,-0.0622086718695124,1.11398695087692e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,40304,0.0583578100051301,0.00274064668514077,0.0529861425022542,0.063729477508006,3.18959145894137e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37896,0.0506468175968177,0.00237794869380273,0.0459860381569644,0.0553075970366711,5.02663782129713e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,40336,0.0746705799605894,0.00351218697441982,0.0677866934907266,0.0815544664304523,6.28535316250171e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,40336,0.0987403107248125,0.00466552285410775,0.0895958859307613,0.107884735518864,4.63037178494608e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37666,0.0790511452690052,0.00374251850614998,0.0717158089969512,0.0863864815410591,2.00062042545784e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40352,0.0521177166636021,0.00247196968738941,0.0472726560763189,0.0569627772508854,2.41469694993649e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40272,0.193276987235419,0.00918567911745454,0.175273056165208,0.21128091830563,5.85042136708178e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37896,0.258450538654637,0.0123108142680536,0.234321342689252,0.282579734620022,2.60582542699485e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40300,0.142307437966706,0.00678862182477842,0.129001739190141,0.155613136743272,2.90333790905373e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37937,0.0714376837409734,0.00341080164530106,0.0647525125161833,0.0781228549657635,7.02383120549948e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37915,0.153099095084402,0.00733156975355715,0.13872921836743,0.167468971801374,2.5057360307448e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40448,0.0769461093593901,0.00369422194753355,0.0697054343422243,0.0841867843765558,4.32803284429461e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,40466,0.0411015427882825,0.00197339689269972,0.0372336848785911,0.044969400697974,4.39910493514249e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39882,0.0338743435796341,0.00162798865900401,0.0306834858079862,0.0370652013512819,7.40217724201305e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40511,0.0696778988616456,0.00336024493008923,0.0630918187986707,0.0762639789246205,2.81244003564831e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,40367,0.0460396980630199,0.00222439405320232,0.0416798857187434,0.0503995104072965,6.2599379320022e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40497,0.0689935429169977,0.00333534305037405,0.0624562705382645,0.0755308152957308,7.80548622939695e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,40429,0.0867613971212765,0.00419659548665998,0.0785360699674229,0.09498672427513,9.93316963577374e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37830,0.060104631827607,0.00290369714364331,0.0544133854260661,0.0657958782291479,1.02591915267729e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,40198,0.0536450906146294,0.00259558460431851,0.0485577447901651,0.0587324364390936,1.17730068987566e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40417,0.0518419196235255,0.00250979674801061,0.0469227179974247,0.0567611212496263,1.44307524027951e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,40327,0.0507654253359091,0.00246114774132074,0.0459415757629204,0.0555892749088978,2.63449956217135e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40039,0.153518441348632,0.00745706752143356,0.138902589006622,0.168134293690642,6.16661402022913e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39975,0.12212709609992,0.00593368634746241,0.110497070858894,0.133757121340946,6.8939924083449e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,40336,0.0965100812402925,0.00470956540369481,0.0872793330490506,0.105740829431534,3.90374066314888e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,37955,0.0834094944579657,0.00406690330239244,0.0754383639852765,0.0913806249306549,4.46805697777787e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,37341,-0.0804482942076706,0.00392933398956475,-0.0881497888272175,-0.0727467995881237,1.05356817056687e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40300,0.0796452165713745,0.00390166360683327,0.0719979559019813,0.0872924772407678,1.91103441966992e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,40288,0.0852032692777869,0.00417762710819504,0.0770151201457246,0.0933914184098492,2.74158249769493e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40300,0.122017343646224,0.00599272722314176,0.110271598288866,0.133763089003582,5.4081515341554e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40223,0.0985661852044326,0.00484111394145443,0.0890776018791819,0.108054768529683,5.55219653303637e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,40223,0.0619893504127779,0.00306321850339574,0.0559854421461222,0.0679932586794335,6.43430020196798e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,40354,0.0600576683568065,0.00296945748485482,0.054237531686491,0.0658778050271219,7.9133794477413e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40531,0.0509054989221479,0.00251999241372108,0.0459663137912546,0.0558446840530412,1.24792186389536e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37895,0.1212155864232,0.00599793245812597,0.109459638805274,0.132971534041127,1.71295630518825e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40398,-0.0605384416592258,0.00299996650296423,-0.0664183760050357,-0.0546585073134159,1.92688822617887e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,37593,0.148642573586841,0.00736497692517748,0.134207218813494,0.163077928360189,3.13073717113056e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,40300,0.136490360637768,0.00678004960566805,0.123201463410658,0.149779257864877,5.09158535979715e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40417,0.0478209680141929,0.00238799426256217,0.0431404992595711,0.0525014367688148,3.9733830270471e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLN,Promotilin,40336,0.156123794225147,0.00781260394510405,0.140811090492743,0.171436497957551,9.14925193997714e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,40336,0.108290509314844,0.00542002703035109,0.0976672563353554,0.118913762294332,9.87001260627241e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40336,-0.0605258222776878,0.00303076546134721,-0.0664661225819283,-0.0545855219734472,1.18190213169225e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37810,0.0546679755675826,0.00273454995618035,0.0493082576534692,0.0600276934816961,1.24047020333104e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,40511,0.0619499167582147,0.00310267322927737,0.055868677228831,0.0680311562875983,1.24079272703855e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39975,0.144882623513741,0.00726005088168028,0.130652923785648,0.159112323241835,1.65418858300236e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,40427,0.121357443381358,0.00608330429656485,0.109434166960091,0.133280719802625,1.76355876166707e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,40300,0.0898321891060399,0.00450342548273081,0.0810054751598875,0.0986589030521922,1.8600227813687e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37658,0.0803239078297075,0.00402221567097139,0.0724403651146036,0.0882074505448114,1.94849086373917e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37896,0.101809891325318,0.00510548741977177,0.0918031359825653,0.111816646668071,3.2384058020054e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40466,0.231803606133432,0.0116401479147708,0.208988916220481,0.254618296046383,3.47706562932657e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40466,0.0607870989077434,0.00306177989027878,0.0547860103227969,0.0667881874926898,1.1309497423069e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37666,0.0661735696533731,0.00332895272519654,0.0596488223119878,0.0726983169947583,1.15513195773507e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OCLN,Occludin,37955,0.0765366303227515,0.00385187578358646,0.068986953786922,0.084086306858581,1.27434519897265e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,40039,0.134013667462985,0.00675147834813233,0.120780769900646,0.147246565025324,1.30353947394771e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,37666,0.0794788343533026,0.00400952685902029,0.0716201617096229,0.0873375069969824,3.38896226305624e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,40340,0.0542227700015399,0.00274036228266142,0.0488516599275235,0.0595938800755563,4.20847603837361e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40448,0.0484858161858714,0.00245428074233821,0.0436754259308886,0.0532962064408543,7.56163637261261e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37895,0.139231337734402,0.00704588153881094,0.125421409918332,0.153041265550471,1.06381507702379e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40336,0.0952384126226436,0.00482719487370411,0.0857771106701835,0.104699714575104,1.27149540486334e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,40451,0.101842104996514,0.00517565139241993,0.0916978282673712,0.111986381725657,3.43519450477499e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,40304,0.0926557644661527,0.00471268096005537,0.0834189097844442,0.101892619147861,4.79361890298868e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,37666,0.0982544102348105,0.00500029862058341,0.088453824938467,0.108054995531154,9.38324115857426e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40336,0.10685177510918,0.00546167195393581,0.0961468980794655,0.117556652138894,3.07278763817797e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40336,0.0932775532814115,0.0047695262499271,0.0839292818315544,0.102625824731269,3.50997167957684e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40300,0.0715567270075852,0.00366504958997187,0.0643732298112403,0.07874022420393,6.62043703269357e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37896,0.0517051961349423,0.00264724906046431,0.0465165879764322,0.0568938042934523,8.53128475358073e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40300,0.0557056660964621,0.00285547923654207,0.0501089267928396,0.0613024054000845,8.94332703982188e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40406,0.156694357562895,0.00803548311502257,0.14094481065745,0.172443904468339,1.02744901013685e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,40336,0.0577672544744028,0.00296444959320792,0.0519569332717153,0.0635775756770903,1.34583326441437e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,37985,0.157610155495051,0.00808061682858224,0.14177214651103,0.173448164479072,1.4006056001448e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37623,0.145296315024816,0.00744901636751978,0.130696242944478,0.159896387105155,1.48351029389585e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,40354,0.0605716232917495,0.00311318476012788,0.0544697811618988,0.0666734654216001,2.38729045872838e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40037,0.157381408750567,0.00809855675574702,0.141508237509303,0.173254579991831,3.88330178074549e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,40406,0.0440821146768802,0.00226989347012313,0.0396331234754389,0.0485311058783216,4.7161953089683e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40466,0.112098942788408,0.00577653050867185,0.100776942991411,0.123420942585404,6.15341718696949e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,40466,0.101900611443059,0.00525257618405974,0.0916055621223022,0.112195660763816,6.87173397238876e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,40336,0.0818550472681507,0.00422498101152423,0.0735740844855632,0.0901360100507382,1.14715269171953e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37937,0.0545547799629929,0.00281396015891211,0.0490394180515252,0.0600701418744607,1.31324167838472e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EZR,Ezrin,40466,0.0403121758325493,0.00208451002146508,0.0362265361904778,0.0443978154746209,2.19495564369534e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40406,0.0566937911315298,0.00293263171532945,0.0509458329694841,0.0624417492935755,2.52006002010473e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,40286,0.0699597175497727,0.00362447592416372,0.0628557447384118,0.0770636903611336,4.52081295536161e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,37993,0.0476573891872996,0.00246692460764188,0.0428222169563215,0.0524925614182777,4.75021814952454e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37985,0.0482017291007451,0.00249594812472781,0.0433096707762786,0.0530937874252117,5.38243715628235e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40300,0.208150366667017,0.0107977787148719,0.186986720385868,0.229314012948166,7.22031835328131e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40466,0.139429687022189,0.00723422178819662,0.125250612317324,0.153608761727054,7.54876910055533e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37623,0.123074627220461,0.00638586903830795,0.110558323905378,0.135590930535545,1.20104182903966e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40198,0.150304764540484,0.00783983307958737,0.134938691704493,0.165670837376475,5.31038487798535e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37895,0.0863070214522444,0.00452353669123927,0.0774408895374154,0.0951731533670734,4.26019939757127e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,40336,0.0894369163148193,0.00469595189921164,0.0802328505923645,0.0986409820372741,5.56440792798749e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FST,Follistatin,40391,0.087330999117339,0.00458842533063427,0.0783376854692958,0.0963243127653822,6.99673046153731e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,40223,0.112342269712569,0.00590534144819126,0.100767800474114,0.123916738951024,8.46264324014087e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,40511,0.0504661788162811,0.00265409477599616,0.0452641530553287,0.0556682045772336,9.72085446351672e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40162,0.0471784701814213,0.00248360399909738,0.0423106063431905,0.0520463340196522,1.43366174458941e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37814,0.0455114582779166,0.00239928748470177,0.0408088548079011,0.0502140617479321,3.38467915823544e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40306,0.0316543501352387,0.00167440872092438,0.0283725090422269,0.0349361912282504,7.6609765946883e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,37776,0.040021688486748,0.00211796302248055,0.0358704809626861,0.0441728960108098,1.30004900672461e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,40300,0.130794329022921,0.00693250906522928,0.117206611255072,0.144382046790771,1.54931000680215e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37567,0.19879300678247,0.0105398848990185,0.178134832380393,0.219451181184546,2.58516184506848e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37623,0.0952265261262124,0.0050534128947365,0.0853218368525288,0.105131215399896,3.50133764948447e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,40198,0.086584277574244,0.00460074098164467,0.0775668252502204,0.0956017298982675,3.75150360639504e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,37985,0.0716333808590226,0.0038090445214179,0.0641676535970435,0.0790991081210017,6.60426387119614e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39881,0.0909415038418425,0.00484106861032405,0.0814530093656074,0.100429998318078,7.33632998995787e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40354,0.0514735589818165,0.00274180459279289,0.0460996219799425,0.0568474959836906,8.60112825728008e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,40412,0.110511058827261,0.00589893683050142,0.0989491426394779,0.122072975015043,1.76827604855931e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40429,0.119599344513614,0.00638646789131598,0.107081867446635,0.132116821580594,2.00962065241636e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40336,0.0708440264084915,0.00378543431345163,0.0634245751541263,0.0782634776628567,2.53728101706368e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40229,0.0488394374548211,0.00261104509077488,0.0437217890769023,0.0539570858327399,3.08560010294357e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTR,Transthyretin,37866,0.0422663703248976,0.00226012907726281,0.0378365173334625,0.0466962233163327,4.63712870639582e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40223,0.061858930653339,0.00331180793184039,0.0553677871069318,0.0683500741997461,5.03311512962727e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,40369,0.0769731468672499,0.00413375025862227,0.0688709963603502,0.0850752973741495,1.42066741056538e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40511,0.0918119872127204,0.00493591314821232,0.0821375974422243,0.101486376983217,2.00852856422097e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,40009,0.0653506439430812,0.0035174123648058,0.0584565157080618,0.0722447721781005,3.16022145100012e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,39975,0.120744407171945,0.00649989691139227,0.108004609225617,0.133484205118274,3.34083118069339e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40466,0.130047541605783,0.00701098560359788,0.116306009822731,0.143789073388835,5.18268079616533e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,37666,0.102689864449665,0.00553015023285643,0.0918507699932668,0.113528958906064,5.28361809794947e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37955,0.0939820336836096,0.00507246657669349,0.0840399991932903,0.103924068173929,1.06487217161501e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,37993,0.18357365063983,0.00991951152336275,0.164131408054039,0.203015893225621,1.56414329903158e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40325,0.16835665869828,0.00911442995817624,0.150492375980255,0.186220941416306,2.16010223726253e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELN,Elastin,37985,0.0573966802482892,0.00310604610423118,0.0513088298839961,0.0634845306125824,2.56628775755296e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,37570,0.0447151409019022,0.00242183967533708,0.0399683351382415,0.0494619466655629,3.64225470149708e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40492,-0.103369446823982,0.00560711668629014,-0.11435939552911,-0.092379498118853,4.07399611057944e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,37593,0.149459868957399,0.0080996246822227,0.133584604580243,0.165335133334556,4.3937516462979e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,40290,-0.103921879909586,0.00564041362145962,-0.114977090607647,-0.0928666692115252,5.07383076481369e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,40484,0.0732228809400896,0.00399321493559128,0.0653961796663307,0.0810495822138486,2.41852499559573e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,40460,0.0427025868613806,0.00233155630953884,0.0381327364946845,0.0472724372280767,3.58805378428734e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,40484,0.178236570185089,0.00973196104283402,0.159161926541134,0.197311213829043,3.61107526356825e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,40336,0.108153353357126,0.0059068117558969,0.0965760023155679,0.119730704398684,3.98732365517307e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,40327,0.0402708142168466,0.0022004963467792,0.0359578413771594,0.0445837870565338,4.7050311685978e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,37623,0.0986234992857101,0.00539031169917613,0.0880584883553248,0.109188510216095,7.24482207431406e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,40325,0.0467553050382081,0.00255821464478847,0.0417412043344227,0.0517694057419934,7.27525997406141e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37985,0.0900784179322074,0.00492523923500106,0.0804249490316053,0.0997318868328095,7.8104055722009e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,40327,0.0564562087315419,0.00308995908385813,0.05039988892718,0.0625125285359038,8.05406809447053e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40466,-0.035161742016445,0.0019258186318831,-0.0389363465349358,-0.0313871374979541,9.98099569505954e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40511,0.0601579938227715,0.00329736150067598,0.0536951652814465,0.0666208223640964,1.27214393378525e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39956,0.0430578686534556,0.00236009764793836,0.0384320772634965,0.0476836600434148,1.35566382283853e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40327,0.0466562765132724,0.00255861911120838,0.041641383055304,0.0516711699712408,1.533564719368e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,40466,0.0936630510090678,0.00514320142387938,0.0835823762182643,0.103743725799871,2.31827008815853e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,40211,0.0606054420191532,0.00332842436430623,0.054081730265113,0.0671291537731934,2.49525992798132e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,40092,0.0671056192440154,0.00369589532522789,0.0598616644065687,0.074349574081462,6.35891769749227e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40223,0.0921755958969666,0.00508302705469324,0.0822128628697679,0.102138328924165,9.41411900325629e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_E,,40336,0.0461197988351285,0.00254524543491528,0.0411311177826945,0.0511084798875624,1.19405517217295e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37896,0.165578116054572,0.00914028456074477,0.147663158315512,0.183493073793632,1.75566979374309e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40300,0.0701872999515988,0.0038789188101866,0.062584619083633,0.0777899808195645,1.88438900576458e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,37623,0.103112216690355,0.00569863595364661,0.0919428902212077,0.114281543159502,2.65265979133107e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40037,0.0779670064927152,0.00432241717420471,0.069495068831274,0.0864389441541564,5.30373781311875e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,40306,0.145197234504231,0.0080763718816471,0.129367545616202,0.161026923392259,1.48602824037659e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,37709,0.204775093653667,0.0114179094068826,0.182395991216177,0.227154196091157,4.37464236632434e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40037,0.0544487021946773,0.00303958287672716,0.048491119756292,0.0604062846330625,4.79231085766816e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40300,0.0547348084689016,0.00305610981360632,0.0487448332342332,0.0607247837035699,4.94050820661404e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOST,Sclerostin,40325,0.0611639688287614,0.00341950845912364,0.054461732248879,0.0678662054086437,7.411714300212e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40409,0.0919066728237935,0.00514152502418968,0.0818292837763817,0.101984061871205,8.98187701433282e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,40300,0.108361548432553,0.00607189786731367,0.096460628612618,0.120262468252488,1.51006575069119e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40149,0.0554472176365095,0.00311390198154863,0.0493439697526742,0.0615504655203448,3.09365262806063e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,40327,0.0374404085803222,0.00210289475336603,0.0333187348637248,0.0415620822969197,3.15482313546512e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,40531,0.0676496382189461,0.00380293208214464,0.0601958913379426,0.0751033850999496,4.05154145191633e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40278,0.0506946556087575,0.00285188079405193,0.0451049692524157,0.0562843419650993,5.20620766880295e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40300,0.0932859327853604,0.005251049285374,0.0829938761860274,0.103577989384693,6.26002124733354e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,40300,0.0519244461015976,0.00292387475842985,0.0461936515750751,0.0576552406281201,7.00294110275729e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,40223,0.0759965017419366,0.00429184607317413,0.0675844834385153,0.0844085200453579,1.7352710659613e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40354,0.0553488517619692,0.00312636411288303,0.0492211781007185,0.06147652542322,1.81425320031787e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37855,0.169824592826541,0.00960303627687873,0.151002641723858,0.188646543929223,3.36851360069716e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40327,0.0357916631221496,0.0020284114308032,0.0318159767177754,0.0397673495265239,5.05092470502486e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39530,0.0594312839937548,0.00337066898735894,0.0528247727785312,0.0660377952089783,6.88112156876919e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40484,0.203035976172876,0.0115245260537125,0.180447905107599,0.225624047238152,8.0127605880702e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40300,0.132880915609586,0.00754898231055259,0.118084910280903,0.147676920938269,1.06135086700169e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,40300,0.083288958002383,0.00473834039598737,0.0740018108262477,0.0925761051785182,1.63118352651456e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,37666,0.0412393301098853,0.002344749060832,0.0366436219506545,0.045835038269116,1.8325837749557e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C3,Complement C3,37355,0.0733618233054305,0.00417620628339036,0.0651764589899854,0.0815471876208756,2.76117689175791e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,40327,0.0520388286917132,0.00296629207639985,0.0462248962219695,0.0578527611614569,2.9418778598249e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37982,0.0345486265261107,0.0019703040947229,0.0306868305004538,0.0384104225517676,4.40291032876302e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40497,0.0819410826719797,0.0046952506334348,0.0727383914304475,0.0911437739135119,1.40053576934951e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39975,0.0813796172187105,0.00467289109251964,0.072220750677372,0.090538483760049,2.75445486886485e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40037,0.112326061938085,0.00645073460727844,0.0996826221078191,0.124969501768351,2.85115359030363e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40511,0.11611657303782,0.00667483397369375,0.10303389844938,0.12919924762626,3.63944889432733e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,40300,0.0845618506231662,0.0048621900159176,0.0750319581919677,0.0940917430543647,4.00172739032735e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,40431,0.0613718681849644,0.00353540902255147,0.0544424665007636,0.0683012698691653,6.90012221743363e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37937,0.164903459298286,0.00950178109230765,0.146279968357363,0.183526950239209,9.58676515942927e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXN,Paxillin,39956,0.0790797240579679,0.00457222114919517,0.0701181706055454,0.0880412775103904,2.12712507637349e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COCH,Cochlin,37985,0.0714249071916583,0.00412680677271381,0.0633363659171393,0.0795134484661774,2.1366887975904e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELP,P-selectin,40398,0.0879074811917951,0.00509937638767959,0.0779127034719431,0.0979022589116471,5.37558897747648e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40466,0.10203847609327,0.00591924125119299,0.0904367632409317,0.113640188945608,5.38384365639872e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,37623,0.083107275251196,0.00481968642148363,0.0736606898650881,0.0925538606373039,6.63794345938585e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40511,0.0826436688230312,0.0047996315673105,0.0732363909511026,0.0920509466949597,7.4911749655758e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37955,0.0964350880020361,0.00560022423475917,0.0854586485019081,0.107411527502164,9.47724582894586e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40268,0.0411501820980261,0.00239244030582588,0.0364609990986074,0.0458393650974448,1.04934589413208e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37917,0.127589117076177,0.00742592781025232,0.113034298568082,0.142143935584271,1.81740559861872e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37985,0.099195419069032,0.00577441753216173,0.087877560705995,0.110513277432069,1.90121901202414e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,40398,0.0761645689563014,0.00444119062787009,0.067459835325676,0.0848693025869268,2.43902407456227e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,40327,0.115186292608848,0.00671656868228636,0.102021817991566,0.128350767226129,2.45398481679832e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40300,0.0910727291404603,0.00531403474383004,0.0806572210425534,0.101488237238367,2.9829602830339e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37895,0.0876928820618448,0.00511481646582835,0.0776678417888213,0.0977179223348684,3.3819151117223e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,40406,0.0616702175478633,0.00360060051193432,0.054613040544472,0.0687273945512546,3.52348888519198e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37666,0.112328210849497,0.00656212487798977,0.0994664460886366,0.125189975610356,5.49217144117434e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37955,0.0718277001430582,0.00419788789556448,0.0635998398677518,0.0800555604183646,5.99349181472351e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37593,0.119903321664846,0.007009451099805,0.106164797509228,0.133641845820463,6.74491587756375e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40511,0.15079325020667,0.00883713351132984,0.133472468524464,0.168114031888877,1.02964463493564e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,40406,0.0872549368403009,0.0051165827842649,0.0772264345831417,0.0972834390974601,1.23336027380364e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40484,0.0557580017813173,0.00327437995325339,0.0493402170729406,0.0621757864896939,1.85858314383635e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,40300,0.0453879300085233,0.00266688445562109,0.040160836475506,0.0506150235415406,2.21196358525462e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,37912,0.0446152497559633,0.00261964402901471,0.0394807474590944,0.0497497520528321,2.28030360753664e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,40417,0.0712349212116014,0.00418677187079841,0.0630288483448365,0.0794409940783662,2.37467623103226e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,39956,0.0685788095753346,0.00403219355257375,0.0606757102122901,0.0764819089383792,2.74987817111375e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39975,0.0745605081959642,0.00438672461569751,0.0659625279491971,0.0831584884427314,3.29889135331344e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,40406,0.0838803735757945,0.00493588316849475,0.0742060425655448,0.0935547045860442,3.33927406686622e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,40223,0.0612990169604991,0.0036087214092553,0.0542259229983588,0.0683721109226395,3.85202021084372e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,40328,0.135910736539521,0.00800563359693853,0.120219694689521,0.15160177838952,4.47474114138792e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37937,0.0701765529409148,0.00413040268605969,0.0620809636762378,0.0782721422055917,4.49559848983554e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40497,0.0762327179106912,0.00450036255825105,0.0674120072965191,0.0850534285248632,8.28344907551225e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,37937,0.0554889183213755,0.00327423184947755,0.0490714238963996,0.0619064127463515,9.22061493488289e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37988,0.0291559195680814,0.0017208605571512,0.025783032876065,0.0325288062600977,9.88489646241053e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,37666,0.0464370725643187,0.00274113098241997,0.0410644558387755,0.0518096892898618,1.05611085297272e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40406,0.0377128258127968,0.00223359646252395,0.0333349767462498,0.0420906748793437,2.08329919595377e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,40223,0.132954768437506,0.00787974687125063,0.117510464569855,0.148399072305157,2.55422277064356e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,40398,0.149243572055662,0.00886494494633611,0.131868279960843,0.166618864150481,4.71494020101193e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40104,0.0308851777378707,0.00183569019412331,0.027287224957389,0.0344831305183524,5.7365081697511e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37623,0.145392163062902,0.00864775692941178,0.128442559481255,0.162341766644549,8.87991791918615e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,37054,0.0365268143267661,0.00217240647098468,0.0322688976436362,0.0407847310098961,9.2960161781351e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,40336,0.122637582156111,0.00730522521604131,0.10831934073267,0.136955823579552,1.04285032482547e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37955,0.169805464888517,0.0101081848473601,0.149993422587691,0.189617507189343,1.0770230394725e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,40484,0.097588854050866,0.00581450059433472,0.0861924328859699,0.108985275215762,1.1007306905694e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40345,0.0733134081841127,0.00437156371336471,0.0647451433059179,0.0818816730623075,1.38358424165485e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,40300,0.168551525290407,0.0100507421873038,0.148852070603292,0.188250979977523,1.39911972138033e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,37961,0.066283713019387,0.0039529249994477,0.0585359800204695,0.0740314460183045,1.78142226706861e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40286,0.0423033458007805,0.00252656363071869,0.0373512810845719,0.0472554105169892,2.17464717103294e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,39955,0.0584030589392663,0.00349016081580115,0.051562343740296,0.0652437741382365,2.62388359699758e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37896,0.134984946324166,0.00807062514934958,0.119166521031441,0.150803371616892,3.62934278353181e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,40187,0.0811910714844398,0.00486868856964399,0.0716484418879376,0.090733701080942,6.63813627305223e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,37873,0.0618163989539889,0.00370625648388144,0.0545521362455813,0.0690806616623965,7.81122561401712e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37623,0.0462486091001993,0.0027727991365613,0.0408139227925391,0.0516832954078594,7.96290771930801e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,40406,0.0770010404089492,0.00462226527140645,0.0679414004769926,0.0860606803409058,8.69752244834796e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDK,Midkine,40347,0.0746650361537515,0.00448599107609432,0.0658724936446067,0.0834575786628964,1.11177544433634e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYY,Peptide YY,37557,0.140280724027512,0.0084319166042126,0.123754167483255,0.156807280571768,1.60893499827216e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40336,0.0406006895852192,0.00244456902770374,0.0358093342909198,0.0453920448795185,1.99231977034448e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37985,0.147561315030658,0.00889182622172817,0.130133335636071,0.164989294425245,3.04011575192609e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,40354,0.0938606461713139,0.00566412848330092,0.0827589543440441,0.104962337998584,3.67319120211356e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,37985,0.10959096776066,0.00660918212198724,0.096636970801565,0.122544964719755,3.79177535339738e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40327,-0.0595649427163009,0.00359938624258108,-0.0666197397517599,-0.052510145680842,5.30924895608715e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,37926,0.0945736146691894,0.00571068914437208,0.0833806639462201,0.105766565392159,5.35553451928805e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40298,0.0708628810356765,0.00428847301607346,0.0624574739241725,0.0792682881471805,7.94842702196303e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37937,0.0912498683252728,0.00552686738636652,0.0804172082479944,0.102082528402551,1.21778723030413e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,40450,0.0639412238103201,0.00387712080540696,0.0563420670317225,0.0715403805889178,1.3262105061421e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40531,0.0500519186367569,0.00303709407306682,0.0440992142535459,0.0560046230199678,1.59603970987215e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40452,0.0381395867429912,0.00231434882127901,0.0336034630532843,0.042675710432698,1.62021427173666e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37985,0.112455176890804,0.00682448925716584,0.0990791779467586,0.125831175834849,2.03881621531586e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,40283,0.0436855958395667,0.00265360891070211,0.0384845223745905,0.0488866693045428,2.15865055489693e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40466,0.0650705793960267,0.00395310866663069,0.0573224864094306,0.0728186723826229,2.20463113916041e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEP,Leptin,40354,0.0931206234291694,0.00566065103599151,0.082025747398626,0.104215499459713,2.61810036536629e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40304,0.0568714332505249,0.00345720579556296,0.0500953098912215,0.0636475566098283,2.64458430631341e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,40484,0.0819230963799326,0.00499157631266854,0.0721396068071023,0.091706585952763,4.82368010135653e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37982,0.0377114774666218,0.00229727536864122,0.033208817744085,0.0422141371891585,5.60241260437462e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,40354,0.0352429296862202,0.00214906092528736,0.031030770272657,0.0394550890997834,6.0128633266417e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40250,0.0649700339468117,0.00396273472882274,0.0572030738783191,0.0727369940153043,6.45942139854201e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,37937,0.134664846835279,0.00821088615659469,0.118571509968354,0.150758183702205,7.16591129919608e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40466,0.0775999782895054,0.0047361846815572,0.0683170563136533,0.0868829002653576,7.57183512526759e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37666,0.121016863088089,0.00738178221963986,0.106548569937595,0.135485156238583,8.21257463072278e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40327,0.0756767662153143,0.00462064476908884,0.0666203024679002,0.0847332299627284,8.49637496377736e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,40187,0.116270850329425,0.00710227857829524,0.102350384315966,0.130191316342883,9.61580053748627e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,40352,0.0370660639897276,0.00226491745807479,0.032626825771901,0.0415053022075542,1.04072524577562e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,37623,0.0823571663543921,0.00503214866897666,0.0724941549631979,0.0922201777455864,1.29068509951022e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40327,0.0526218153588833,0.00321819051888561,0.0463141619418675,0.0589294687758991,1.30566115855185e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40300,0.0469646237204126,0.00287229943119032,0.0413349168352795,0.0525943306055456,1.3184575659988e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40327,0.0764252705463985,0.00467779481986508,0.0672567926994629,0.085593748393334,1.62294587190596e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37603,0.0820653986730119,0.00501889136365749,0.0722283716002432,0.0919024257457806,1.64381710233647e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39956,0.0725952701274611,0.00444401776439091,0.063884995309255,0.0813055449456673,1.7316282580019e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37937,0.058253603854724,0.00356409293152045,0.0512679817089439,0.0652392260005041,1.77200937363425e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBIN,Erbin,40300,0.148016572159808,0.00907657269562082,0.130226489676391,0.165806654643225,2.65130893244552e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39956,0.113741074446747,0.00697555406244469,0.100068988484355,0.127413160409138,2.79980484825321e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,40300,0.0423013054229801,0.00259488012007332,0.0372153403876364,0.0473872704583238,2.90633160303966e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,37931,0.109160293383518,0.0066942904224774,0.0960394841554628,0.122281102611574,3.27055799245587e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFM,Afamin,38008,0.026969338986325,0.00165488075229365,0.0237257727118295,0.0302129052608206,3.78931719367631e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37896,0.0768662167096212,0.00471982072179314,0.0676153680949066,0.0861170653243357,4.56962635668268e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,37955,0.148883378986843,0.00914788273850495,0.130953528819373,0.166813229154312,5.39069310536144e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,37896,0.159976947067679,0.00983025884848348,0.140709639724652,0.179244254410707,5.52999858763167e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40417,0.189448780452961,0.0116793364315239,0.166557281047175,0.212340279858748,1.05818447267826e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40531,0.0968696496915326,0.00597268524617269,0.0851631866090341,0.108576112774031,1.08568020348747e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,40336,0.0536262093810585,0.00330893274797055,0.0471407011950362,0.0601117175670808,1.33885332827259e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37709,0.160803087451002,0.00991853616669468,0.14136275656428,0.180243418337723,1.50620486490798e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,40353,0.0825785994910992,0.00509941739551367,0.0725837413958924,0.092573457586306,1.64029498293952e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,40466,0.042715832529632,0.00263832859543457,0.0375447084825802,0.0478869565766837,1.71463878071934e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,40448,0.0743921591249982,0.00459539380035449,0.0653851872763034,0.083399130973693,1.77448152490787e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40466,0.137761429439768,0.00851013217200688,0.121081570382634,0.154441288496901,1.78625658427651e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,40511,0.0587095305854783,0.00362754068662593,0.0515995508396915,0.0658195103312652,1.88471132928638e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,40417,0.149510421610723,0.00924821893951269,0.131383912489278,0.167636930732168,2.52774521656111e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,37666,0.155163173454059,0.00959519956494843,0.13635658230676,0.173969764601358,2.92870346733437e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39975,0.0514671074332829,0.00318698288269298,0.0452206209832047,0.0577135938833611,3.42916072635095e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39848,0.126903184367139,0.0078585550744478,0.111500416421221,0.142305952313057,3.5015272403013e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40223,0.0584773632478009,0.00362309366499837,0.0513760996644041,0.0655786268311977,3.89092669928273e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,40341,0.0739787108880317,0.00458399479855094,0.0649940810828719,0.0829633406931916,3.96603812085062e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37955,0.12029945965579,0.00746110785289473,0.105675688264116,0.134923231047464,6.05426057500327e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40406,0.135776180591641,0.00843354586738271,0.119246430691571,0.152305930491711,7.34130484165101e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,40300,0.129219179740879,0.00803328363405395,0.113473943818134,0.144964415663625,9.24395004352211e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,40406,0.0821000584723792,0.00510746052250026,0.0720894358482787,0.0921106810964797,1.09222167082725e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40223,0.0842472132882115,0.00524193822279787,0.0739730143715277,0.0945214122048953,1.15504024441376e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,39956,0.050388289439563,0.00313652374158811,0.0442407029060503,0.0565358759730757,1.30903391517618e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,40304,0.163282916507826,0.0101692782218258,0.143351131193048,0.183214701822605,1.46407186048512e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MME,Neprilysin,40300,0.115667970501746,0.00721023722365148,0.101535905543389,0.129800035460103,1.83720635845264e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,37982,0.0369669673757448,0.00230475129967892,0.0324496548283741,0.0414842799231155,2.28771941401775e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37914,0.0851683045547071,0.00531043065419066,0.0747598604724934,0.0955767486369208,2.35805453894543e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,37666,0.0771948662980923,0.00481986641147726,0.0677479281315969,0.0866418044645877,3.41075799554002e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,40511,0.132862464619129,0.00830525433459511,0.116584166123323,0.149140763114936,3.68268165460436e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37926,0.153784186659793,0.00961880822805678,0.134931322532802,0.172637050786784,5.18890573838162e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37557,0.0902409850841841,0.00564499510608576,0.079176794676256,0.101305175492112,5.52413437824439e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37623,0.0760222243181238,0.00475817184738831,0.0666962074972427,0.0853482411390049,6.30839838198992e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37896,0.108313676908864,0.00678351498797155,0.0950179875324393,0.121609366285288,7.20357583014878e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40223,0.0636068154776603,0.00398660114313593,0.0557930772371139,0.0714205537182067,7.30700857885097e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37985,0.0911790057780598,0.00572165422067265,0.0799645635055415,0.102393448050578,1.17109844968325e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40223,0.133302612759978,0.0083794069443669,0.116878975149019,0.149726250370937,1.52616650027393e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37593,0.125364375254774,0.00787721946209281,0.109925025109072,0.140803725400476,1.68520457619068e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39975,0.0984163299958543,0.0061972740998816,0.0862696727600864,0.110562987231622,2.39856224086945e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,40285,0.0615994113427755,0.00387926308948285,0.0539960556873891,0.0692027669981618,2.40496335790923e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,40484,0.0513130108129927,0.00323196238780021,0.0449783645329043,0.0576476570930811,2.46742921896686e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40484,0.0886690233155525,0.00558556582837579,0.077721314291936,0.0996167323391691,2.5486316551377e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,37896,0.0832057588758067,0.00523793584737485,0.072939404614952,0.0934721131366614,2.60732346973291e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40465,0.0858984399391004,0.00541518876120061,0.0752846699671472,0.0965122099110536,3.0882297547946e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37896,0.148178243603026,0.00933606985058714,0.129879546695875,0.166476940510177,3.22726384217436e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40511,0.0640515561769686,0.00403885273508157,0.0561354048162087,0.0719677075377285,3.26109687566723e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40223,0.0760676613436551,0.00480482346808173,0.0666502073462149,0.0854851153410953,5.09234958643338e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40336,0.0461120694843517,0.00291391086642951,0.0404008041861498,0.0518233347825535,5.61709313914352e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40391,-0.118789270914412,0.00751625744281079,-0.133521135502321,-0.104057406326503,7.7121975268177e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40466,0.0930606639264609,0.00589546962147072,0.0815055434683783,0.104615784384544,1.03606663927912e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,40466,0.0475923125874494,0.00301796975769279,0.0416770918623716,0.0535075333125273,1.31879634000111e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40417,0.174456494738058,0.0110678092513419,0.152763588605428,0.196149400870689,1.47816476721844e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,40142,0.0647665976857617,0.00410987733642467,0.0567112381063693,0.072821957265154,1.59344405805694e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40037,0.134668639419012,0.00854756633834563,0.117915409395855,0.15142186944217,1.69542069596594e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37896,0.0554529303247716,0.0035203541302167,0.0485530362295468,0.0623528244199963,2.07798594110598e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37896,0.071314315627803,0.00452729395156658,0.0624408194827325,0.0801878117728735,2.07812866644698e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,40398,0.042493848517838,0.00270464457509354,0.0371927451506547,0.0477949518850214,3.27603479182251e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40497,0.0528225934208448,0.00336267381590771,0.0462317527416657,0.0594134341000239,3.40847067669869e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37623,0.143200750887125,0.00911957512682803,0.125326383638542,0.161075118135708,4.58262401817137e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37593,0.0678678351377668,0.00432254006374734,0.059395656612822,0.0763400136627116,4.71355561477074e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37955,0.133323561117346,0.0085029909038791,0.116657698945743,0.149989423288949,6.35733340285822e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39975,0.0929141421634467,0.00593109894028543,0.0812891882404873,0.104539096086406,6.84329442912773e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40417,0.118787348630458,0.00758850617481596,0.103913876527818,0.133660820733097,8.02486192581479e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,40298,0.0378996216429199,0.00242154705070692,0.0331533894235344,0.0426458538623055,8.41186282092036e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39975,0.108315658754875,0.00694200089489534,0.0947093370008801,0.12192198050887,1.80175906242211e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,40417,0.0936648600336502,0.00600522902376193,0.0818946111470768,0.105435108920224,1.91752456983232e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37332,0.0684540793190558,0.00439215382957998,0.0598454578130791,0.0770627008250326,2.85563657301253e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40300,0.115774032952442,0.00744303923016718,0.101185676061314,0.13036238984357,3.7178723780582e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,39956,0.0689158372964844,0.00444426615751144,0.060205075627762,0.0776265989652068,7.92684561938991e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37552,0.116488420503799,0.00751381059633809,0.101761351734976,0.131215489272621,9.89082199237173e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,40531,0.0772772109106767,0.00498904369496818,0.0674986852685391,0.0870557365528144,1.00001280329448e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37896,0.131270652553474,0.00847050850267511,0.114668455888231,0.147872849218717,1.05226539287182e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40485,0.043843592913624,0.00283746165024903,0.0382821680791359,0.0494050177481121,1.78498818338784e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40327,0.0800807831393639,0.00518395816379399,0.0699202251383277,0.0902413411404001,1.9109363144477e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40336,0.0700689354225033,0.0045358959756361,0.0611785793102566,0.0789592915347501,1.91454054201606e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40300,0.1331143390838,0.00861854422137084,0.116221992409913,0.150006685757687,1.99441883408576e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB2,Calretinin,39956,0.043070343144037,0.00278987698058169,0.0376021842620969,0.0485385020259771,2.2644992237076e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40352,0.0525311146341584,0.00340630120716659,0.0458547642681119,0.0592074650002049,2.84095145227002e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37623,0.10246357565132,0.00664028603562766,0.0894486150214898,0.11547853628115,2.9781299243644e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37985,0.0845427675586527,0.00548104509384008,0.0737999191747261,0.0952856159425793,3.17302282194291e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37896,0.115995516729886,0.00752313326830212,0.101250175524014,0.130740857935758,3.50330054072239e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40336,0.0981481523726327,0.00637786395851647,0.0856475390139405,0.110648765731325,4.69290488587128e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37982,0.0370486592076399,0.00240600399079935,0.0323328913856732,0.0417644270296066,4.72392527786659e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37955,0.105104513757392,0.00683046215703832,0.0917168079295971,0.118492219585187,5.57804066994041e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,40288,0.042636665564808,0.00277266779533447,0.0372022366859525,0.0480710944436636,5.59578302546753e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40286,0.0395242085985965,0.00257272608683514,0.0344816654683997,0.0445667517287934,6.99988870247568e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40354,0.0379888532174463,0.00247288027745666,0.0331420078736313,0.0428356985612614,7.03620756483739e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,40417,0.0589864273325858,0.00384156797865493,0.0514569540944221,0.0665159005707495,7.84806658051098e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40039,0.0936809488123444,0.00610869778622757,0.0817079011513384,0.10565399647335,1.0711138813664e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37955,0.10326675265812,0.00673097259109845,0.0900740463795674,0.116459458936673,1.11356338176809e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2,Brorin,40162,0.0528335271341187,0.00344697993316915,0.0460774464651072,0.0595896078031303,1.20437233628497e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37896,0.121849216792801,0.00794802127928262,0.106271095085407,0.137427338500195,1.3264395937116e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,40531,0.0603577459832634,0.00394102016593579,0.0526333464580292,0.0680821455084975,1.42104909344958e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37623,0.0952840557391497,0.00621894215564191,0.0830949291140915,0.107473182364208,1.5561585536557e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37666,0.0969227961087894,0.00633913312088563,0.0844980951918535,0.109347497025725,2.51423650850787e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40300,0.18609950161966,0.0122150576382107,0.162157988648767,0.210041014590553,4.82215543041475e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,40406,0.111310102371061,0.00730660285102212,0.0969891607830579,0.125631043959065,4.87357190395119e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40327,0.046393156449868,0.00305465561408235,0.0404060314462666,0.0523802814534694,9.85516281304881e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,40511,0.0733412772996217,0.00483363098336936,0.0638673605722178,0.0828151940270257,1.21509596471506e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,40349,0.0527428529137847,0.00348221428873072,0.0459177129078725,0.0595679929196969,1.83104424254417e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,40223,0.070428981168498,0.00465547905329091,0.0613042422240478,0.0795537201129482,2.41959189918074e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,40354,0.0356727846839145,0.0023590774087043,0.0310489929628541,0.0402965764049749,2.65666244623582e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,37982,-0.0324953401070952,0.00214846866968373,-0.0367063386996753,-0.0282843415145151,2.91213390951993e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37711,0.0567237214047969,0.0037513205014824,0.0493711332218914,0.0640763095877024,3.14671204067355e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37623,0.0607015277765395,0.00401822839388732,0.0528258001245203,0.0685772554285586,3.92992448973109e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,37666,0.0397799868623705,0.00263548419271597,0.0346144378446472,0.0449455358800938,4.72311109682899e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,39956,0.0800369920428688,0.00530784344491946,0.0696336188908267,0.090440365194911,5.11958231825223e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40327,0.0649896281537369,0.00431287674418225,0.0565363897351397,0.0734428665723341,5.85301621405016e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,37993,0.0332764156329199,0.00220949286223844,0.0289458096229326,0.0376070216429072,7.58051154520168e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,37567,0.0550207806338747,0.00365436407701156,0.047858227042932,0.0621833342248173,8.35210979631864e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,40336,0.125065430380722,0.00831524321588404,0.108767553677589,0.141363307083855,8.91293997507704e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,39986,0.0663450024409665,0.00441114644924532,0.0576991554004456,0.0749908494814873,9.10066619565345e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40352,0.06708911784873,0.00446282773684106,0.0583419754845215,0.0758362602129385,9.97734080357398e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,37593,0.0512758362818864,0.00341099476835618,0.0445902865359083,0.0579613860278645,1.18481929617198e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37666,0.0384895157525269,0.00256238744184233,0.0334672363665159,0.0435117951385378,1.39907432610906e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40448,0.0781352099448662,0.00521297048592294,0.0679177877924573,0.0883526320972752,1.91733621933052e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37937,0.117986598763166,0.00786948197413319,0.102562414093865,0.133410783432467,2.07973010391607e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37937,0.0526499057170353,0.0035118694612872,0.0457666415729124,0.0595331698611582,2.10896852698925e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40511,0.0586157907181049,0.00391539993049941,0.050941606854326,0.0662899745818837,2.49816107503818e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37985,0.119539603964537,0.00798740110569485,0.103884297797376,0.135194910131699,3.08714528601143e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,39929,0.0915190886642988,0.0061191805564248,0.0795254947737062,0.103512682554891,3.18705940660066e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37937,0.120952991261576,0.00808329113060752,0.105109740645585,0.136796241877566,3.22264897431135e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39975,0.0849009930031986,0.0056874864020126,0.0737535196552539,0.0960484663511433,4.84139179592002e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37557,0.0984454603004278,0.0065927207402931,0.0855237276494533,0.111367192951402,5.22136916033002e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,37937,0.0994321462342467,0.0066598031223286,0.0863789321144827,0.112485360354011,5.25749241937888e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39975,0.0832647363015588,0.00558240809111695,0.0723232164429696,0.094206256160148,5.79124545412106e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37896,0.0621965228942479,0.00416828722687053,0.0540266799295816,0.0703663658589141,6.00543475250194e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40300,0.118408560156268,0.0079411613942027,0.102843883823631,0.133973236488905,6.11904704969137e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40336,0.147424256317484,0.00989058293824446,0.128038713758525,0.166809798876443,6.59770598063328e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,37807,0.132728495656547,0.00891153307599521,0.115261890827596,0.150195100485497,9.03896259279394e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40391,0.115032211580085,0.00773787287929645,0.0998659807366636,0.130198442423506,1.17629144254913e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40395,0.0939592955680883,0.00632252254059141,0.0815671513885291,0.106351439747647,1.26747494155684e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAX,Protein max,39956,0.137493491176881,0.00925220907097807,0.119359161397764,0.155627820955998,1.30324166933558e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40302,0.0862751747663124,0.00580678383284371,0.0748938784539387,0.0976564710786861,1.33833418140665e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,40223,0.0811139375676947,0.0054595279691788,0.0704132627481043,0.0918146123872852,1.35009367460491e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,39660,0.029648662978334,0.00199608112642944,0.0257363439705323,0.0335609819861357,1.47045835537032e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,37993,0.0539718335506597,0.00363252342437343,0.0468520876388878,0.0610915794624316,1.5170377954074e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37955,0.0988487942304707,0.00665484395624912,0.0858053000762224,0.111892288384719,1.61957779502992e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,40497,-0.071229173425446,0.00480176025227208,-0.0806406235198992,-0.0618177233309927,1.87860639200929e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,40465,0.079270742030935,0.00535131715151693,0.0687821604139618,0.0897593236479082,2.5483716215364e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37558,0.0648945347815351,0.00438273696581147,0.0563043703285447,0.0734846992345256,3.3033247259488e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40300,0.0999209142317836,0.00675531445533036,0.0866804978993361,0.113161330564231,3.53899235177405e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40511,0.0349053550757567,0.00236058057023341,0.0302786171580993,0.0395320929934142,3.75348500372456e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,37982,-0.0709526482223848,0.00479670793297355,-0.080354195771013,-0.0615511006737566,3.99325123412509e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39831,0.157819569546817,0.0106843368300097,0.136878269359998,0.178760869733636,4.87637401834127e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,40354,0.158155783303509,0.0107084606542683,0.137167200421143,0.179144366185875,4.8875444206348e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39975,0.0720225618233924,0.00487747110002782,0.0624627184673379,0.081582405179447,5.18960434691913e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39956,0.111178621148718,0.00753375403000756,0.0964124632499028,0.125944779047532,5.92284743163209e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,37895,0.129065541092037,0.00874758279001043,0.111920278823617,0.146210803360458,6.94636646269885e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40354,0.100542358453439,0.00682277593334019,0.0871697176240921,0.113914999282786,7.91258981044242e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40531,0.0408408673714422,0.00277498365760004,0.0354018994025462,0.0462798353403383,1.03223420552358e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40037,0.0975419431875606,0.00662922004188578,0.0845486719054645,0.110535214469657,1.1127049830948e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37937,0.106680145311675,0.00724670672648857,0.0924766001277574,0.120883690495593,1.12428636051007e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,40325,0.0387663604557472,0.00263583875611724,0.0336001164937574,0.043932604417737,1.20740745274908e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37955,0.0800560757799959,0.00544363700105939,0.0693865472579195,0.0907256043020723,1.39343210350071e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40336,0.0795090558031662,0.00542454969757648,0.0688769383959163,0.0901411732104161,2.5035480905199e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,40300,0.0972466816261535,0.0066379850302092,0.0842362309669435,0.110257132285364,2.78544520263045e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORT1,Sortilin,40325,0.0472023649751566,0.00322324660269047,0.0408848016338833,0.0535199283164299,3.02128265585608e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37937,0.0896845503771439,0.00612650567549696,0.0776765992531699,0.101692501501118,3.71884120482955e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37955,0.088796366178608,0.00607254659672149,0.0768941748490339,0.100698557508182,4.69493301208719e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,37955,0.0712727272422558,0.00487616058487402,0.0617154524959027,0.0808300019886088,5.12221011160849e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37623,0.068544461893435,0.00468945552031199,0.0593531290736235,0.0777357947132465,5.21955681018467e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40323,0.0470860246964445,0.00322381601478395,0.040767345307468,0.053404704085421,5.29333539962459e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40336,0.0434763478405824,0.00297754877968991,0.0376403522323902,0.0493123434487746,5.62930858229035e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39956,0.0790710152991476,0.00541916707604146,0.0684494478301064,0.0896925827681889,6.65778537038949e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,40037,0.0694047777207531,0.0047595603486714,0.0600760394373571,0.078733516004149,7.53349933642267e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,39975,0.0491756701112123,0.00337309796407164,0.0425643981016319,0.0557869421207927,7.93534550998316e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40336,0.122748925741297,0.00843147810488137,0.106223228655729,0.139274622826864,1.04772230291766e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,37896,0.0872957314636132,0.00599312101818567,0.0755492142679693,0.0990422486592571,1.06667442718705e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40300,0.0357825898184071,0.00245946072206523,0.0309620468031592,0.0406031328336549,1.20275769666285e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40417,0.0494255590039048,0.00339823519281433,0.0427650180259887,0.0560860999818209,1.27645098560053e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,37743,0.0365470946144463,0.00251675047236039,0.0316142636886199,0.0414799255402726,2.04083803936184e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37955,0.0926291194062614,0.00638052189638859,0.0801232964893397,0.105134942323183,2.13540821236778e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,40354,0.0514909286992928,0.00355585756559818,0.0445214478707203,0.0584604095278652,3.20962325040065e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37593,0.0990125770988842,0.00683429407308106,0.0856173607156453,0.112407793482123,3.35179449559808e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37666,0.0891161363385825,0.00615591276289126,0.0770505473233156,0.101181725353849,3.91132479333287e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,38008,0.0408888816352896,0.00282539812054656,0.0353511013190184,0.0464266619515609,4.09252992538566e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,40039,0.0609991370740126,0.00422203826142576,0.0527239420816181,0.0692743320664071,5.20891157450253e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,38008,0.0381026654517195,0.00263629611535149,0.0329355250656306,0.0432698058378084,5.35554038315041e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,40336,0.108134465291135,0.00749078962872632,0.0934525176188314,0.122816412963439,6.11802438446148e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2,Complement C2,40367,0.0306816691313698,0.00212831543736812,0.0265101708741283,0.0348531673886113,8.10108767050529e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZN,Kazrin,37896,0.132781512098629,0.00923714660663365,0.114676704749627,0.150886319447631,1.64863562480759e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37623,0.110647440179509,0.00770507946690871,0.095545484424368,0.12574939593465,2.05653159625934e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,38008,0.0223757746927758,0.00155889404813061,0.0193203423584398,0.0254312070271117,2.2113247492616e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,40327,0.0566867547846405,0.00395495300594211,0.048935046892994,0.064438462676287,2.64368802565818e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37623,0.0974024204465504,0.0067981374338921,0.0840780710761218,0.110726769816979,3.26234934775972e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,37993,-0.0770413814762635,0.00537849553989351,-0.0875832327344548,-0.0664995302180723,3.37145035165118e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,37896,0.097866071628725,0.00683309498793434,0.0844732054523737,0.111258937805076,3.46804697980203e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40300,0.0577721901178427,0.00403669412923125,0.0498602696245495,0.065684110611136,3.58436408311691e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,37937,0.0583586003134888,0.00407586535163713,0.05036990422428,0.0663472964026976,3.67603621640781e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37896,0.187628281838237,0.0131209801185126,0.161911160805953,0.213345402870522,4.76946767268293e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37896,0.111145465141071,0.00777367779204289,0.0959090566686674,0.126381873613476,4.92028822361841e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37895,0.092019017914206,0.0064365650982142,0.0794033503217061,0.104634685506706,5.01728805019386e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,40300,0.10893572004241,0.00762459953606218,0.0939915049517284,0.123879935133092,5.06366298471325e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37985,0.0929306479220575,0.006501802883844,0.0801871142697232,0.105674181574392,5.22545429070605e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40259,0.0337799307402765,0.00237012858739093,0.0291344787089903,0.0384253827715627,8.32982502474443e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,40336,0.114793732608138,0.00806129727035371,0.0989935899582447,0.130593875258031,9.87428400738232e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39860,0.0478558098277972,0.00336055977856169,0.0412691126618163,0.0544425069937782,1.00265928220285e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,40406,0.0398789215541873,0.00280071976049872,0.0343895108236098,0.0453683322847648,1.00282816991802e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,40223,0.0471026760927652,0.00330828347868302,0.0406184404745465,0.053586911710984,1.02485228906021e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37666,0.0742957644893573,0.00522008851216433,0.0640643910055153,0.0845271379731994,1.24837720910497e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,40265,0.0995144122959666,0.00699925072621817,0.085795880872579,0.113232943719354,1.35556207086523e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,40531,0.0721045358323268,0.00507252779495278,0.0621623813542194,0.0820466903104343,1.40223651936566e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,40245,0.036072855563431,0.00254336651108102,0.0310878572017122,0.0410578539251498,2.2138001397956e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,40336,0.0911203852431964,0.00643031245032574,0.0785169728405579,0.103723797645835,2.63609976440771e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,40187,0.0812516180341023,0.00573414558395864,0.0700126926895433,0.0924905433786612,2.67652946395053e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,40300,0.0751846525260084,0.00530653875578045,0.0647838365646787,0.0855854684873381,2.72054900458386e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37946,0.0854791548640307,0.00603119294598671,0.0736580166898967,0.0973002930381646,2.84938900828569e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39956,0.0848195111626631,0.00598849297968354,0.0730820649224834,0.0965569574028429,2.94129822583377e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,37937,0.0842825248912629,0.005953156693354,0.0726143377722891,0.0959507120102368,3.52946079194901e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37567,0.0860682316034316,0.00608623184728609,0.0741392171827509,0.0979972460241123,4.51861382280145e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,40336,0.0610910222772951,0.00432865173669864,0.0526068648733658,0.0695751796812245,5.88892919076544e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39975,0.0556393492110213,0.00394789778109468,0.0479014695600758,0.0633772288619669,7.87801410323191e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40328,0.0765548609372361,0.00543342753979227,0.0659053429592432,0.0872043789152289,8.19279212791484e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37557,0.0851154639151381,0.00604067748417242,0.0732757360461602,0.0969551917841161,9.23095635535223e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40039,0.0868988938375713,0.00617708051919074,0.0747918160199574,0.0990059716551851,1.12143311425275e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,40336,0.101641428426678,0.00723577205359969,0.0874593152016226,0.115823541651733,1.48337545256975e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40327,-0.0657529283566994,0.00468180306254732,-0.0749292623592922,-0.0565765943541067,1.54112106443654e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37623,0.0768706158523346,0.00547107104664655,0.0661473166009073,0.0875939151037618,1.60573499506602e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,40336,0.103738315319614,0.00739767154062194,0.0892388790999954,0.118237751539233,2.07155567765197e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,40010,0.06009994743459,0.00428623686696277,0.051698923175343,0.068500971693837,2.14200175297269e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40037,0.0507677614588987,0.00362074508308406,0.043671101096054,0.0578644218217435,2.14728318736626e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39956,0.0607361263422017,0.00433186932477754,0.0522456624656377,0.0692265902187657,2.17200847760401e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40327,0.0524160098978521,0.00374009047626683,0.0450854325643691,0.0597465872313351,2.33142003643298e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40531,0.0525933984474724,0.00375525953114812,0.0452330897664221,0.0599537071285228,2.63586441081526e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37985,0.1331733773224,0.00950738193281131,0.11453890873409,0.15180784591071,2.8626088813658e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,37666,0.0711377193373304,0.00507840348558072,0.0611840485055922,0.0810913901690686,2.89060942706739e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,40167,0.0872804876345846,0.0062347474839923,0.0750603825659597,0.0995005927032095,2.91381519309591e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37985,0.0337228790375711,0.00240887490448142,0.0290014842247875,0.0384442738503547,3.19570801293999e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,39975,0.051782998438589,0.00370185801645233,0.0445273567263424,0.0590386401508356,3.4043101814774e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,38008,0.025845213520145,0.00184710050269675,0.0222248965348594,0.0294655305054306,3.52289358328087e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40223,0.0512375288708797,0.0036658051707059,0.0440525507362961,0.0584225070054632,3.94018154905983e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,37896,0.0353272331884155,0.00252705845237552,0.0303741986217595,0.0402802677550716,4.22694594569285e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39975,0.0754589597137382,0.00540092124370494,0.0648731540760765,0.0860447653513998,4.30297264191241e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37895,0.0552936710019522,0.00396047880185877,0.0475311325503091,0.0630562094535954,5.44009623660385e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37955,0.0645342601936871,0.00462979190502438,0.0554598680598393,0.0736086523275349,7.39620034092798e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,40391,0.071032417568041,0.0051003177624347,0.061035794753669,0.081029040382413,7.83767786103398e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37955,0.112613237592794,0.00808201014893737,0.096772497700877,0.128453977484711,7.93543956794655e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,40478,0.0860436429001741,0.00617933496255569,0.0739321463735649,0.0981551394267832,8.10318877374787e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RETN,Resistin,40278,0.0512308896940741,0.00367917288691905,0.0440197108357127,0.0584420685524354,8.14630052229994e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,37666,0.0517998867443556,0.00371987888271808,0.0445089241342282,0.0590908493544831,9.07908833889276e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37982,0.035069371165569,0.00251929102631887,0.030131560753984,0.040007181577154,9.54496045841353e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37623,0.110613962411931,0.00794912422074754,0.0950336789392657,0.126194245884596,1.0433176652891e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37895,0.14148643829432,0.0101699629521572,0.121553310908092,0.161419565680549,1.0727147412159e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40335,0.0699461781384198,0.00503190818829554,0.0600836380893605,0.079808718187479,1.13312017896487e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40417,0.0318769913748575,0.00229487058135061,0.0273790450354103,0.0363749377143047,1.29667270244355e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40327,0.056417414386471,0.00406287260023538,0.0484541840900096,0.0643806446829324,1.3832853349095e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37982,0.0579149128423683,0.00417028399906138,0.049741156204208,0.0660886694805286,1.50006107890975e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40406,0.0389692577240338,0.00280809628168193,0.0334653890119372,0.0444731264361304,1.55346448326293e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,37666,0.0838378509484883,0.00604459226819696,0.0719904501028222,0.0956852517941543,1.94291601396469e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37709,0.0648646513843543,0.00469841778474885,0.0556557525262465,0.074073550242462,4.67847535680171e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40354,0.0971059179497971,0.0070422759389272,0.0833030571094997,0.110908778790094,5.24819794435499e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,40327,0.0655178589187059,0.00475144367324167,0.0562050293191522,0.0748306885182596,5.24993158591586e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40330,0.0550369325716621,0.00399254648970603,0.0472115414518383,0.0628623236914859,5.55428765175687e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37750,0.0166448530892539,0.00120789409423529,0.0142773806645528,0.0190123255139551,6.62264072754087e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40049,0.0908336722892087,0.00659988360010499,0.0778979004330029,0.103769444145414,7.58136580688285e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37875,0.107379477060836,0.00779858880097794,0.0920942430109197,0.122664711110753,7.64461371248226e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,40336,-0.0415655169812104,0.00302131700729191,-0.0474872983155025,-0.0356437356469182,8.08967917787132e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37414,0.0657476948558908,0.00477683136421695,0.0563851053820256,0.075110284329756,8.40467757189983e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40336,0.129121937459717,0.00939050059509652,0.110716556293328,0.147527318626107,8.91920873008874e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,40367,-0.0326582548001676,0.00237541120461829,-0.0373140607612194,-0.0280024488391157,9.13228913173837e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPSE,Heparanase,37843,0.113448724442555,0.00825073358960402,0.0972772866069307,0.129620162278178,9.91531768185992e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40300,0.0470332462318393,0.00342811143190566,0.0403141478253042,0.0537523446383744,1.35216554623147e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37993,0.0737344460634582,0.00537306584399133,0.0632032370092352,0.0842656551176812,1.42488939412865e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40531,0.0499033004836134,0.00363893069691177,0.0427709963176663,0.0570356046495604,1.45857787150854e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37937,0.0781940758360341,0.00570341465796166,0.0670153831064292,0.0893727685656389,1.70337285649644e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,40345,0.11314335576474,0.00825945495041878,0.0969548240619189,0.129331887467561,1.80256997802237e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,37955,0.0930419660891915,0.00679021398379103,0.0797331466809611,0.106350785497422,1.88922911772204e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,38008,0.0795287015539235,0.00580659862998639,0.0681477682391502,0.0909096348686968,2.04720532753008e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,40039,0.111751970383571,0.00816648880209922,0.0957456523314564,0.127758288435685,2.21740056506612e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37623,0.0368786751739253,0.00269646981796892,0.0315935943307062,0.0421637560171444,2.72196414076862e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",38008,0.0199119715060868,0.00145657091395823,0.0170570925147287,0.0227668504974449,2.90603576244755e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,40039,0.0595422283268467,0.00435865377276563,0.0509992669322261,0.0680851897214674,3.05197263229853e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37955,0.0750389432775671,0.00549117409984626,0.0642762420418685,0.0858016445132658,3.1206026624021e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40198,0.0293251600001118,0.00214978622459412,0.0251115789999073,0.0335387410003163,3.96587530077789e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37945,0.0240989903271665,0.00176724578050218,0.0206351885973822,0.0275627920569508,4.61714322594629e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40511,0.0820509314801677,0.00602256044675309,0.0702467130045317,0.0938551499558038,4.94259118976752e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FN1,Fibronectin,38008,0.0318051903504871,0.0023335940176483,0.0272313460758964,0.0363790346250778,5.07381977858154e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37896,0.124550241034824,0.00913876818387749,0.106638255394425,0.142462226675224,5.13484945823237e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40354,0.105187784726591,0.00772238543510164,0.0900519092737913,0.12032366017939,5.15901095970549e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,37985,0.0353330631367225,0.00259389399688937,0.0302490309028193,0.0404170953706257,5.6319361885919e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37905,0.0496937347029338,0.0036538823958524,0.0425321252070631,0.0568553441988045,7.54365619090564e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37993,0.0373487216179458,0.00274854422339725,0.0319615749400872,0.0427358682958045,8.7975983877071e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37623,0.110381888666368,0.00812573523734278,0.0944554476011762,0.12630832973156,9.4889138126269e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,40327,0.0473440018397082,0.00348736247955684,0.0405087713797768,0.0541792322996396,9.52107122183421e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELE,E-selectin,40531,0.060187900895483,0.00443376701053085,0.0514977175548425,0.0688780842361234,9.58362661231955e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37567,0.059362305290023,0.00437041551961977,0.0507962908715683,0.0679283197084778,9.70568459988284e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37896,0.0777227799403188,0.00572661563284243,0.0664986132999476,0.0889469465806899,1.10136513608266e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,40336,0.0992127590224141,0.00731444187267684,0.0848764529519674,0.113549065092861,1.11784216078948e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,37666,0.0892755003881164,0.00657935191282868,0.0763799706389722,0.102171030137261,1.16179511167952e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40223,0.0955358399950084,0.00704743976348452,0.0817228580585788,0.109348821931438,1.2472864361437e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,40466,0.0725517231425276,0.00535372134732706,0.0620584293017665,0.0830450169832886,1.3139039298561e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37570,0.0430956726623007,0.00317932578878038,0.0368641941162912,0.0493271512083103,1.41030812450755e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37955,0.0791805853594112,0.00584254888550704,0.0677291895438174,0.090631981175005,1.43350242930855e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTD,Biotinidase,38008,0.0249305866900362,0.0018398011720827,0.0213245763927541,0.0285365969873183,1.46324907956847e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,37976,0.026934643033701,0.00198951730678765,0.0230351891123972,0.0308340969550048,1.73139997181892e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40354,-0.0475867093553184,0.00352138276650449,-0.0544886195776672,-0.0406847991329696,2.19862973148399e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40300,0.0836432275852527,0.00619026640490973,0.0715103054316296,0.0957761497388757,2.24998810993809e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40223,0.0934753679470132,0.00691926505769102,0.0799136084339388,0.107037127460088,2.33653131636594e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,40371,0.0811012436388647,0.00600447777278856,0.0693324672041991,0.0928700200735302,2.40910654202974e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,40147,0.0443898843141936,0.0032872904619399,0.0379467950087914,0.0508329736195958,2.53721753972921e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37593,0.0653566765068791,0.00483729643097691,0.0558755755021643,0.0748377775115938,2.5417556532118e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39975,0.0560970126327714,0.00416075782488864,0.0479419272959896,0.0642520979695531,3.38593351861226e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40336,0.123758641706152,0.00918593988742637,0.105754199526796,0.141763083885507,3.81410671790075e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40414,0.0380233702110146,0.00282307859319297,0.0324901361683564,0.0435566042536729,4.00608018920209e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40039,0.065314411951811,0.00485019485505062,0.0558080300359118,0.0748207938677102,4.18897340589769e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,40406,0.0856652527501688,0.0063621114078212,0.0731955143908393,0.0981349911094984,4.2191563228779e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NADK,NAD kinase,40354,0.0640151555126661,0.00476024175214106,0.0546850816784696,0.0733452293468626,5.30757392891642e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37666,0.0946933065633226,0.00703840357151558,0.0808980355631521,0.108488577563493,5.44167232876544e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,40511,0.0608218349310655,0.00452753697921354,0.051947862451807,0.069695807410324,6.37795100016826e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40037,0.111024606255885,0.00826426816449849,0.0948266406534677,0.127222571858302,6.43046093655159e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37666,0.100679310822551,0.00749227125994496,0.0859944591530586,0.115364162492043,6.74046530483054e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,37878,0.0551210860026278,0.00410246870436725,0.0470802473420679,0.0631619246631876,6.82663910852362e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40437,0.0331774427860121,0.00247137834255346,0.0283335412346073,0.0380213443374169,7.21746839615491e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40352,0.110753572959561,0.00825845001037209,0.0945670109392313,0.12694013497989,8.6920016813219e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,40354,0.0536941187093609,0.00400377073910716,0.0458467280607109,0.061541509358011,8.69747654769853e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,40369,0.126826387110488,0.00945772867634243,0.108289238904857,0.145363535316119,8.81858642757381e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40004,0.0616725903468721,0.00459895403694576,0.0526586404344584,0.0706865402592858,8.88596267703086e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,37985,0.115971898341807,0.0086475391583794,0.0990227215913836,0.132921075092231,9.49223710478045e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40417,0.0326386471175436,0.00243496393930869,0.0278661177964986,0.0374111764385886,9.49451174438394e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37985,0.0405858294779999,0.0030280893933986,0.0346507742669386,0.0465208846890612,1.05381028648559e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,37896,0.0404053710875868,0.00301486772219953,0.0344962303520757,0.0463145118230979,1.07321102160802e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,40417,-0.0743026367830787,0.00554726573134175,-0.0851752776165085,-0.0634299959496489,1.08042096333373e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40286,0.0513846544741225,0.00383716146438,0.0438638180039377,0.0589054909443073,1.13127406184437e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,40511,0.0446893967631711,0.0033383448784658,0.0381462408013781,0.051232552724964,1.19465655236105e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,37895,0.0979245266586936,0.00731667364795753,0.0835838463086968,0.11226520700869,1.36853531794105e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,40300,0.0334560972016539,0.00250383335856459,0.0285485838188673,0.0383636105844405,1.67115642441021e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40406,0.0861818292720199,0.0064551793284674,0.0735296777882238,0.098833980755816,1.93139545104686e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40398,0.0505034158214641,0.00378483415226082,0.0430851408830329,0.0579216907598953,2.12493278316562e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9,Complement component C9,37982,-0.0579099558553409,0.00433862938055917,-0.0664136694412369,-0.049406242269445,2.2043943534992e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,40166,0.0692805736679112,0.00519483771098802,0.0590986917543747,0.0794624555814477,2.3550317129318e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40466,0.0761141321403311,0.00570871323455138,0.0649250542006104,0.0873032100800518,2.4422896697195e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40039,0.0450450900918029,0.00337873530230165,0.0384227688992917,0.0516674112843141,2.5096605847944e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,40531,0.0626840716334246,0.00470334709708258,0.0534655113231427,0.0719026319437064,2.61938042422085e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39975,0.0749909485814841,0.00562748923245254,0.0639610696858771,0.0860208274770911,2.72701698315486e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37593,0.0630833799149175,0.00473264883050474,0.0538073882071282,0.0723593716227067,2.85052085914159e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,37937,0.0324455180395439,0.00243573704918927,0.0276714734231329,0.0372195626559549,3.15339172483061e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40039,0.07103739599939,0.00533729274960322,0.0605763022101677,0.0814984897886123,3.37228855414151e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,37557,0.0706921890738457,0.00530974372414949,0.0602850913745127,0.0810992867731787,3.51499090686867e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37955,0.0652489849795126,0.00490353806514594,0.0556380503718266,0.0748599195871987,3.79653970315281e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,37993,0.0979328200785482,0.00736626415443933,0.0834949423358471,0.112370697821249,4.42569970106207e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37937,0.0541941686235811,0.00407698329337324,0.0462032813685695,0.0621850558785926,4.55857623046071e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37923,0.0482172924602689,0.00362754581670073,0.0411073026595355,0.0553272822610024,4.60519005418585e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40512,0.0280079141893298,0.00210855596943412,0.0238751444892389,0.0321406838894206,4.72673316318871e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40039,0.084855270664136,0.00639242243468554,0.0723261226921524,0.0973844186361197,5.37547048396337e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37955,0.0925543831161094,0.00697475119717814,0.0788838707696402,0.106224895462579,6.15182740751468e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40039,0.0476508106264437,0.00359448409681858,0.0406056217966793,0.0546959994562081,6.78959600554165e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLG,Plasminogen,37700,0.0264571355520828,0.00199573713187086,0.022545490773616,0.0303687803305497,7.38983040146697e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37567,0.0959828849416324,0.00724105632989211,0.0817904145350439,0.110175355348221,7.57682930536496e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,40223,0.095437225563844,0.00720950925407267,0.0813065874258616,0.109567863701826,8.66637837238511e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37666,0.0250538774095023,0.00189503336279465,0.0213396120184248,0.0287681428005798,1.18790858975624e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40531,0.0842416465231603,0.00637641198432029,0.0717438790338926,0.0967394140124281,1.21258278536526e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,40304,0.0786187934860284,0.00595085381919449,0.0669551200004072,0.0902824669716496,1.2224631013577e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,40223,0.113255247567589,0.00857495569720926,0.0964483344010587,0.130062160734119,1.28600553523824e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37603,0.09456394449698,0.00715717784759179,0.0805358759157001,0.10859201307826,1.32903167793423e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39975,0.0670808369906681,0.00508381230168064,0.0571165648793741,0.0770451091019622,1.53086162481893e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBN,Nibrin,40039,0.0596248062736171,0.00452125279103056,0.0507631508031972,0.068486461744037,1.6816614215535e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,37666,0.059608114962079,0.00451793231420164,0.0507529676262437,0.0684632622979142,1.69547590721301e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37985,0.0868165850718744,0.00658317089465793,0.0739135701183449,0.099719600025404,1.81000797548088e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40187,0.130498216331694,0.00990901204104998,0.111076552731236,0.149919879932152,2.12020225109676e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,40336,0.0455469642581894,0.00345862938594109,0.0387680506617448,0.0523258778546339,2.12657993939849e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37896,0.136640572027732,0.0103783317165528,0.116299041863289,0.156982102192175,2.41331388931185e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40484,0.0364420463783266,0.00277101612279167,0.0310108547776549,0.0418732379789983,2.67762398596423e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,40300,0.0851854980094129,0.00649440328975704,0.0724564675614891,0.0979145284573367,4.21966530628634e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,40180,0.067559913770589,0.00515370482854918,0.0574586523066326,0.0776611752345454,4.68556606962496e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,40037,0.0584858439686669,0.00446330326674549,0.0497377695658457,0.067233918371488,5.04152792367927e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,37593,0.0517039030340378,0.00395337545486917,0.0439552871424942,0.0594525189255813,7.64477294457859e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37666,0.101494195547493,0.00777344494265637,0.0862582434598863,0.116730147635099,1.0125201792573e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,40304,0.0452015323064232,0.00346507849995288,0.0384099784465156,0.0519930861663309,1.07527483004099e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39975,0.0343878932206179,0.00263778196986485,0.0292178405596828,0.039557945881553,1.20773323009788e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,39975,0.049884195296296,0.00382673628677471,0.0423837921742176,0.0573845984183745,1.22298683963974e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,40511,0.102654267928214,0.00787594747281213,0.0872174108815017,0.118091124974925,1.23277659519017e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37937,0.034971034004544,0.0026846981989281,0.029709025534645,0.0402330424744431,1.4860813685354e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37593,0.104246938180601,0.00800475073045614,0.0885576267489072,0.119936249612295,1.56496553231961e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40466,0.0760764809691385,0.00584804425650696,0.0646143142263849,0.0875386477118922,1.70706035139062e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,37985,0.0749822510822908,0.00576443326667654,0.0636839618796048,0.0862805402849768,1.87971685737371e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,40417,0.106534185247458,0.00819449186606203,0.0904729811899763,0.122595389304939,1.90004808172497e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,40531,0.022386204449098,0.00172254541022,0.0190100154450668,0.0257623934531292,2.01290623843531e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40368,0.0310042762705393,0.00238565361727414,0.026328395180682,0.0356801573603966,2.01858928907183e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40300,0.133927100907251,0.0103062196985743,0.113726910298045,0.154127291516456,2.05810730235896e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,40429,0.0693976301936021,0.00534618298670438,0.0589191115396616,0.0798761488475427,2.45760906137769e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,40302,0.0794264730637621,0.00612130933291254,0.0674287067712535,0.0914242393562707,2.64367598455676e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,37929,0.11237359700955,0.00866985229663257,0.0953806865081498,0.129366507510949,3.42399827966242e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37896,0.0889056365813345,0.00686071606676858,0.0754586330904681,0.102352640072201,3.552738439182e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,40354,0.0520879147611237,0.00402290539426565,0.044203020188363,0.0599728093338844,3.76753405253042e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40327,0.0890403501142714,0.00687962620869103,0.075556282745237,0.102524417483306,4.03270596710125e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37666,0.0629506546815711,0.00486338325870484,0.0534184234945097,0.0724828858686326,4.34004559846606e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37937,0.0746712310044528,0.00576956207646121,0.0633628893345888,0.0859795726743168,4.37944339460936e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,37895,0.0410364565539482,0.00317354555192785,0.0348163072721696,0.0472566058357268,5.0838581509756e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40336,0.115013861068416,0.00891214451651677,0.0975460578160433,0.132481664320789,6.51624647142589e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,37896,0.0818878591957599,0.00634592754933098,0.0694498411990712,0.0943258771924486,7.16976347170122e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40406,0.0303708121865594,0.00235523710777273,0.0257545474553248,0.0349870769177939,7.42202229021476e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40417,0.126555625669237,0.00981477807929674,0.107318660633815,0.145792590704658,7.47887059110937e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40327,0.0303481404244479,0.00235370810079689,0.025734872546886,0.0349614083020098,7.55886120339592e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37623,0.0373013172019365,0.00289201984779623,0.0316329583002559,0.0429696761036171,7.82422117788231e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37896,0.125099795065604,0.00970193814457295,0.106083996302241,0.144115593828967,8.11809091930451e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40333,0.107413472688844,0.00834064588488341,0.0910658067544725,0.123761138623215,9.21326545502077e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,40305,0.0534023545796113,0.00414781882115915,0.0452726296901393,0.0615320794690832,9.64487898004201e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,37536,0.045033540866391,0.00349783656245898,0.0381777812039714,0.0518893005288106,1.05841425536652e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37896,0.0675534771911424,0.00524814423096907,0.057267114498443,0.0778398398838418,1.08183953568062e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40400,0.0583494152931902,0.00453535941710789,0.0494601108356588,0.0672387197507217,1.0845834868077e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40039,0.0478637561970396,0.00372020629260237,0.040572151863539,0.0551553605305403,1.08920675545978e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,40369,0.0337572782936637,0.00262506289539875,0.0286121550186822,0.0389024015686453,1.16974198422093e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37557,0.0711086897269093,0.00552722567894265,0.0602753273961817,0.0819420520576368,1.19433892594663e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSG,Basigin,40497,0.0230523180085997,0.00179361877563691,0.0195368252083514,0.026567810808848,1.2783097276134e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,37982,0.0829545622944249,0.00645175564771215,0.0703091212249091,0.0956000033639408,1.29312501875812e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,40300,0.0940319352275673,0.00732453616474273,0.0796758443446715,0.108388026110463,1.54629935890687e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38480,-0.0357251042422109,0.00278214058041936,-0.0411780997798329,-0.030272108704589,1.57440427154822e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37985,0.102537111851239,0.00798705299503732,0.0868824879809657,0.118191735721512,1.66400629343681e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,37929,0.0959895965810262,0.00747889469778638,0.0813309629733649,0.110648230188687,1.73661808960027e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,37896,0.0803063826926018,0.00625865492803359,0.068039419033656,0.0925733463515477,1.81761170254602e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38008,0.0308578785587163,0.00240562772948568,0.0261428482089243,0.0355729089085082,1.90194504957289e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,40336,0.0457962457516433,0.0035739881797532,0.0387912289193271,0.0528012625839596,2.10346340364537e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40406,0.0420518434679008,0.00328505383091736,0.0356131379593028,0.0484905489764989,2.47201711071586e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37666,0.0803532171776558,0.00627808366979953,0.0680481731848487,0.0926582611704629,2.76465123845404e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARC,SPARC,40406,0.0802584497984541,0.00628315838821727,0.0679434593575482,0.0925734402393599,3.50309721860056e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39934,0.0654984278426781,0.00512945685674353,0.0554446924034607,0.0755521632818954,3.75711755019894e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,40511,0.0517819445271724,0.00405949450041674,0.0438253353063556,0.0597385537479892,4.38196086678136e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,40417,0.0868121967577185,0.00680620912356426,0.0734720268755325,0.100152366639904,4.44359505965733e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,37593,0.0495656893167331,0.0038843037330866,0.0419524539998834,0.0571789246335829,4.52034856947254e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,37617,0.0752350203614864,0.00590068858547494,0.0636696707339555,0.0868003699890172,5.14595081701737e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,37479,0.0621736980702294,0.00487905053446927,0.0526107590226697,0.0717366371177892,5.66859986450273e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,40307,0.0760492014533627,0.00597187968874906,0.0643443172634146,0.0877540856433109,5.76625390757537e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37666,0.0718345300774761,0.00564137131516027,0.060777442299762,0.0828916178551903,6.34510945619259e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",40484,0.0835674885359653,0.00656837989771156,0.0706934639364506,0.09644151313548,6.67094720948231e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39975,0.0612342307663068,0.00481774254933846,0.0517914553696034,0.0706770061630102,7.92464033781577e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPART,Spartin,37666,0.0875425431444179,0.00688630331650424,0.0740453886440696,0.101039697644766,8.27117367564072e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40417,0.117720594501742,0.00927207314797488,0.0995473311317113,0.135893857871773,9.33887095327019e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37895,0.0933076917859488,0.00735273068487763,0.0788963396435886,0.107719043928309,1.08767147165317e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37666,0.134128312992335,0.0105718843980213,0.113407419572213,0.154849206412457,1.13824439356246e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,37937,0.0642473383511748,0.00506458609112579,0.0543207496125682,0.0741739270897813,1.15099611702145e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,40484,0.0321917826101433,0.00254005611796324,0.0272132726189353,0.0371702926013512,1.24050936919469e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37955,0.0892728491355697,0.00705652246473341,0.0754420651046922,0.103103633166447,1.77623610319816e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,37937,0.0701710454065618,0.00554952706755295,0.059293972354158,0.0810481184589656,1.93123223497039e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,37985,0.0339664212103676,0.00269152960269734,0.0286910231890808,0.0392418192316544,2.63150388278563e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37666,0.0252988419159373,0.00200630926238948,0.0213664757616539,0.0292312080702207,3.02090594198238e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37955,0.054172278317689,0.00429976661841298,0.0457447357455996,0.0625998208897785,3.4217683025252e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40417,0.0469397032219245,0.0037278847861331,0.0396330490411036,0.0542463574027454,3.49357178668375e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,40336,0.102630641313683,0.00815365471377561,0.0866494780746828,0.118611804552683,3.70101322996714e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40300,0.0388252801646384,0.00308507596075088,0.0327785312815666,0.0448720290477101,3.80804962318399e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39973,0.0548603504288342,0.00436102984080969,0.0463127319408472,0.0634079689168212,4.0980889110232e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40466,0.0513884916875745,0.0040957023601425,0.0433609150616952,0.0594160683134538,6.09863155805257e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,40332,0.112258252139141,0.00895551974601701,0.0947054334369476,0.129811070841334,7.09417666736582e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,40300,0.0997916178409132,0.00797141220605965,0.0841676499170363,0.11541558576479,8.71291230448601e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37955,0.0953109830222415,0.00761278134247909,0.0803899315909825,0.1102320344535,9.18286100079549e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37593,0.109049052817938,0.00871314076266571,0.0919712969231135,0.126126808712763,9.82099448133411e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40300,0.0432410300994148,0.00345735123766048,0.0364646216736002,0.0500174385252293,1.00820307466067e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37895,0.0781816374301618,0.00625053931890694,0.0659305803651042,0.0904326944952194,1.06680553611701e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37895,0.0532022669353143,0.00425431088267826,0.0448638176052649,0.0615407162653637,1.10032700984391e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,40484,0.0299055913305954,0.00239312230908219,0.0252150716047943,0.0345961110563965,1.14414893083425e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,38008,0.0208439627384444,0.00166840118340579,0.017573896418969,0.0241140290579197,1.2744842826336e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40301,0.0399488427819089,0.0031998887050371,0.0336770609200362,0.0462206246437816,1.33475370938987e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37666,0.0916758096051503,0.00734284530404566,0.0772838328092208,0.10606778640108,1.42978618580889e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37666,0.0424172954608992,0.00339757233112278,0.0357580536918985,0.0490765372298998,1.43803331928723e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40446,0.047399711209568,0.00379921381338925,0.0399532521353251,0.0548461702838109,1.47401655633496e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,40024,0.0426434753133757,0.00341880891033923,0.0359426098491108,0.0493443407776405,1.54566134106391e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39971,0.0863096439247817,0.0069237162625109,0.0727391600502603,0.0998801277993031,1.69673640585415e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39975,0.039878774894259,0.00320054186898672,0.033605712831045,0.046151836957473,1.82304346879344e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37741,0.0619933160561868,0.00497331331011642,0.0522456219683586,0.071741010144015,1.82459817404099e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40374,0.0370079811195747,0.00297107188939747,0.0311846802163557,0.0428312820227937,1.89504694575751e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37593,0.101274544568055,0.00813001630445251,0.0853397126113282,0.117209376524782,2.03327302645818e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,40039,0.0876154478420352,0.00703792674409575,0.0738211114236075,0.101409784260463,2.0854660190622e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40484,0.0671814185913688,0.00539789793271333,0.0566015386432507,0.0777612985394869,2.14669559113282e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37895,0.0610147603399774,0.00490373619701199,0.0514034373938339,0.0706260832861209,2.40439334206815e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39975,0.0639305918250749,0.00514086366181339,0.0538544990479206,0.0740066846022291,2.46242526031321e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,40484,0.0451988930280979,0.003636582350929,0.038071191620277,0.0523265944359187,2.64704718235108e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37895,0.0961469237708253,0.00773212972555722,0.0809919495087332,0.111301898032917,2.64731982034511e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37985,0.0321129550747009,0.00258270116279745,0.0270508607956179,0.0371750493537839,2.66786145497752e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37973,0.0534714195326758,0.00430385920712658,0.0450358554867077,0.0619069835786439,3.01281201454911e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,40391,0.0324025241370844,0.00260938222113793,0.0272881349836541,0.0375169132905148,3.04928197283268e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37985,0.108167774486878,0.008712717694497,0.0910908478056639,0.125244701168092,3.37152043423835e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40300,0.0601459945359727,0.00484874937308245,0.0506424457647311,0.0696495433072143,3.6007372489308e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40406,0.0675938569565628,0.00545164989250509,0.0569086231672528,0.0782790907458727,3.85144239071242e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37937,0.0586609791003813,0.00473294939093842,0.049384398294142,0.0679375599066206,4.3630076582422e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40495,-0.128920839305079,0.0104103174770356,-0.149325061560068,-0.108516617050089,4.61684196336633e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,37937,0.0773304662528241,0.00624309176499924,0.0650940063934256,0.0895669261122226,4.7918649847308e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37985,0.0517165671256527,0.00418254587134975,0.0435187772178072,0.0599143570334982,6.25126538235388e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,37623,0.0545831054539035,0.00441636091042963,0.0459270380694614,0.0632391728383455,6.7733602006346e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40354,0.0703572058996257,0.00569630927442187,0.0591924397217588,0.0815219720774925,6.92169523106234e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,40354,0.0724540501383027,0.00587192699719503,0.0609450732238005,0.083963027052805,8.05380256357243e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,37985,0.0704513237353023,0.00571378788730131,0.0592522994761918,0.0816503479944129,9.58703163991015e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,37436,0.078516598418385,0.00637034463695836,0.0660307229299466,0.0910024739068234,1.0343809130858e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,40037,0.0648437715185121,0.00526620127480865,0.0545220170198871,0.0751655260171371,1.11485347290443e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40354,0.0918765671029829,0.00746701742159968,0.0772412129566476,0.106511921249318,1.23406226006233e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40372,0.0246770832977622,0.00200681318234598,0.0207437294603641,0.0286104371351603,1.35518495602245e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40300,-0.0217742030381963,0.00177110213720231,-0.0252455632271129,-0.0183028428492798,1.39960188708765e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37666,0.0738501606272368,0.00600454345214731,0.0620812554610281,0.0856190657934456,1.41637541939383e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37682,0.0706252067107086,0.00574265704945362,0.0593695988937795,0.0818808145276377,1.42775791000632e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37593,0.0474324780901037,0.00385815202490085,0.0398705001212981,0.0549944560589094,1.50850736652052e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,40198,0.0497956021647732,0.00405245369716879,0.0418527929183223,0.057738411411224,1.51710824090578e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,40531,0.0289129763738583,0.00235310959916549,0.024300881559494,0.0335250711882227,1.51744761050356e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40203,0.0440075331196709,0.00358221504833484,0.0369863916249346,0.0510286746144072,1.56909384093985e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,40327,0.132100494803686,0.0107543606755853,0.111021947879539,0.153179041727834,1.59505615570188e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37666,0.137223050308704,0.0111774561798898,0.11531523619612,0.159130864421288,1.85989779099686e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,37567,0.14314929013145,0.0116624564801978,0.120290875430262,0.166007704832638,1.92145775896156e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37985,0.0895602975546581,0.00729770374223968,0.0752567982198683,0.103863796889448,1.94228753854662e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,40187,0.0834276642351422,0.00680110778906748,0.07009749296857,0.0967578355017145,1.9620433110351e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,37593,0.0550696074036052,0.00449090289621003,0.0462674377270336,0.0638717770801769,2.21971191330796e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37982,0.0788979256185752,0.00643565128817795,0.0662840490937464,0.0915118021434039,2.27344221012592e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40327,0.0412744829819135,0.00337023273548654,0.0346688268203599,0.0478801391434671,2.49740171987708e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40466,0.0512307497845677,0.00418659761864256,0.0430250184520283,0.0594364811171071,2.81058836809129e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,37895,0.0349536200792727,0.00285591047091243,0.0293560355562843,0.040551204602261,2.92563689659998e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40223,0.103057891560964,0.0084298893519441,0.0865353084311534,0.119580474690774,3.25325459238851e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,37637,0.111894683802747,0.00914875942060302,0.0939631153383649,0.129826252267129,3.26967993310214e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,40336,0.0964092979036415,0.00788838688023041,0.0809480596183899,0.111870536188893,3.39151341140337e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRN,Progranulin,40257,0.0263563971803439,0.00215796377613459,0.0221267881791201,0.0305860061815677,3.75101079402261e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40336,0.0867965896565199,0.0071086828819026,0.0728635712079908,0.100729608105049,3.91271893864366e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39975,0.0598506401552178,0.00490565760907457,0.0502355512414316,0.0694657290690039,4.43408100016596e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGMN,Legumain,40417,0.0384649347091069,0.0031557011978521,0.0322797603613167,0.044650109056897,5.03730532623231e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37985,0.0434827699897909,0.00356601805140792,0.0364933746090314,0.0504721653705505,5.06784231347541e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37937,0.10491744890464,0.00860916960075346,0.088043476487163,0.121791421322117,5.52114970664292e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37623,0.0281652783613471,0.00231162159329634,0.0236345000384863,0.0326960566842079,5.74691525132718e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,40037,0.0914709219379377,0.00751672100995169,0.0767381487584324,0.106203695117443,6.47950004313413e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39956,0.0667376146529146,0.00548424678168733,0.0559884909608075,0.0774867383450218,6.49349014143112e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40037,0.0996496947169315,0.00818931551898101,0.0835986362997287,0.115700753134134,6.53760255308095e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,38008,0.0272362830474298,0.00223795718054077,0.0228498869735699,0.0316226791212897,6.73430400228279e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,37895,0.0222985600883211,0.00183270638771775,0.0187064555683943,0.0258906646082479,7.01942518890917e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40187,0.025687713376837,0.00211281488062368,0.0215465962108146,0.0298288305428595,7.37430240079273e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,40511,0.0682502737753074,0.00561514588312538,0.0572445878443816,0.0792559597062331,7.62886362938939e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37955,0.116676540401107,0.00959851378049977,0.0978634533913272,0.135489627410886,8.03654235578647e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,40406,0.0687350929659765,0.00566700475473924,0.0576277636466876,0.0798424222852654,1.04348392239801e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40336,0.1036934568926,0.00855075271943385,0.0869339815625097,0.12045293222269,1.07292847113276e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40336,0.0886484808710608,0.0073117622429525,0.0743174268748739,0.102979534867248,1.10894293307182e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,40437,0.05241134538329,0.00432754688024006,0.0439293534980195,0.0608933372685605,1.29476441416675e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,40336,0.0604409011997187,0.00499334910509132,0.0506539369537397,0.0702278654456977,1.40889617149416e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37896,0.0898704222133135,0.00742690572714489,0.0753136869881095,0.104427157438517,1.56493694472996e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39956,0.0808679007012269,0.00668950174048183,0.0677564772898825,0.0939793241125713,1.71280335729755e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37637,0.0922974923688962,0.00763188604326544,0.077338995724096,0.107255989013696,1.71571699807368e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEXN,Nexilin,37982,0.0736894293838982,0.00609391242504563,0.0617453610308087,0.0856334977369876,1.726239792072e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40466,0.0614165521674284,0.00508188199116328,0.0514560634647484,0.0713770408701085,1.76463017373658e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40300,0.0603631153967794,0.00499478693964345,0.0505733329950783,0.0701528977984806,1.77447916768816e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37937,0.0820867348733037,0.00679712421498034,0.0687643714119422,0.0954090983346651,2.08592784710868e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,37896,0.110553430633702,0.00915878868298659,0.0926022048150485,0.128504656452356,2.24301210785195e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,40354,0.0297965325485688,0.00247049121161352,0.0249543697738063,0.0346386953233313,2.37362905413453e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37666,0.0657916216887952,0.00545604002773515,0.0550977832344343,0.0764854601431561,2.61670333459966e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37593,0.0482462221956152,0.0040052792607788,0.0403958748444888,0.0560965695467417,3.05928184297485e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,37710,0.0412117927979996,0.0034264290182604,0.0344959919222092,0.04792759367379,3.78426631790415e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,39975,0.104339901296161,0.00867877649895168,0.0873294993582155,0.121350303234106,3.80245084225531e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,40350,0.0422819476265661,0.00351905047503616,0.0353846086954952,0.0491792865576369,4.1156187197644e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,37896,0.0377184999878915,0.0031383347711596,0.0315673638364186,0.0438696361393643,4.19136919514876e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37955,0.106077086625652,0.00882633123642127,0.0887774774022667,0.123376695849038,4.20342398634749e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37896,0.0697002134570769,0.005799548764608,0.0583330978784452,0.0810673290357086,4.21258639990541e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,40437,0.074456240030534,0.00620734713876811,0.0622898396385485,0.0866226404225195,5.23933488726092e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,40037,0.0406993924568807,0.00339449992775222,0.0340461725984863,0.047352612315275,5.61228340117225e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37955,0.0855230496970605,0.0071378054604716,0.0715329509945362,0.0995131483995849,6.50698135956134e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,37593,0.0466904746501325,0.00389671418392113,0.039052914849647,0.0543280344506179,6.55136523482964e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40336,0.111126170523625,0.00927950497504665,0.0929383407725334,0.129314000274716,6.62233673264363e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40336,0.064977930159924,0.00542995895961126,0.0543352105990859,0.075620649720762,7.36356592631828e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37874,0.0751217007636901,0.00628546360153379,0.0628021921046839,0.0874412094226963,9.33121970884364e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,40327,0.0565048197833472,0.00473430582144936,0.0472255803733065,0.065784059193388,1.0707028510126e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37985,0.0575714043075785,0.00482232190948985,0.0481196533649783,0.0670231552501786,1.08759716187033e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37623,0.0824339215091168,0.00690598365276679,0.0688981935496939,0.0959696494685397,1.12438044872812e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37709,0.113143458028736,0.00948441706755595,0.0945540005763264,0.131732915481146,1.2216301839034e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,40354,0.0836753112167537,0.0070185782292675,0.0699188978873894,0.097431724546118,1.25238311827388e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39975,0.0558993813461393,0.00468851189176297,0.0467098980382838,0.0650888646539947,1.2523842809204e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37985,0.031694600509364,0.0026605006673643,0.02648001920133,0.036909181817398,1.47260537483664e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37593,0.0611435446490201,0.00513289608433986,0.051083068323714,0.0712040209743263,1.5054975867204e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40511,0.0775116191199008,0.00651488552647102,0.0647424434880176,0.090280794751784,1.66775481272514e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,40072,0.0362107859197471,0.00304348775981186,0.0302455499105158,0.0421760219289783,1.67898863658777e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,37557,0.0498772075301894,0.0041929088277683,0.0416591062277635,0.0580953088326152,1.83246416093516e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37955,0.125127349893677,0.010548702582771,0.104451892831445,0.145802806955908,2.70149397955206e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,39956,0.0707283274623951,0.00596597918589235,0.0590350082580461,0.0824216466667441,2.78569015840519e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37623,0.0499681650514644,0.00421801956983323,0.0417008466945913,0.0582354834083376,3.27490245654195e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,37666,0.0379557099214215,0.00320705296044923,0.031669886118941,0.044241533723902,3.7366625208258e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40336,0.0850546852055363,0.00718999260738447,0.0709622996950628,0.0991470707160099,3.74515334936083e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37386,0.0369669119757671,0.00312357967762349,0.030844695807625,0.0430891281439091,3.77941926650162e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37623,0.0650572478222457,0.00550416758292192,0.0542690793597187,0.0758454162847726,4.48784861240262e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37623,0.068247736592506,0.00577780085787275,0.0569232469110754,0.0795722262739366,4.90641737855106e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,40406,0.0307345612518836,0.0026035134128767,0.0256316749626453,0.0358374475411219,4.99707994971913e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37709,0.0520224824095316,0.00440546256503753,0.0433877757820581,0.0606571890370052,5.09631008947018e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,40428,0.0625461254140023,0.00530064434198037,0.0521568625037208,0.0729353883242839,5.31759522614416e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,40352,0.0554291720626141,0.00469919744544458,0.0462187450695428,0.0646395990556855,5.59975292577836e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,40406,0.0720166621704863,0.00610716968073313,0.0600466095962493,0.0839867147447232,5.81594251172056e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,40464,0.0646234977872364,0.00548307761196762,0.0538766656677799,0.075370329906693,6.24643834029745e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40327,0.0454720537133415,0.00385860149869925,0.0379091947758909,0.053034912650792,6.36642795049295e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40300,0.076895365036317,0.00653165472613804,0.0640933217730864,0.0896974082995476,7.32397126423885e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,40327,0.027787870875261,0.00236084780813624,0.023160609171314,0.032415132579208,7.53228541941975e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,40265,0.042013458998805,0.00357147506273689,0.0350133678758407,0.0490135501217694,8.15667666143753e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,40223,0.105652769664808,0.0089840545319248,0.0880440227822355,0.123261516547381,8.51409084670515e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37985,0.0778359838600787,0.00661632509112959,0.0648679866814647,0.0908039810386927,8.52242286501224e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,37879,0.0928841733995558,0.00790489289169306,0.0773905833318374,0.108377763467274,1.00724916790014e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,40111,0.0707982796341073,0.00602948719261406,0.0589804847365837,0.0826160745316308,1.05419232584484e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37982,-0.0271520494786946,0.00231301132842589,-0.0316855516824094,-0.0226185472749799,1.14773119932627e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40398,-0.0390945155906282,0.00333890364114957,-0.0456387667272813,-0.032550264453975,1.54687684520086e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37623,-0.0663206157219579,0.00566602603811637,-0.077426026756666,-0.0552152046872498,1.72132793090175e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,40037,0.0512029120893777,0.00438012748800826,0.0426178622128815,0.0597879619658738,1.94375870959751e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40354,0.0705978655229713,0.00604280344448269,0.0587539707717852,0.0824417602741574,2.09311704592054e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,37773,0.1141980945741,0.00977189539753212,0.0950451795949369,0.133351009553263,2.12916444334629e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,40354,0.131822497188592,0.0112870161222182,0.109699945589044,0.153945048788139,2.18897164128826e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39956,0.0573591943985629,0.00491208101436943,0.0477315156103988,0.0669868731867269,2.25648817596851e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39975,0.0794257859289402,0.00680525201539512,0.0660874919787658,0.0927640798791146,2.41679351530236e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,37937,0.111164050842022,0.00952200067192428,0.0925009295250507,0.129827172158994,2.43638616240776e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,40327,0.048537378234864,0.00416152472070942,0.0403807897822735,0.0566939666874544,2.6317797130267e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40210,0.0976737043985109,0.00837862879066841,0.0812515919688008,0.114095816828221,2.82452237176646e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39975,0.0418139518236998,0.00359051003553839,0.0347765521540445,0.048851351493355,3.25442765667507e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37666,-0.0260524542183165,0.00223708180119776,-0.0304371345486641,-0.0216677738879689,3.42585852945139e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40177,0.0297425273643618,0.00255564872793949,0.0247334558576004,0.0347515988711232,3.54688164981498e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37955,0.0802888321736489,0.00689675951120024,0.0667711835316964,0.0938064808156014,3.57042302376634e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,40466,0.0268188106321392,0.00230600269405437,0.0222990453517926,0.0313385759124857,3.86995854139498e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40282,0.0919683789297307,0.00790877778814438,0.0764671744649677,0.107469583394494,3.944393292818e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37937,0.109220288169547,0.00940331558479284,0.0907897896233531,0.127650786715741,4.85418461092003e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37955,0.0388384676425886,0.00334505978072125,0.0322821504723749,0.0453947848128022,5.10496521011256e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGRN,Neugrin,37937,0.0227657060133302,0.00196426183996456,0.0189157528069997,0.0266156592196608,6.4923153598339e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40392,0.113211670330413,0.00977238381454425,0.0940577980539066,0.13236554260692,6.54022933560914e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37895,0.0564020616904779,0.00487379888760851,0.0468494158707653,0.0659547075101906,7.95046989382298e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,40258,0.0871651500172138,0.00754447785841522,0.07237797341472,0.101952326619708,9.41887794106776e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,37716,0.0259903756574674,0.00224894934397857,0.0215824349432694,0.0303983163716654,9.58614607272614e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,39956,0.0736440882855936,0.00637544433910201,0.0611482173809537,0.0861399591902336,9.72500874883074e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,40511,0.0348891941649818,0.00302278377863699,0.0289645379588533,0.0408138503711103,1.0698706003645e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,40417,0.0436355396164608,0.00378214275575407,0.0362225398151829,0.0510485394177388,1.13286126458e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37709,0.0571157772575898,0.00495291866136237,0.0474080566813196,0.0668234978338601,1.27760509053535e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,40263,0.0742564814587481,0.00644403222684394,0.061626178294134,0.0868867846233622,1.33409090701344e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39975,0.0608288611807695,0.005279846255154,0.0504803625206676,0.0711773598408713,1.37766462095474e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,40223,0.0740636522464566,0.00643021261524076,0.0614604355205847,0.0866668689723284,1.41774475608804e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37896,0.0791756387855381,0.00687386153199762,0.0657028701828228,0.0926484073882535,1.48310979513847e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39975,0.0865061986738365,0.00751932149361254,0.071768328546356,0.101244068801317,1.66421092917886e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37623,0.0473596932624658,0.00411547281639774,0.0392933665423263,0.0554260199826054,1.68742844893211e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37955,0.068953346320088,0.0060016659816431,0.0571900809960675,0.0807166116441084,2.07367138463996e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37955,-0.0463989575967208,0.00403989479720019,-0.0543171513992331,-0.0384807637942084,2.16708865478727e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,40324,0.0991708442408739,0.00864027361183589,0.0822359079616755,0.116105780520072,2.2492039627841e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37895,0.0966876098560102,0.0084246101228684,0.0801753740151881,0.113199845696832,2.38897259314898e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,37937,0.0383213824311348,0.00333982748022931,0.0317753205698854,0.0448674442923843,2.4627609385735e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39975,0.0605906393810081,0.00529445811931482,0.0502135014671511,0.0709677772948652,3.32426593190877e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37895,0.0358918179324435,0.00313735537348783,0.0297426014004074,0.0420410344644797,3.63252763496424e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37955,0.0359438018935509,0.00314202181718221,0.0297854391318738,0.0421021646552281,3.64588663840522e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40187,0.096876267379727,0.00847152320530051,0.080272081897338,0.113480452862116,3.65578818851213e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,39975,0.0630589261790972,0.00551490961515538,0.0522497033333927,0.0738681490248017,3.722488705138e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40354,0.0357779419540951,0.00312974066797976,0.0296436502448548,0.0419122336633354,3.81230190354185e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNST,Consortin,40354,0.10965354126086,0.00959490822689576,0.0908475211361444,0.128459561385576,3.95847966007218e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI3,Elafin,40069,0.0542611584147652,0.00474864710402169,0.0449538100908827,0.0635685067386478,4.05359365157646e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40353,-0.101335767036614,0.00888114271977902,-0.118742806767381,-0.0839287273058473,4.86612849391718e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37623,0.0569394446707354,0.00499513974046276,0.0471489707794284,0.0667299185620424,5.84566270907901e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,37567,0.0814184243422129,0.00714812180538756,0.0674081056036533,0.0954287430807725,6.46850027863901e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40367,-0.0300415622778088,0.00263941467702704,-0.0352148150447818,-0.0248683095108358,6.71636399645782e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37937,0.0270364570065503,0.00237641979461012,0.0223786742091145,0.0316942398039861,7.45023078833101e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39956,0.067109452232667,0.0059097875300142,0.0555262686738392,0.0786926357914949,9.11454518980453e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40395,0.0525710438298761,0.00463797683967218,0.0434806092241186,0.0616614784356336,1.14457928975856e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40406,-0.0245146156788705,0.0021651978255701,-0.0287584034169879,-0.0202708279407531,1.32280428249449e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANG,Angiogenin,40304,0.0346956161198085,0.00306569081456032,0.0286868621232703,0.0407043701163468,1.39776749416427e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40173,0.0438282546865832,0.00387847263332957,0.0362264483252572,0.0514300610479092,1.69756989106671e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,37895,0.0382336178016031,0.00338240561043085,0.0316041028051586,0.0448631327980476,1.70956416708756e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40275,0.0760519769931845,0.00673884697067127,0.0628438369306688,0.0892601170557002,2.00253320103978e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,37982,-0.0479460704278866,0.00424904632422229,-0.0562742012233623,-0.0396179396324109,2.13095601859518e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37955,0.0625288886118995,0.00554283609659145,0.0516649298625802,0.0733928473612187,2.20384160246992e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,40466,0.13107049578891,0.0116367318542016,0.108262501354675,0.153878490223145,2.56094536308018e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,40467,0.0233308071628387,0.0020716845991355,0.0192703053485331,0.0273913089771443,2.61210664989706e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37709,0.066818229808546,0.0059386112735686,0.0551785517123516,0.0784579079047405,3.08933822802957e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,40354,0.0764083196279227,0.00679693674237734,0.0630863236128631,0.0897303156429823,3.28349216998762e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37985,0.0275107396633269,0.00244677560815485,0.0227150594713434,0.0323064198553104,3.35211688067669e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,37955,0.0661426067187744,0.00590073192874616,0.0545771721384319,0.0777080412991169,4.93533112670999e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39754,0.0307992383989775,0.00275004283947573,0.025409154433605,0.0361893223643499,5.31347123401855e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,40485,0.0267787271279561,0.00239202046301773,0.0220903670204413,0.0314670872354708,5.52413844169685e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,40202,0.0448140065717421,0.0040035094514216,0.0369671280469557,0.0526608850965284,5.63270751123393e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37593,0.0402940672495629,0.00359849206990592,0.0332410227925473,0.0473471117065785,5.67309931594031e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,40424,-0.0255331031304158,0.00228437625591263,-0.0300104805920045,-0.021055725668827,6.74372807197499e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37985,0.0705153593803303,0.00631144143636724,0.0581449341650505,0.08288578459561,7.42431398483127e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37557,0.0668617534437082,0.00598959151191378,0.0551221540803572,0.0786013528070592,8.34448100839934e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,39956,0.0609238499140687,0.00546590217350018,0.0502106816540084,0.0716370181741291,9.61403574680828e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37557,0.0431373906968048,0.00387122099721995,0.0355497975422537,0.0507249838513559,1.04137624213607e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,37985,0.0711723870963994,0.00638840695429328,0.0586511094659846,0.0836936647268142,1.05763103361456e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39975,0.0649377246170719,0.00583563587669342,0.0534998782987528,0.076375570935391,1.17936954145143e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37896,0.0871018604525035,0.00782851479023139,0.07175797146365,0.102445749441357,1.24690284892978e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGN,Biglycan,39951,-0.120290456453423,0.0108188354723833,-0.141495373979295,-0.0990855389275521,1.30658384791183e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,40319,0.10152789876655,0.00913788314436974,0.0836176478035858,0.119438149729515,1.4192187490596e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFB,Complement factor B,37765,0.0324965977792331,0.00292580597616259,0.0267620180659544,0.0382311774925117,1.54995366391182e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,37593,0.0415407619270673,0.00374079592341582,0.0342088019171723,0.0488727219369623,1.592356970217e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37896,0.112288061145974,0.0101200112766366,0.0924528390437664,0.132123283248182,1.75081271316923e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40223,0.0342817963926455,0.00309187284410777,0.0282217256181943,0.0403418671670967,1.83364527547801e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37593,0.091454220899163,0.00824803165212872,0.0752880788609907,0.107620362937335,1.91790607580401e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37896,0.100873979574968,0.00910793933666935,0.0830224184750959,0.11872554067484,2.1910385855023e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40177,0.0293600910735512,0.00265355730232532,0.0241591187609936,0.0345610633861088,2.37494984193169e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40417,0.116784755416519,0.010562189826142,0.0960828633572806,0.137486647475757,2.57280014681798e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40354,0.0566008582878384,0.005120603289999,0.0465644758394403,0.0666372407362364,2.67141939159048e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39918,0.0744834385973456,0.00673947962204157,0.0612740585381441,0.0876928186565471,2.74160991150149e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40336,0.0835013502975683,0.00756038788382415,0.068682990045273,0.0983197105498636,2.95055617840948e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40300,0.0352017963518623,0.00319765349850632,0.0289343954947899,0.0414691972089347,4.38908191928624e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,37937,0.0821726964238576,0.00746516981499077,0.0675409635864758,0.0968044292612395,4.63038919994425e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40039,0.0647572327256304,0.0058883239602551,0.0532161177635304,0.0762983476877304,4.97708496321414e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37830,0.0576974177091642,0.00524621999860034,0.0474148265119075,0.0679800089064208,5.15563204379565e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37623,0.0912253634644783,0.0083123066264006,0.0749332424767332,0.107517484452224,6.67705740708648e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40484,0.0565433351329214,0.00515668765338115,0.0464362273322944,0.0666504429335485,7.06811758022637e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37593,0.0439026518869014,0.00400784390865319,0.0360472778259411,0.0517580259478616,8.368263564542e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37982,0.0236466862320445,0.0021595070462088,0.0194140524214753,0.0278793200426138,8.68746396055441e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,39920,0.0434355642161005,0.00396825450633428,0.0356577853836853,0.0512133430485157,8.8045951678113e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,37567,0.0442026206453243,0.00403858831274868,0.0362869875523369,0.0521182537383117,9.25073698746707e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,40255,0.0551489445549736,0.0050424252349293,0.0452657910945122,0.065032098015435,9.64433205068014e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40327,-0.0419353226121123,0.00383718721817369,-0.0494562095597328,-0.0344144356644919,1.0553170917177e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37666,0.0852732090463563,0.00780527111326188,0.069974877664363,0.10057154042835,1.14848837901497e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,40319,0.0806549978950964,0.00738971067764489,0.0661711649669124,0.0951388308232803,1.23212349942623e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40484,0.0328260281560886,0.00300858694003814,0.0269291977536139,0.0387228585585634,1.28025529930569e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39975,0.0441147501543616,0.0040450826838979,0.0361863880939217,0.0520431122148015,1.36207033267629e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40284,0.0266684596574077,0.00244598346173633,0.0218743320724045,0.0314625872424109,1.39824664548819e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,37567,0.0475005682410872,0.00435843750474658,0.0389580307317839,0.0560431057503904,1.53717351755375e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40300,0.0231852232683333,0.00213292031573815,0.0190046994494865,0.0273657470871801,1.9980407241081e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40300,0.0914200338534093,0.00841372134784752,0.0749291400116281,0.10791092769519,2.10031532750601e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,39752,0.0898782689547455,0.00827204964647609,0.0736650516476524,0.106091486261839,2.12377334229747e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,40336,-0.0412288442113609,0.00379571476815475,-0.0486684451569442,-0.0337892432657776,2.18410399196937e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40445,0.029296002773625,0.00269944831523626,0.0240050840757619,0.0345869214714881,2.41422836348171e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,40336,0.0651364208870012,0.00600424199955432,0.0533681065678747,0.0769047352061277,2.53037763740435e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,37397,0.0765374184324325,0.0070583890901999,0.0627029758156407,0.0903718610492243,2.80556925491697e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40352,0.0383925380514856,0.00354220603374869,0.0314498142253382,0.045335261877633,2.8138950228882e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,40300,0.0398434522696066,0.00368027583166054,0.0326301116395519,0.0470567928996612,3.22051576374238e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,39975,0.0782920528267887,0.00724267494393388,0.0640964099366783,0.0924876957168991,3.8634033365525e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,39975,0.0515084218964522,0.00476808883592081,0.0421629677780474,0.0608538760148569,4.17114366052792e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40037,0.10623844216965,0.0098378420249111,0.0869562718008245,0.125520612538476,4.34139049740898e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37895,0.0489135787297065,0.00452975965171953,0.0400352498123363,0.0577919076470768,4.52932861215906e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,40374,0.0231317509604655,0.00214381107793861,0.0189298812477058,0.0273336206732251,4.75977232047334e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,40198,0.0507620090877536,0.00470617039666022,0.0415379151102995,0.0599861030652076,4.96822079635347e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40336,0.0508796770523599,0.00471821114892697,0.041631983200463,0.0601273709042567,5.09935961075278e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,40406,0.0395454356030197,0.00366949577619166,0.032353223881684,0.0467376473243553,5.48701464717454e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39975,0.0888642066287634,0.00825082093297078,0.0726925976001406,0.105035815657386,5.91755282346766e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40037,0.0362536879863924,0.00336676509060835,0.0296548284088,0.0428525475639848,6.05691983128981e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37937,0.0957652233272651,0.00889707362394129,0.0783269590243402,0.11320348763019,6.57122102631037e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37896,0.0449356692344518,0.00417640751885206,0.0367499104975018,0.0531214279714019,6.88539485057352e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,40306,0.0841528488079379,0.00782698178313867,0.0688119645129861,0.0994937331028897,7.20639507464286e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,37666,0.0673760038400549,0.00627567790155367,0.0550756751530097,0.0796763325271001,8.88819184094835e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,40204,0.064671901818524,0.00602956219645789,0.0528539599134666,0.0764898437235815,9.52637910373603e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40398,0.0259651350681336,0.00242095300335345,0.0212200671815608,0.0307102029547063,9.56668339734505e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37955,0.0455687082100847,0.00425010024212413,0.0372385117355214,0.053898904684648,1.03012510483544e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37955,0.0473502611509531,0.00441695188429916,0.0386930354577267,0.0560074868441794,1.04878634407739e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39975,0.0815515718439854,0.00761834283147329,0.0666196198942978,0.0964835237936731,1.19925939569762e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,37895,0.0606841201712074,0.00567215522260012,0.0495666959349112,0.0718015444075037,1.32210125299166e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,40511,0.0727387963704874,0.00680534565394844,0.0594003188887485,0.0860772738522264,1.41572708898092e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37709,0.0668109264821228,0.00625257419278249,0.0545558810642691,0.0790659718999765,1.52860602933211e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39975,0.0472778764217017,0.00442737754295451,0.0386002164375108,0.0559555364058925,1.58590956563229e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,37895,0.0370775704947898,0.0034777446665686,0.0302611909483153,0.0438939500412642,1.96746273310165e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,40336,0.0609695819328022,0.00572396024152997,0.0497506198594035,0.072188544006201,2.1033178919548e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,39956,0.0588214629915539,0.00552469503045321,0.0479930607318656,0.0696498652512422,2.22101921786362e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37557,0.0642015261426637,0.0060433820839278,0.0523564972581652,0.0760465550271622,2.96469157622521e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37858,0.0411708000606331,0.00387838138904596,0.033569172538103,0.0487724275831632,3.20942737495792e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37993,0.0211857940671233,0.00199632563324878,0.0172729958259557,0.0250985923082909,3.30774130762047e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37567,0.0683171106812393,0.00644108867003336,0.0556925768879739,0.0809416444745047,3.55000593739594e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,40417,0.030939199732902,0.00291931792242385,0.0252173366049512,0.0366610628608527,3.71500032204255e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,37962,0.0534365204935288,0.00504073405841652,0.0435566817390324,0.0633163592480252,3.73721767768187e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40511,0.0243912139317083,0.00230306721284442,0.0198772021945332,0.0289052256688833,4.01128039214131e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37666,0.0894262360968472,0.00844555345446546,0.0728729513260949,0.1059795208676,4.28374005662373e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40223,0.0277044595262808,0.00262101532065975,0.0225672694977877,0.0328416495547739,5.00944402510047e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,40429,0.0581552960035173,0.00550337733652823,0.047368676423922,0.0689419155831126,5.15366093864294e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37567,0.040778918142608,0.00386467086249522,0.0332041632521174,0.0483536730330986,6.33535157562714e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37666,0.0240950908865411,0.0022861681881693,0.0196142012377292,0.0285759805353529,7.19342880626941e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40354,0.0599837795372944,0.00569639610011863,0.0488188431810619,0.0711487158935269,7.63254927219184e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,40039,0.0620785942222426,0.00589651717821591,0.0505214205529394,0.0736357678915458,7.83574194254472e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40336,0.114614662076847,0.0108894999193919,0.0932712422348391,0.135958081918855,8.03765729216485e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,37567,0.0644057643723177,0.00613142996829576,0.052388161634458,0.0764233671101774,1.04502393356307e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,40283,0.0821445855287705,0.00782466935804802,0.0668082335869963,0.0974809374705446,1.06985506542414e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,38008,0.0391611977025555,0.00373043934849799,0.0318495365794995,0.0464728588256116,1.10990983111201e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,40043,0.0388387832806,0.00370651480994286,0.031574014253112,0.046103552308088,1.31894602987451e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,40531,-0.0257311871059275,0.00245614862952987,-0.0305452384198061,-0.020917135792049,1.3429931607282e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39975,0.0444350050739767,0.00424133253843012,0.0361219932986537,0.0527480168492998,1.34605598535146e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40417,0.0965475856807824,0.00921729980826534,0.0784816780565824,0.114613493304983,1.36797889482373e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,37623,0.0687128909836226,0.00656303544623213,0.0558493415090076,0.0815764404582376,1.49966989984903e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,40037,0.044175110950108,0.00422207688123979,0.035899840262878,0.052450381637338,1.55410166246025e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,40211,0.04513047627505,0.00431354636161727,0.0366759254062802,0.0535850271438199,1.55708251240915e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37666,0.104383473636613,0.00998028413931493,0.0848221167235558,0.12394483054967,1.67645650496528e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,37937,0.127072996011284,0.0121572906663929,0.103244706305154,0.150901285717415,1.78732676468395e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37666,0.0830940627349496,0.00795507233960885,0.0675021209493162,0.0986860045205829,1.93170575596644e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,37896,0.0638422137587353,0.00611551082162728,0.0518558125483459,0.0758286149691248,2.04933428062465e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40037,0.0454112420088466,0.0043519490275508,0.036881421914847,0.0539410621028462,2.08776057962014e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,40300,0.0335699060919987,0.0032179568248295,0.0272627107153328,0.0398771014686645,2.13924776472852e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37709,0.0683173704250915,0.00654920279306825,0.0554809329506777,0.0811538078995053,2.23466589729187e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,37557,0.0624674162668757,0.00599678317042636,0.05071372125284,0.0742211112809114,2.60859910057383e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37593,0.0454357695810747,0.00436396760761368,0.0368823930701519,0.0539891460919975,2.75353161444769e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37666,0.0965594508600326,0.00928508352270244,0.0783606871555358,0.114758214564529,3.12130142907799e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37955,0.0634450453182367,0.00610114027587124,0.0514868103775291,0.0754032802589444,3.12373604499244e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40300,0.050577790943011,0.00487781892334566,0.0410172658532535,0.0601383160327685,4.13053641466281e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,40187,0.0288173595956603,0.00277962614641286,0.0233692923486911,0.0342654268426295,4.20468183975517e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40037,0.0516990892773074,0.00499073682886199,0.0419172450927379,0.0614809334618769,4.59339950313942e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37567,0.0567236425214001,0.00548096199668071,0.0459809570079059,0.0674663280348943,5.26581245761567e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37993,0.0760223834540444,0.00737073930493348,0.0615757344163748,0.090469032491714,7.52155302185596e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40466,0.0443027029328475,0.00429741141607007,0.0358797765573502,0.0527256293083448,7.6603872434297e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40406,0.07671460504321,0.00744228765901722,0.0621277212315362,0.0913014888548837,7.7633371276462e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,40336,0.0486682140348139,0.00472475512956144,0.0394076939808734,0.0579287340887543,8.37356172500872e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,37536,0.0505700375160582,0.0049151641159205,0.040936315848854,0.0602037591832624,9.85658501119598e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40300,0.049311660291551,0.0047957719741127,0.0399119472222901,0.0587113733608119,1.01247020457263e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,40354,0.0628673750809926,0.00611838245873951,0.0508753454618631,0.074859404700122,1.08931207480356e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,40336,0.0649678538498242,0.00632569441285133,0.0525694928006356,0.0773662148990129,1.14348734935395e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,39946,0.101127800757308,0.00984843008742007,0.0818248777859644,0.120430723728651,1.17310473224103e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37593,0.0519555038054242,0.00506394717875947,0.0420301673350557,0.0618808402757928,1.32284805133317e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37666,0.0379528506837012,0.00370275382549079,0.0306954531857393,0.0452102481816632,1.46395200501919e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37955,0.0848590593609747,0.00828483495517632,0.0686207828488291,0.10109733587312,1.56914308935644e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37536,0.0913817113636342,0.00892966662655901,0.0738795647755786,0.10888385795169,1.73575048048757e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,40336,0.0279941631747237,0.00273826442747764,0.0226271648968675,0.0333611614525798,1.85614321568272e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40406,0.0220283063030336,0.00215635761373114,0.0178018453801205,0.0262547672259466,2.00922790767372e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37557,0.0572222799711155,0.00561275749189362,0.046221275287004,0.068223284655227,2.57148159043664e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,40327,0.0668238267970534,0.00657050631208138,0.0539456344253739,0.079702019168733,3.19351846843897e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,40037,0.0675911547317337,0.00665017775623,0.0545568063295229,0.0806255031339445,3.42172440272178e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37623,0.0507150192092611,0.00498989971733385,0.0409348157632868,0.0604952226552355,3.54181423984075e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40327,0.0325871058460379,0.00320873230679634,0.0262979905247171,0.0388762211673587,3.70270173783283e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37955,0.0543413607512845,0.00535046805772584,0.0438544433581418,0.0648282781444271,3.79047351879842e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37593,0.0635903795602202,0.00626752038112931,0.0513060396132068,0.0758747195072337,4.23452369622729e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37623,0.0402117399244401,0.00397912942464886,0.0324126462521283,0.0480108335967519,6.37363877460134e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POSTN,Periostin,37993,-0.0341361752148465,0.00337848282869854,-0.0407580015590957,-0.0275143488705974,6.44686078868071e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39892,0.0514996498722795,0.00509961634272657,0.0415044018405354,0.0614948979040235,6.63948561967452e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40223,0.0229321561132476,0.00227562686459896,0.0184719274586336,0.0273923847678616,8.21874667565155e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,39956,0.0634269798508297,0.00629545554668561,0.0510878869793259,0.0757660727223335,8.43173544237765e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40511,0.0260557130593852,0.00258696989271545,0.0209852520696629,0.0311261740491075,8.65305313219441e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37955,0.112803816785941,0.011210612544948,0.0908310161978432,0.134776617374039,9.83652810295525e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,40484,-0.0146614702240407,0.00145793759419793,-0.0175190279086686,-0.0118039125394127,1.01316849252198e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40354,0.0303172243077551,0.00301681541709479,0.0244042660902494,0.0362301825252609,1.08757505389478e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,37985,0.0468947588511853,0.0046655383892426,0.0377503036082698,0.0560392140941008,1.09771939221796e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,40466,0.0328096805842378,0.00326666691637543,0.026407013428142,0.0392123477403337,1.1498275102801e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,40039,0.0422562983857465,0.00421107927312183,0.0340025830104277,0.0505100137610653,1.26735750747396e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40327,-0.0241248261492547,0.00240504908332627,-0.0288387223525742,-0.0194109299459352,1.31080865191726e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,40531,0.0784446685580703,0.00782886971008858,0.0631000839262967,0.0937892531898439,1.46099239605245e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37985,0.0289127947281158,0.00288738171599057,0.0232535265647743,0.0345720628914573,1.60545404851635e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37895,0.0439772540569726,0.0043933828362774,0.0353662236978689,0.0525882844160764,1.66685342878841e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37557,0.0596367230097542,0.00595994812508736,0.047955224684583,0.0713182213349254,1.73718099537478e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,40387,0.0286848671690185,0.00286902278247047,0.0230615825153764,0.0343081518226607,1.82105345329994e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,37819,0.0261834218571526,0.0026204078452909,0.0210474224803824,0.0313194212339228,1.99393551359329e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,40209,0.0204570483360662,0.00204855754439758,0.016441875549047,0.0244722211230855,2.05874919741577e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,40283,0.0966575068674681,0.00968070582597482,0.0776833234485575,0.115631690286379,2.08884881004314e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,40511,0.0241474619305822,0.0024225835125067,0.019399198246069,0.0288957256150953,2.46846083560699e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40354,-0.0238700761028092,0.00239647627564671,-0.0285671696030767,-0.0191729826025416,2.65575013606752e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39956,0.0466510178561669,0.00468853413065786,0.0374614909600775,0.0558405447522563,2.96036254339141e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37557,0.0600996311553399,0.00604123646389754,0.0482588076861007,0.0719404546245791,3.10306594877397e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,39941,0.049958528324715,0.00502332383347135,0.0401128136111112,0.0598042430383189,3.10332230641165e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,40309,0.0358526225556775,0.0036056939781502,0.0287854623585031,0.0429197827528519,3.15349215471286e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37955,0.051910800188406,0.00522052822999531,0.0416785648576152,0.0621430355191968,3.23204560809017e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,40266,0.0478827322764691,0.00483029894733295,0.0384153463396966,0.0573501182132417,4.26848661147447e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39975,0.0676966342079287,0.00683838531709959,0.0542933989864135,0.0810998694294439,4.89530703730695e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,40327,-0.0224620780083262,0.0022709627233357,-0.0269131649460642,-0.0180109910705882,5.30874962142155e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37709,0.0594231287508732,0.00601465531964166,0.0476344043243755,0.0712118531773708,6.11757257855103e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD248,Endosialin,37993,-0.0353201887132744,0.00357557483372092,-0.0423283153873674,-0.0283120620391814,6.18790694930385e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,37985,0.0494791876057837,0.00501131736133326,0.0396570055775705,0.0593013696339968,6.48314426576321e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,37982,0.0797876009011374,0.00809544173850919,0.0639205350936594,0.0956546667086154,7.71814829660708e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37937,-0.0358399982991097,0.0036373751537242,-0.0429692536004092,-0.0287107429978103,7.92438682980175e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,39975,0.0849254215447932,0.00863471021683695,0.0680013895197928,0.101849453569794,9.24135555475631e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37709,0.0324993305403195,0.00330910846056217,0.0260134779576177,0.0389851831230214,1.09079446945955e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37623,0.0677007501232174,0.00689709286175943,0.0541824481141689,0.0812190521322659,1.15096420323558e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37593,0.0697996074729562,0.00712254234548113,0.0558394244758132,0.0837597904700993,1.34796566916317e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40484,0.0470284653556561,0.00480792766964648,0.037604927123149,0.0564520035881632,1.56398946584453e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,40391,0.0265575535816546,0.00271887941201459,0.021228549934106,0.0318865572292032,1.7890644185407e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,37814,0.0389423039788039,0.00398583843368551,0.0311300606487803,0.0467545473088275,1.79799830137153e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40511,0.0602166701581572,0.00616944550082252,0.048124556976545,0.0723087833397693,1.92095129446743e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,40012,0.0486068584814884,0.00498128024428047,0.0388435492026986,0.0583701677602781,1.97885692913468e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39975,0.0589223278198448,0.00604345474436951,0.0470771565208806,0.070767499118809,2.14360799147736e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,40354,0.0588948878173319,0.0060435922880788,0.0470494469326975,0.0707403287019664,2.23803260903549e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39975,0.0421940861812971,0.00433059074509361,0.0337061283209136,0.0506820440416806,2.28468225752193e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37567,0.0601623395291915,0.00617602727506818,0.0480573260700579,0.0722673529883251,2.39333933004872e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40336,0.0323983424877642,0.00333017268813479,0.02587120401902,0.0389254809565084,2.62484599209609e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,37562,0.0373443101265006,0.00383913556951611,0.029819604410249,0.0448690158427521,2.74405456466205e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,37623,0.0358531913584168,0.00369240197397265,0.0286160834894304,0.0430902992274032,3.24495000717772e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37993,0.0537362073850835,0.00553801212538894,0.0428817036193212,0.0645907111508459,3.45212493065422e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,40134,0.0661836231883078,0.00682573256826094,0.0528051873545164,0.0795620590220992,3.61185090796714e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,40354,-0.0264563894907606,0.00273417514883576,-0.0318153727824787,-0.0210974061990425,4.37938357427575e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,37623,0.0437714285508012,0.0045337420160943,0.0348852941992563,0.052657562902346,5.55817123583206e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40336,0.086276571887995,0.00894193405337257,0.0687503811433848,0.103802762632605,5.72856252226637e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,37896,0.0586904401175844,0.0060845895490321,0.0467646446014815,0.0706162356336874,6.03449976219479e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40305,0.058263891689332,0.00604911369988228,0.0464076288375628,0.0701201545411013,6.73798445695175e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37985,0.0408418673959289,0.00424334431200605,0.0325249125443971,0.0491588222474608,7.37309000910902e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,39956,0.0378328087857612,0.00393317525932027,0.0301237852774934,0.0455418322940289,7.6574508018293e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39975,0.0378506265681931,0.0039373833340528,0.0301333552334496,0.0455678979029366,8.09383040050474e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37896,0.0840054277128063,0.0087461366659656,0.0668629998475137,0.101147855578099,8.95772394195752e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37557,0.0583266053669008,0.00607407303359984,0.0464214222210451,0.0702317885127565,9.19729711298213e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37985,0.0214835179515215,0.00224408283452726,0.017085115595848,0.0258819203071949,1.21124790045905e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37567,0.0529847955337785,0.00553828676311677,0.0421297534780697,0.0638398375894874,1.29458257864964e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40336,0.0400011037913403,0.0041858466238879,0.03179684440852,0.0482053631741606,1.39520658341205e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,40253,0.035652600009884,0.00373339839935235,0.0283351391471534,0.0429700608726146,1.48805590395493e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37557,0.0593488372704115,0.00622017168845159,0.0471573007610464,0.0715403737797766,1.65582374064533e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,37916,0.0271451564281575,0.00284784841592893,0.0215633735329368,0.0327269393233782,1.80643038241351e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37220,0.0920965593100671,0.00966302294341541,0.0731570343409729,0.111036084279161,1.83910334132612e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39975,0.0838266776438818,0.00879908802690501,0.0665804651111479,0.101072890176616,1.85755792587172e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,40531,0.0273801013464924,0.00287457328994871,0.021745937698193,0.0330142649947919,1.88141751400939e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,40294,0.0240668865201696,0.00252816374762543,0.0191116855748237,0.0290220874655154,1.98533375857944e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40417,0.0737230097851516,0.00775029079552961,0.0585324398259136,0.0889135797443897,2.12518598192904e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,37896,0.0296346942259716,0.00311938537316791,0.0235206988945625,0.0357486895573807,2.4446474325101e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,40354,-0.0440044163684053,0.00463718049918922,-0.0530932901468162,-0.0349155425899944,2.64383337140857e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37593,0.0344758719012041,0.00363293374799864,0.0273553217551268,0.0415964220472815,2.70783983309636e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40429,0.028522443564591,0.00300759106754084,0.0226275650722109,0.034417322056971,2.79760387759592e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAST,Gastrin,37937,0.11027309390574,0.011627446144918,0.0874832994617002,0.133062888349779,2.85446008795403e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40223,0.0590106063238603,0.00622677528386976,0.0468061267674756,0.0712150858802451,2.98340159012507e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37937,0.0185711409520037,0.00196082018283781,0.0147279333936416,0.0224143485103658,3.22283223343111e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40374,-0.0267092145999447,0.00282280318506278,-0.0322419088426677,-0.0211765203572216,3.43595285860304e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,37900,0.0812984931791755,0.0085989638026711,0.0644445241259401,0.0981524622324108,3.77711396978756e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37557,0.103204250665721,0.0109401985284673,0.0817614615499255,0.124647039781517,4.62598002005744e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPL,Periplakin,37593,0.0278218268689543,0.00295278495574448,0.0220343683556951,0.0336092853822135,5.1440803102419e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40484,0.0271977914098968,0.00289023849594167,0.0215329239578511,0.0328626588619425,5.60759480853577e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40039,0.0298614917888437,0.0031744460775821,0.0236395774767828,0.0360834061009047,5.81078765128662e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,40336,0.065460816925781,0.00696805428040001,0.0518034305361969,0.079118203315365,6.51886682637345e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,40179,-0.0392365563239177,0.00418050203640419,-0.0474303403152699,-0.0310427723325655,7.09306043403121e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37785,0.046975545034082,0.00500473752686142,0.0371662594814336,0.0567848305867303,7.21283777565455e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMD,Dystrophin,37623,0.0435613881425833,0.00464471162864618,0.0344577533504367,0.0526650229347298,7.755777116444e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGN,Mimecan,40327,0.034022999911603,0.00363102116374598,0.0269061984306609,0.0411398013925451,8.20117545503293e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40268,0.0280992884764189,0.00300037233289818,0.0222185587039385,0.0339800182488993,8.58640495658643e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40039,0.0483557523410041,0.00516322805029703,0.0382358253624219,0.0584756793195862,8.59035415668108e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH1,Somatotropin,40325,-0.146056071453419,0.0156018980980701,-0.176635791725637,-0.115476351181202,8.89838795232673e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39956,0.0319031274041499,0.0034100257746935,0.0252194768857506,0.0385867779225492,9.42012506757754e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37993,0.0335287182670706,0.00359260632776063,0.0264872098646598,0.0405702266694814,1.19031992383983e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,40286,0.0587489396864037,0.00629662295023901,0.0464075587039353,0.0710903206688722,1.19341998740387e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,39929,0.0741344707418062,0.00795189325588118,0.058548759960279,0.0897201815233333,1.28228991263485e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,40274,0.0595737085583827,0.00639494843021003,0.0470396096351711,0.0721078074815944,1.36715474231705e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40354,0.0405083871371075,0.00435402598247281,0.0319744962114608,0.0490422780627542,1.52999264673646e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37985,0.073469761119823,0.00789934262391671,0.0579870495769462,0.0889524726626997,1.60556067330626e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,37985,0.0445151361826648,0.00478822257444136,0.0351302199367597,0.0539000524285698,1.66586783572144e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37955,0.0603066106965357,0.00649603663503425,0.0475743788918686,0.0730388425012029,1.88487250662926e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37955,0.0393651087397424,0.00424078570947827,0.031053168749165,0.0476770487303198,1.90426334280006e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37557,0.0296611932045683,0.00320001409173203,0.0233891655847735,0.035933220824363,2.1671634932771e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37982,0.0435205526428344,0.00471816233627726,0.034272954463731,0.0527681508219378,3.27876147910108e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40328,0.0796665373296025,0.00864927964024159,0.062713949234729,0.0966191254244761,3.63464686467064e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39956,0.0919755709879307,0.00999143594975984,0.0723923565264015,0.11155878544946,3.82920336243788e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40512,0.0222969574620063,0.00242231998220176,0.0175492102968909,0.0270447046271218,3.83653257758194e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40448,0.0542034159411208,0.00589155298677567,0.0426559720870405,0.0657508597952011,4.00540506887295e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37895,0.0505213989740516,0.00549276843843077,0.0397555728347272,0.0612872251133759,4.18428439421808e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,39872,0.0697027366076342,0.00758143442037335,0.0548431251437024,0.084562348071566,4.26468566153043e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37623,0.0840802525042639,0.00914342474175839,0.0661591400104175,0.10200136499811,4.27805108301435e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40336,0.0975376069968958,0.0106100825465143,0.0767418452057279,0.118333368788064,4.28775680752878e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,40391,0.0466514425533745,0.00507715382675526,0.0367002210529342,0.0566026640538148,4.46464838183799e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,37557,0.032443234465314,0.00353065241692482,0.0255231557281413,0.0393633132024866,4.55385453722024e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37895,0.0238435289943427,0.00259557735176942,0.0187561973848746,0.0289308606038107,4.65720794285757e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40037,0.0430475313913223,0.00469173508391081,0.0338517306268571,0.0522433321557875,5.06228582283474e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,40393,0.0522707742280059,0.00570326977779728,0.0410923654635233,0.0634491829924886,5.54400439063881e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,40168,0.0845669983982349,0.00923653875259475,0.0664633824431492,0.102670614353321,6.05284665325386e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37557,0.0303217229873525,0.0033126849640053,0.0238288604579022,0.0368145855168029,6.33459212467836e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,39956,0.0427171255660888,0.00467075167608695,0.0335624522809584,0.0518717988512192,6.6493003468985e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,37623,0.0956255605778229,0.0104566580532603,0.0751305107934327,0.116120610362213,6.83067669545743e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,39975,0.0560864478397664,0.00613741112803866,0.0440571220288106,0.0681157736507221,7.10430902382451e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,37976,-0.0295887716439785,0.00323892374959064,-0.0359370621931762,-0.0232404810947809,7.43268475831907e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39920,0.0382467046637089,0.00419287592601402,0.0300286678487214,0.0464647414786964,8.27992467371064e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37623,0.0634849433149998,0.00696085564132741,0.0498416662579981,0.0771282203720016,8.56680558023637e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,39985,0.07293083672708,0.00800715883842578,0.0572368054037655,0.0886248680503945,9.37791690058284e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37593,0.0275199495683237,0.00302213663792924,0.0215965617579824,0.033443337378665,9.75613251559036e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37937,0.0306013397372572,0.0033606882742435,0.0240143907197399,0.0371882887547744,9.76302126150347e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37895,0.0334851306394661,0.00367875407172403,0.026274772658887,0.0406954886200452,1.00733954585939e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37993,0.0210606964664339,0.00231472698864972,0.0165238315686804,0.0255975613641874,1.04139902030423e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBN1,Drebrin,37593,0.0421036879799679,0.00462794856785012,0.0330329087869817,0.0511744671729541,1.05379603856029e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40300,0.0497073583169643,0.0054666359341623,0.0389927518860061,0.0604219647479224,1.07689375841729e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37895,0.0878106225084143,0.00965565606582357,0.0688855366194001,0.106735708397429,1.08468941477361e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37874,0.0338760787387575,0.00372648585561005,0.0265721664617618,0.0411799910157532,1.12114164194679e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39920,0.0534595036152188,0.00588410971102326,0.0419266485816132,0.0649923586488243,1.15604158750029e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37896,0.0370199251778713,0.00407402903041406,0.0290348282782597,0.0450050220774828,1.16066665788089e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40466,0.0770628491354034,0.00850333779158088,0.0603963070639049,0.0937293912069019,1.41756173975467e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLGN,Calmegin,37567,0.0361419803580616,0.00398900031231006,0.0283235397459339,0.0439604209701893,1.48154893643335e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,40417,-0.0357379991360159,0.00394987527929514,-0.0434797546834344,-0.0279962435885974,1.62253841538614e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,39919,0.0548110388130754,0.00605923644913108,0.0429349353727785,0.0666871422533723,1.65827326964165e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40223,0.047208116976137,0.00521936167648517,0.0369781680902261,0.057438065862048,1.67079307556146e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37955,0.0562861146053125,0.00622173973961085,0.0440915047156752,0.0684807244949498,1.67252133233064e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37939,0.0179119307647349,0.00198076102010631,0.0140296391653265,0.0217942223641433,1.73051294008521e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37709,0.0600884912638526,0.00664969084487552,0.0470550972078966,0.0731218853198086,1.84273178365757e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,40327,0.0729924165599068,0.00808101038646518,0.057153636202435,0.0888311969173785,1.86601164774885e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,40039,0.0911920497101683,0.0101278727481053,0.0713414191238818,0.111042680296455,2.42224634808365e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37623,0.0405022767344116,0.00449947760666412,0.0316833006253499,0.0493212528434733,2.52729239545422e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40320,0.0179378411560806,0.00199474386475417,0.0140281431811625,0.0218475391309988,2.68349032006689e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37937,0.0477001282202212,0.00530797261859081,0.0372965018877832,0.0581037545526592,2.88732305590921e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,40223,0.0487318537314194,0.00542591987785257,0.0380970507708284,0.0593666566920104,2.97288849295685e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,37955,0.055138585699243,0.00613957956338707,0.0431050097550044,0.0671721616434817,3.03852477221259e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40511,0.0468077088786992,0.00521821972125011,0.036579998225049,0.0570354195323494,3.28503659471625e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,40037,0.0286974559458336,0.00320009575219922,0.0224252682715231,0.0349696436201441,3.36649141159292e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,37937,0.0244469448131584,0.00273162004552496,0.0190929695239295,0.0298009201023873,4.02776716808771e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37955,0.0721294595181805,0.00806309057323979,0.0563258019946305,0.0879331170417305,4.1740261916202e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39975,0.0639075054702955,0.00715184182608453,0.0498898954911698,0.0779251154494211,4.48900302053284e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40327,0.0238045158129805,0.00266776816430679,0.0185756902109392,0.0290333414150218,5.02516623233891e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,40391,0.0685062904743451,0.00768446471513258,0.0534447396326853,0.083567841316005,5.40227871171985e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37982,0.0313834267582331,0.00352638278431549,0.0244717165009748,0.0382951370154915,6.30859812923591e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40417,0.0208970652477914,0.00235411609790269,0.0162829976959021,0.0255111327996807,7.59858156253501e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,37693,0.0244322163146646,0.00275204090761606,0.0190382161357371,0.0298262164935921,7.68360642483129e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,40374,0.0384591082683761,0.00433665306751596,0.0299592682560448,0.0469589482807073,8.19584655082852e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,37477,0.0410956327234872,0.00463742998903086,0.0320062699449867,0.0501849955019877,8.89085444010299e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40286,0.0271991050313995,0.00307291301484612,0.0211761955223011,0.0332220145404979,9.55596159740117e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40037,0.0452206770636381,0.00511474832192159,0.0351957703526718,0.0552455837746045,1.04643330833591e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37623,0.0579461685976558,0.00655623935208502,0.0450959394675691,0.0707963977277424,1.093680703161e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,37623,0.0537074713296744,0.00608143313100413,0.0417878623929063,0.0656270802664425,1.16330446822053e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40398,0.0325318616859302,0.00368639569804367,0.0253065261177646,0.0397571972540958,1.20803272394861e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37623,0.0326928796257513,0.00370913089552998,0.0254229830705125,0.03996277618099,1.3555583750218e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,37557,0.0316282557373377,0.00359379204160136,0.024584423335799,0.0386720881388764,1.52689496625477e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,37623,0.0731271767632465,0.00831304060425102,0.0568336171789145,0.0894207363475785,1.58273160557785e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37593,0.0247183958409227,0.00281036357576266,0.0192100832324279,0.0302267084494175,1.60060167113023e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37557,0.0302462557196875,0.0034430197182995,0.0234979370718205,0.0369945743675545,1.75917644130725e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,40344,0.0333359253302346,0.00379604989500352,0.0258956675360277,0.0407761831244415,1.77122972377128e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,37666,0.0405694422011689,0.00461888135043686,0.0315164347543126,0.0496224496480251,1.77960457955012e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40352,-0.0264951243607741,0.00301908689968044,-0.0324125346841477,-0.0205777140374004,1.86550772665369e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37937,0.0228429376852169,0.00260579657018911,0.0177355764076462,0.0279502989627875,2.06673178368143e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40220,0.0455990083629257,0.00520399398170525,0.0353991801587834,0.055798836567068,2.10474002503318e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40427,0.0217908777311374,0.00248862303072905,0.0169131765909085,0.0266685788713663,2.21867259651121e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37666,0.031687460809439,0.00361970258857135,0.0245928437358391,0.0387820778830388,2.30354896108635e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37985,0.046560220520274,0.00532172838994792,0.0361296328759761,0.0569908081645719,2.40266657969233e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40309,0.0853022120914764,0.00975589058219314,0.0661806665503779,0.104423757632575,2.47976466323663e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37557,0.021850970736529,0.0025056236431693,0.0169399483959171,0.0267619930771408,3.09303441026151e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,40223,0.0434016091396754,0.00498643939951789,0.0336281879166203,0.0531750303627304,3.51860846708734e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40162,0.0250157869338258,0.00287511676108771,0.0193805580820939,0.0306510157855577,3.61811358035097e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,37937,0.055365836734083,0.00636411681654344,0.0428921677736579,0.0678395056945082,3.70965080629067e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,40255,0.0230307678495763,0.00264901941607388,0.0178386897940714,0.0282228459050811,3.83549163745232e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,40336,0.0511703839548087,0.00589134753567178,0.039623342784892,0.0627174251247254,4.12603268378791e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37896,0.0212114698230088,0.00244536069871686,0.0164185628535238,0.0260043767924939,4.63935835471863e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAYN,Layilin,40187,0.0265610641155513,0.00306293317290172,0.0205577150966639,0.0325644131344386,4.66405097001571e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37850,0.037333228999421,0.00430650712023201,0.0288924750437662,0.0457739829550757,4.85421278753521e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39975,0.0270374572350776,0.00312711168715428,0.0209083183282552,0.0331665961419,5.84082114637792e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37567,0.0417026831281281,0.00482881872589875,0.0322381984253665,0.0511671678308896,6.47664790408205e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40484,0.0272917358785521,0.00316167165289018,0.0210948594388873,0.0334886123182168,6.58408232517284e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40300,0.0286333255669304,0.00332062032286253,0.0221249097341199,0.035141741399741,7.13843673137864e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40300,0.0168974777908052,0.00196046254850412,0.0130549711957371,0.0207399843858732,7.37539637293076e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40511,0.0200777720457061,0.00233013657211423,0.0155107043643622,0.02464483972705,7.53276232375102e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40300,0.0237671848198736,0.00276583469451017,0.0183461488186336,0.0291882208211135,9.24199424292047e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,39956,0.0514727397902533,0.00599194742072807,0.0397285228456263,0.0632169567348803,9.48853069427547e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,40223,0.0256650240315035,0.00298832463643577,0.0198079077440894,0.0315221403189176,9.63025067930981e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39956,0.0284952124985816,0.00331785325720141,0.0219922201144668,0.0349982048826964,9.64349505012126e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,37477,0.0435053615654695,0.00506498676259302,0.0335779875107872,0.0534327356201518,9.72598248909824e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37623,-0.0277807178546972,0.00323635276453132,-0.0341239692731786,-0.0214374664362158,1.01856448954955e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,40437,0.0558993062477644,0.00651428151137642,0.0431313144854666,0.0686672980100622,1.02547557703128e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37780,0.0320353643113635,0.00374119531905895,0.0247026214860079,0.039368107136719,1.22062162494722e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37896,0.0164600774965923,0.00192396873964308,0.0126890987668919,0.0202310562262927,1.30212056815013e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,40466,0.0269066051232063,0.00315520555405445,0.0207224022372596,0.033090808009153,1.62477407194493e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,40379,0.0430909988857858,0.00505867225835107,0.0331760012594177,0.0530059965121539,1.76302236891005e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,40172,0.0256236321172094,0.00300851633035504,0.0197269401097135,0.0315203241247053,1.78343025195259e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40531,0.0117544264254167,0.00138276994951385,0.00904419732436956,0.0144646555264639,2.0490492717942e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40300,0.0416207841634413,0.00490245110319004,0.0320119800011888,0.0512295883256937,2.25139962251586e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40406,0.0205482063216662,0.00242207680755086,0.0158009357788665,0.0252954768644659,2.37033797421334e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37709,0.0273502590744551,0.00322437512394086,0.021030483831531,0.0336700343173791,2.43903988170277e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40391,0.0577863425550161,0.00682492398410283,0.0444094915461746,0.0711631935638577,2.73574388713379e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37623,0.0379699302734035,0.00448712209530389,0.0291751709666078,0.0467646895801991,2.90428875907216e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,39975,0.0348265175314258,0.00411682801106952,0.0267575346297295,0.042895500433122,2.92078692094728e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40307,0.0667718887398077,0.00790258259849085,0.0512828268467656,0.0822609506328497,3.18005551999852e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,40391,0.062376691618689,0.00738879794289468,0.0478946476506154,0.0768587355867626,3.38311666698278e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37709,0.0583704630248863,0.00691374976572284,0.0448195134840695,0.0719214125657031,3.42170080497228e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40336,-0.0395375385708925,0.00469905881961771,-0.0487476938573432,-0.0303273832844418,4.29899328859177e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,40336,0.0506018196295701,0.00601446224960838,0.0388134736203377,0.0623901656388025,4.31984741138422e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40354,0.0437258472311079,0.00519908903963432,0.0335356327134246,0.0539160617487912,4.43340572427968e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37955,0.0501948167093147,0.00596891110536866,0.0384957509427921,0.0618938824758372,4.5321562773637e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37666,0.0507727284807455,0.00603882469699824,0.038936632074629,0.0626088248868621,4.60586768859305e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,40406,0.0228487551165925,0.00272416827076214,0.0175093853058987,0.0281881249272863,5.38030939346273e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,37557,0.0454104250033572,0.00541407951558396,0.0347988291528127,0.0560220208539018,5.47170484071923e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40380,0.0893299376929848,0.010653347586838,0.0684493764227823,0.110210498963187,5.48551523795377e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40223,-0.0872753185307665,0.0104113594559767,-0.107681583064481,-0.0668690539970523,5.60487419560177e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,40300,0.0702579941436339,0.00838984182981293,0.0538139041572006,0.0867020841300673,6.0216858104366e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37623,0.0396833029774125,0.00474580037631142,0.0303815342398421,0.0489850717149829,6.79466460012766e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37709,0.0259747994422587,0.00311500901485707,0.0198693817731388,0.0320802171113785,8.25427295227084e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,40256,0.0576733191411593,0.00693323977779674,0.0440841691766777,0.0712624691056409,9.63783431955601e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,40300,0.0367646070779394,0.00442045891105293,0.0281005076122756,0.0454287065436031,9.75451308731349e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37895,0.0427615066257623,0.00514189495172815,0.0326833925203751,0.0528396207311495,9.94231328300157e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,40037,-0.0175088357438455,0.00210641401081552,-0.0216374072050439,-0.0133802642826471,1.01660637775705e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37937,0.0341854039421177,0.00412275411902638,0.026104805868826,0.0422660020154094,1.2194891662409e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40352,0.0219060441736439,0.00264414664176128,0.0167235167557918,0.027088571591496,1.2772337764345e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37937,0.0638346135593761,0.00770600012253483,0.0487308533192078,0.0789383737995443,1.30529032112881e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37709,0.0561313396708756,0.00679829243695673,0.0428066864944404,0.0694559928473108,1.63865010970412e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37666,-0.0239905563932793,0.00290816580128758,-0.029690561363803,-0.0182905514227556,1.74194102295333e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37536,0.0346390306555678,0.00420131568034562,0.0264044519220904,0.0428736093890453,1.81109853769174e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37593,0.0210666128653632,0.00255540559291696,0.0160580179032459,0.0260752078274804,1.82345751268611e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37557,0.045314608515636,0.00549908732556251,0.0345363973575335,0.0560928196737385,1.87862182586816e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37557,0.0300823247865644,0.00365233363848548,0.0229237508551329,0.037240898717996,1.94085727471531e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37895,0.0483929212413094,0.00588429407551961,0.036859704853291,0.0599261376293278,2.14629284466481e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,37954,0.0266655129727886,0.00324304236262644,0.0203091499420407,0.0330218760035364,2.17608939608336e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,40027,0.0318485392448565,0.00387427170646895,0.0242549667001774,0.0394421117895357,2.18450946444995e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37709,0.0642169569318657,0.00781769735608807,0.048894270113933,0.0795396437497983,2.3304561175843e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,39975,0.043228870478492,0.00526869879932917,0.0329022208318069,0.0535555201251772,2.48847446206e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40198,0.0290000591975818,0.00353541367479545,0.0220706483949827,0.0359294700001808,2.52975786890271e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37955,0.029127938815531,0.00355068649791471,0.0221685932796181,0.0360872843514438,2.54537053797679e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C5,Complement C5,38008,0.0112260074198435,0.00136874612719594,0.00854326501053942,0.0139087498291475,2.5826036689145e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40039,0.049841524026408,0.00607806987023961,0.0379285070807383,0.0617545409720776,2.58489472230884e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,37896,0.0832520692918081,0.0101547496681162,0.0633487599423003,0.103155378641316,2.65676606568581e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39975,0.044995874270285,0.0054898942608046,0.034235681519108,0.055756067021462,2.67486250902965e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37709,0.0246755091014389,0.00301287900488167,0.0187702662518708,0.0305807519510069,2.84966451873682e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40223,0.0352126805777828,0.00430222210539714,0.0267803252512044,0.0436450359043612,2.93508075440697e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37666,0.0267035536957949,0.0032636910406719,0.020306719256078,0.0331003881355118,3.04525244948104e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,40517,0.0245534836844101,0.0030081322312721,0.0186575445111167,0.0304494228577034,3.52670021801589e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39956,0.0437081622523323,0.0053549661270979,0.0332124286432204,0.0542038958614442,3.54142994434005e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,37993,0.0167573465774931,0.0020549612099701,0.0127296226059517,0.0207850705490345,3.81024444487612e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40354,0.0526534060379253,0.00646121936635115,0.039989416079877,0.0653173959959735,3.93560517611748e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,40246,0.0421330875997553,0.00517249683775651,0.0319949937977526,0.0522711814017581,4.05409538603189e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,40466,0.0475675917154235,0.00585126752266919,0.0360991073709919,0.0590360760598551,4.62527708670052e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40325,0.0141428263374293,0.00174007262106867,0.0107322840001348,0.0175533686747239,4.69434348925729e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,40371,0.0666634621617372,0.00820223411846644,0.050587083289543,0.0827398410339314,4.70287077937853e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37559,0.0207849483546415,0.00255679854436329,0.0157736232076895,0.0257962735015936,4.70378161663107e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,40484,-0.0249310075255161,0.0030768549855605,-0.0309616432972147,-0.0189003717538175,5.7569388325496e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37666,0.0303345689889909,0.00374916911390204,0.022986197525743,0.0376829404522389,6.43094835701067e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,37593,0.0122306181050639,0.00151294918301885,0.009265237706347,0.0151959985037809,6.81538839345843e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37895,0.0396197182769653,0.00490175053821102,0.0300122872220717,0.0492271493318589,6.86902480954313e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37623,0.0373139733763236,0.00461909838938674,0.0282605405331256,0.0463674062195217,7.14229493371815e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40223,0.0752084467248835,0.00931734790443147,0.0569464448321978,0.0934704486175691,7.41850174257481e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,37623,-0.0305787579671226,0.00379076276983003,-0.0380086529959894,-0.0231488629382557,7.84709386701965e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,40354,0.0617175212892069,0.00766936631520484,0.0466855633114054,0.0767494792670084,9.05918564001205e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37955,0.0282448130081266,0.00351362696634725,0.021358104154086,0.0351315218621672,9.83444071258397e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37896,0.0367301935174321,0.00457073341876456,0.0277715560166536,0.0456888310182106,1.00556509055216e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37623,0.0492566396229909,0.00612986381297745,0.0372421065495551,0.0612711726964267,1.01076313659591e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,40307,0.0438107356369706,0.00545437484892338,0.0331201609330807,0.0545013103408604,1.02406491940667e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40466,0.0208798673964083,0.00260827016829563,0.0157676578665489,0.0259920769262677,1.27343884944659e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40300,0.014735237895361,0.0018427580149419,0.0111234321860748,0.0183470436046471,1.37010117091219e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37593,0.0455908778427029,0.0057060016783238,0.0344071145531883,0.0567746411322176,1.46147900476075e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,38008,0.0141787980261045,0.0017822578347061,0.0106855726700806,0.0176720233821285,1.92448790122019e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37993,-0.0183799020553735,0.00231428428075193,-0.0229158992456473,-0.0138439048650997,2.14663009070987e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,39975,0.0532941374861281,0.00671873798263376,0.0401254110401659,0.0664628639320903,2.2995804698953e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,40374,0.0209837166148929,0.00264655731908075,0.0157964642694946,0.0261709689602911,2.36081737388386e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37648,0.0387245174080288,0.00488712280946291,0.0291457567014815,0.0483032781145761,2.48777105839685e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,39975,0.0431353560184175,0.00544593574120074,0.032461321965664,0.0538093900711709,2.5219360441552e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37985,0.056177749068389,0.00709516274461606,0.0422712300889415,0.0700842680478364,2.60590916715995e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37937,0.0252600331746116,0.00319052151609727,0.019006611003061,0.0315134553461623,2.61793187199559e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,37623,0.0212126490992554,0.00268053876715267,0.0159587931156361,0.0264665050828746,2.69997399944925e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37896,0.0391769721491056,0.00495372580458898,0.0294676695721112,0.0488862747261,2.80552644037695e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,37593,0.0835863797308861,0.0105714013754143,0.0628664330350741,0.104306326426698,2.84987299324812e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,40327,-0.0171203363700832,0.00216891893818668,-0.0213714174889291,-0.0128692552512373,3.1293901880723e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39975,0.0517039005811802,0.00659918960468058,0.0387694889560063,0.0646383122063541,4.99525338340949e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37993,0.0243733083276311,0.00312079378659245,0.0182565525059099,0.0304900641493523,6.13926316624193e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37593,0.0365960338863924,0.00469002424819061,0.0274035863599388,0.045788481412846,6.5029608989282e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39975,0.0366323350319287,0.00470085562717784,0.0274186580026601,0.0458460120611973,6.97326815643724e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37593,0.0247936179248844,0.00318431495507516,0.0185523606129371,0.0310348752368317,7.42268020740295e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,37929,0.0324986996923136,0.00417423449104289,0.0243172000898695,0.0406801992947576,7.44584375853065e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,39898,0.0295829904561473,0.00380662813341657,0.0221219993146509,0.0370439815976438,8.24635604713089e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,40511,0.0337854311004992,0.00435402004487991,0.0252515518125346,0.0423193103884639,9.03030243797229e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40336,0.0633855487453756,0.00817775275619065,0.0473571533432419,0.0794139441475093,9.66878457149518e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40336,0.0450759998113912,0.00581825018685228,0.0336722294451608,0.0564797701776217,9.94787597256373e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40300,0.0384274094474693,0.00497233041803648,0.0286816418281178,0.0481731770668208,1.15546376170917e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39975,0.0352685213736907,0.00456446629386016,0.0263221674377248,0.0442148753096566,1.17045013939359e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37896,0.0374219772500227,0.00484450620629732,0.0279267450856799,0.0469172094143654,1.20105594613328e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39975,0.0355127518658056,0.00460149596565516,0.0264938197731215,0.0445316839584897,1.25678223390818e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39975,0.0398231198170769,0.00516246425975361,0.0297046898679598,0.049941549766194,1.29342058122404e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37937,0.0329595229986591,0.00427964879017193,0.0245714113699221,0.0413476346273961,1.43877280651422e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37937,0.0246991584261558,0.00321210920671988,0.0184034243809849,0.0309948924713268,1.58050979347625e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,40511,0.041681670158307,0.00542602263334668,0.0310466657969475,0.0523166745196665,1.65875030872729e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40319,0.016654288921683,0.00216989931514607,0.0124012862639967,0.0209072915793693,1.74816760653282e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37557,0.0352791637013301,0.00459849685306767,0.0262661098693174,0.0442922175333427,1.81425798503691e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37593,0.0227211319174085,0.00296254720901271,0.0169145393877436,0.0285277244470734,1.84849089919367e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40039,0.0333211819150746,0.00435515958728015,0.0247850691240055,0.0418572947061437,2.11106899358511e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37593,0.0599036711484617,0.00784152182264988,0.0445342883760679,0.0752730539208554,2.33509103594711e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,37593,0.0393573958679808,0.00515618897421984,0.02925126547851,0.0494635262574517,2.45068595243933e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40466,0.019034018320811,0.00249443189543276,0.0141449318057628,0.0239231048358592,2.46771503052853e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40273,0.0174049918963812,0.00228452225512742,0.0129273282763315,0.021882655516431,2.70800877824524e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,40039,0.0403911069988615,0.00530738846288471,0.0299886256116075,0.0507935883861155,2.88947632610265e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39956,0.0433080335726764,0.00569973900778905,0.0321365451174098,0.0544795220279429,3.17282171015346e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,37895,0.0530918410725635,0.0069887850498086,0.0393938223749386,0.0667898597701883,3.23768730998284e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,40466,0.0176495912443586,0.00232455056319479,0.0130934721404968,0.0222057103482204,3.30565673247195e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37623,0.0193849750025552,0.00255578104490116,0.0143756441545489,0.0243943058505614,3.55414012186866e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39975,0.0323618645499107,0.00427010339646443,0.0239924618928404,0.0407312672069809,3.68686123543397e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40325,0.0213290081489166,0.00281484997308838,0.0158119022016634,0.0268461140961698,3.72196549855988e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40187,0.0500171143984598,0.00660518750334561,0.0370709468919024,0.0629632819050172,3.86692253087969e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37982,0.0408491870095201,0.00540220679888017,0.030260861683715,0.0514375123353253,4.23831496837702e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40300,0.0151818099813468,0.0020137721845982,0.0112348164995343,0.0191288034631592,4.99208399885089e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37557,0.0389094478131684,0.00516501852391005,0.0287860115063047,0.049032884120032,5.27267887240278e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNLY,Granulysin,40327,0.0341149527260313,0.00453016499489957,0.0252358293360282,0.0429940761160345,5.32109979135085e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37895,0.0292754327600194,0.00389872650679479,0.0216339288067016,0.0369169367133372,6.33435451684198e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40466,-0.0302229811431925,0.00402661147222022,-0.0381151396287441,-0.0223308226576409,6.42553948419881e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,40382,0.0203508399778455,0.00271205729028042,0.0150352076888958,0.0256664722667951,6.52438930874661e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,37937,0.0643893493831251,0.00858003944541532,0.0475724720701111,0.0812062266961391,6.54969626300512e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37895,0.0259288892784197,0.00345606220833629,0.0191550073500806,0.0327027712067589,6.65707279277594e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,40327,0.0374049013553072,0.00499473240375409,0.0276152258439492,0.0471945768666652,7.3116084968529e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,40263,0.0249430380249515,0.00333537297630268,0.0184057069913982,0.0314803690585047,7.92152614592461e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40446,0.0230431786906838,0.00308446967257278,0.0169976181324411,0.0290887392489264,8.38782609843102e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,37929,0.0172286965518548,0.00230916504370439,0.0127027330661941,0.0217546600375154,9.1115746723797e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,39956,0.0327483294969409,0.00439609009477704,0.0241319929111779,0.0413646660827039,9.86862269477083e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40325,0.0485349567941501,0.00651901081172525,0.0357576956031686,0.0613122179851315,1.01806716969524e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37937,0.0305366350277667,0.00410190474807847,0.0224969017215329,0.0385763683340005,1.03206975835708e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37916,0.0256651707858685,0.00345680233645418,0.0188898382064183,0.0324405033653187,1.19965042062791e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAT,Catalase,37781,0.0362271634258836,0.00488142201214187,0.0266595762820855,0.0457947505696817,1.22871843073938e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,37965,0.030395525732065,0.00409642159083186,0.0223665394140346,0.0384245120500955,1.24089623154726e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40406,0.0229659430624521,0.00309626208797156,0.0168972693700279,0.0290346167548764,1.25526883941929e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39920,0.0289091845231269,0.00390424995279795,0.0212568546156429,0.0365615144306109,1.38382029774491e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,40511,-0.0257673178000523,0.00348038257936899,-0.0325888676556155,-0.0189457679444891,1.39120832783364e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40327,0.0787264701426602,0.0106343416409785,0.0578831605263424,0.099569779758978,1.39770928259579e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,40349,0.0509151416625909,0.00688082068536254,0.0374287331192803,0.0644015502059015,1.43446614327396e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,40037,0.0201544539543727,0.00272524108045451,0.0148129814366818,0.0254959264720635,1.48069477506973e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,40377,-0.0255181504881732,0.00346204996110456,-0.0323037684119381,-0.0187325325644082,1.77904705654729e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37593,0.0233320305218206,0.00316708403945412,0.0171245458044905,0.0295395152391506,1.8486457373929e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39834,0.066386785869605,0.0090363765174903,0.048675487895324,0.084098083843886,2.13491441176964e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40336,0.0237148638962814,0.00323351144526325,0.0173771814635654,0.0300525463289974,2.34001514190307e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37593,0.0283160665968633,0.00386161088015854,0.0207473092717526,0.035884823921974,2.38747461636518e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,40039,0.0223985567974979,0.00305593298838035,0.0164089281402724,0.0283881854547234,2.42288552899412e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,40019,0.0276811089780078,0.00377676211193079,0.0202786552386235,0.0350835627173922,2.42679391737187e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37964,-0.0317298755157838,0.00433237204198199,-0.0402213247180685,-0.0232384263134991,2.54492873111322e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,37895,0.0261606364309297,0.00357325493035345,0.0191570567674369,0.0331642160944225,2.59660392413429e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,37982,0.0426626523435312,0.00582783799069782,0.0312400898817635,0.054085214805299,2.60998933552116e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37567,0.0347225079240581,0.00474965025479577,0.0254131934246584,0.0440318224234578,2.81484981057107e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37955,0.0284882200504569,0.00390663742900415,0.0208312106896087,0.036145229411305,3.21761035276942e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,37993,0.0306387433898531,0.00420975458844809,0.0223876243964948,0.0388898623832113,3.57367918294179e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,39956,-0.047710157778851,0.00655693430167731,-0.0605617490101385,-0.0348585665475635,3.5956017988056e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37666,0.0237420931648244,0.00327295949178749,0.0173270925609209,0.0301570937687279,4.27141367813039e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,37895,0.0313673584391764,0.00432710084724259,0.0228862407785809,0.0398484760997719,4.42626666105087e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37557,0.0456100851135828,0.00630798385377653,0.0332464367601808,0.0579737334669848,5.077845761869e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,39956,0.0338781228803604,0.00469556960025677,0.0246748064638571,0.0430814392968636,5.6467394576851e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,37895,0.0266317057944621,0.00369101673445624,0.0193973129949279,0.0338660985939964,5.6708229828313e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,37603,0.0268236997327295,0.00371813715910837,0.0195361509008771,0.0341112485645819,5.71874332955285e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,37536,0.041422010312163,0.00574375080943692,0.0301642587256666,0.0526797618986593,5.83098631504708e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37993,-0.021246658001417,0.002949602255956,-0.0270278784230907,-0.0154654375797432,6.19095867533069e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37955,0.0370589535859595,0.00515290490314732,0.0269592599757907,0.0471586471961282,6.72805621317709e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2,Prothrombin,38008,0.00946868239867545,0.0013171656060757,0.00688703781076709,0.0120503269865838,6.88443604045148e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37567,0.0389331288153244,0.00541625085636208,0.0283172771368547,0.049548980493794,6.92010344151332e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFD,Complement factor D,38008,0.0122585453616069,0.00170592471140002,0.00891493292726283,0.0156021577959509,7.02723909188224e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39920,0.03046199402983,0.00425118198923262,0.0221296773309341,0.0387943107287259,8.09814253111891e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,40121,-0.0340522392649598,0.00475936796807051,-0.043380600482378,-0.0247238780475416,8.75178448980909e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,40466,0.0187543905899805,0.00262342419726448,0.0136124791633421,0.0238963020166189,9.13049564949893e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37985,0.0195005551929708,0.00272984341384354,0.0141500621018374,0.0248510482841041,9.5655085311146e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,40039,0.0188486234009474,0.00264465160615082,0.0136651062528918,0.024032140549003,1.07020940525332e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40037,0.0558030057539737,0.00783586205405873,0.0404447161280186,0.0711612953799288,1.11433841618122e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37593,0.0230931290197191,0.0032454035325254,0.0167321380959693,0.0294541199434689,1.17169307284961e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,40039,0.0181728909418076,0.00255899286163548,0.0131572649330021,0.0231885169506131,1.28669277981998e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,40336,0.0397726340634955,0.00560640815205142,0.0287840740854747,0.0507611940415162,1.3565470198242e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40325,-0.0307384260480631,0.00434175610340228,-0.0392482680107316,-0.0222285840853947,1.50496454504983e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39956,0.0174195456854957,0.0024618948544196,0.0125942317708332,0.0222448596001581,1.55101423278407e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37937,0.0394358979144443,0.00557576259513762,0.0285074032279746,0.050364392600914,1.59395468687748e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40305,0.0397145043289808,0.00561658727239323,0.0287059932750901,0.0507230153828715,1.60321863959746e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40300,-0.0264689170213798,0.00374530950233316,-0.0338097236459528,-0.0191281103968068,1.64658423449256e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37593,0.035754490719927,0.00506357452963518,0.0258298846418421,0.045679096798012,1.73473650816335e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40511,0.0207074085414055,0.00293632994324758,0.0149522018526403,0.0264626152301708,1.83369865852452e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPS,Colipase,40306,0.0431611675063337,0.0061204266859164,0.0311651312019375,0.0551572038107298,1.83665528266924e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,37666,0.0325508149828564,0.00462349035231914,0.0234887738923108,0.0416128560734019,2.01285543154035e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40306,0.055061045881115,0.0078250226652064,0.0397240014573105,0.0703980903049196,2.05147341000364e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39975,0.033024273653711,0.00469337229750719,0.0238252639505969,0.0422232833568251,2.05574469006906e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,40354,0.0266458697214607,0.00378919300687147,0.0192190514279926,0.0340726880149287,2.11776006982025e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39975,0.0336137801958371,0.00480127932987282,0.0242032727092864,0.0430242876823878,2.64549840550676e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,40327,-0.0178742166627479,0.0025561935563183,-0.0228843560331318,-0.0128640772923641,2.80770835572498e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40484,0.0236073393137645,0.00337879363976588,0.0169849037798233,0.0302297748477056,2.92055716960189e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,40223,0.0216054225308709,0.00309606182222166,0.0155371413593165,0.0276737037024254,3.10544262148107e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,39956,0.0281847174068084,0.00404523848803901,0.020256049970252,0.0361133848433649,3.3589490170895e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40131,0.0183946875564785,0.00264295274045822,0.0132145001851804,0.0235748749277766,3.5400851784215e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40531,-0.0161017056455227,0.00231635167814892,-0.0206417549346945,-0.0115616563563508,3.75789728410265e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37557,0.0729145041181161,0.0104903119900361,0.0523534926176454,0.0934755156185868,3.8081033061624e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,40336,0.0240720425202708,0.00346625218488342,0.0172781882378993,0.0308658968026423,3.94001113322449e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40466,0.0141830537121557,0.00205193879254489,0.0101612536787677,0.0182048537455437,4.95809625649177e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40406,0.0539485723767731,0.00783530736016363,0.0385913699508524,0.0693057748026938,5.98096611108253e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,40223,0.0217487014307282,0.00315884292171581,0.0155573693041652,0.0279400335572912,5.99588547039824e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37709,0.0456618220862212,0.00665254776321998,0.0326228284703101,0.0587008157021324,7.00298873658034e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40354,-0.0598514803054116,0.00876015272733158,-0.0770213796509815,-0.0426815809598417,8.6631171130595e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40465,0.017843291674856,0.00262414250499762,0.0126999723650607,0.0229866109846513,1.08569035499903e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37557,0.0228852940340346,0.00337205424700856,0.0162760677098978,0.0294945203581714,1.19619723972133e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,40327,-0.0191772805700715,0.00282796603866027,-0.0247200940058456,-0.0136344671342973,1.23302679934084e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,37993,0.0553086739037336,0.00815575963381729,0.0393233850214517,0.0712939627860155,1.23826527601159e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,40039,0.033046140135406,0.00488297413550844,0.0234755108298094,0.0426167694410025,1.35580642367211e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40417,0.0158679557182303,0.00234528941571199,0.0112711884634348,0.0204647229730259,1.37103591472257e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,40341,-0.016640760335155,0.00246476149529835,-0.0214716928659398,-0.0118098278043702,1.51424821428438e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,39898,0.0687145964198638,0.010202831112691,0.0487170474389895,0.088712145400738,1.69884290104575e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,40039,0.0311219230943635,0.00462739048070114,0.0220522377521892,0.0401916084365377,1.80966938358175e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40314,-0.0147174687248929,0.00219155123833183,-0.0190129091520233,-0.0104220282977625,1.93723829239534e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37557,0.0223975760941969,0.00333685347779143,0.0158573432777257,0.0289378089106681,1.99623352895909e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40306,0.0242395009703493,0.00361855059896475,0.0171471417963784,0.0313318601443203,2.17391124922651e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,37896,0.0361988084718904,0.00540463385541891,0.0256057261152694,0.0467918908285115,2.20089665615912e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39956,0.0384208743217866,0.00574920375237152,0.0271524349671384,0.0496893136764347,2.42383881326108e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40223,0.0300486225270508,0.00450164844736639,0.0212253915702127,0.038871853483889,2.55431713385281e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37623,0.0568317594156809,0.00854834133293595,0.0400770104031264,0.0735865084282354,3.08227562504245e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39956,0.0432549646065265,0.00652217129019204,0.0304715088777501,0.0560384203353029,3.42148153458581e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,37982,0.0143630544097224,0.00217081122984562,0.010108264399225,0.0186178444202198,3.81781922933504e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37896,0.0557022615893421,0.00841879658661321,0.0392014202795802,0.072203102899104,3.81947775416593e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37895,0.0196590890932729,0.00297959352861932,0.013819085777179,0.0254990924093668,4.32612331877679e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37630,-0.0287411815996276,0.00436040505957286,-0.0372875755163904,-0.0201947876828648,4.52278904599917e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,40336,-0.0280142100409597,0.00425594988302078,-0.0363558718116805,-0.019672548270239,4.77530264709409e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40531,0.0160942167172539,0.00244723972001935,0.011297626866016,0.0208908065684919,4.96574569113926e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37973,0.0143125789234115,0.00217617039278418,0.0100472849535545,0.0185778728932685,4.97826904261227e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37895,0.0221138058234266,0.00336534583842858,0.0155177279801066,0.0287098836667467,5.18078472959136e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,40406,0.0126095692162716,0.00191946888871511,0.00884741019438996,0.0163717282381532,5.21159246296512e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39975,0.0268673679061945,0.00409292617869078,0.0188452325959606,0.0348895032164284,5.39205243354936e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37593,0.0226782247726511,0.00345590551426351,0.0159046499646946,0.0294517995806076,5.502087862868e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40300,0.0604010429850058,0.009207627621561,0.0423540928467462,0.0784479931232653,5.55144462163665e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,37955,0.017889458490703,0.00273008049132005,0.0125385007277157,0.0232404162536903,5.85471969182698e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37982,-0.034739768081097,0.00530251488666889,-0.045132697258968,-0.0243468389032259,5.89972783580997e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,40327,0.0386843263385595,0.00592199198023969,0.0270772220572898,0.0502914306198293,6.67291301651422e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40271,0.0350449066845151,0.00537541255145733,0.0245090980836587,0.0455807152853714,7.26865537743462e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37895,0.0239178627755874,0.00367600103288287,0.016712900751137,0.0311228248000378,7.96526791635746e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37477,0.0358222822996672,0.00551074888398853,0.0250212144870496,0.0466233501122847,8.30055152490121e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,40037,0.0259909470714316,0.00400028704806921,0.018150384457216,0.0338315096856473,8.42705657869086e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40300,0.0206080353393555,0.00317660431414666,0.014381890883628,0.0268341797950829,8.98935217901967e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40300,-0.0189988722313098,0.00293112080803744,-0.0247438690150631,-0.0132538754475564,9.33255834650522e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40406,-0.0163287165519255,0.00252410998115392,-0.0212759721149872,-0.0113814609888638,1.01458961157482e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,39998,0.0360953971829485,0.00558426109253636,0.0251502454415773,0.0470405489243198,1.05165636501758e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,40336,-0.0345233988397651,0.00534838823036919,-0.0450062397712887,-0.0240405579082415,1.11417123417569e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39975,0.0173498967762795,0.00269784604891249,0.0120621185204111,0.022637675032148,1.30457637617741e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37536,0.0445143320403846,0.00692869538678302,0.0309340890822899,0.0580945749984794,1.36764784282552e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39975,0.0336571398844879,0.00523973186952608,0.0233872654202167,0.043927014348759,1.37099157362356e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37593,0.0225304803853996,0.00351068927440343,0.0156495294075689,0.0294114313632303,1.43116752621366e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,40362,-0.0211703091851308,0.0033027812147449,-0.0276437603660308,-0.0146968580042308,1.49769376143629e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,40439,-0.0241803393852851,0.00378708465079803,-0.0316030253008492,-0.0167576534697209,1.76184132182306e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,39804,0.0441830464533988,0.00692702760853766,0.0306060723406649,0.0577600205661326,1.84121768677408e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F3,Tissue factor,40388,-0.0159711407824205,0.00250553520219321,-0.0208819897787192,-0.0110602917861218,1.88799708610255e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,39801,0.0227980937582577,0.00358551851925661,0.0157704774605148,0.0298257100560006,2.0965481021051e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40330,-0.0100406819436379,0.00157978053251617,-0.0131370517873696,-0.00694431209990624,2.13075793209508e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37623,0.0323395151723548,0.00509742102543924,0.0223485699624939,0.0423304603822157,2.3076598367819e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40327,0.0209771360472833,0.00331011208902513,0.014489316352794,0.0274649557417726,2.40149113728186e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40406,-0.0253363847795458,0.00399883875580728,-0.0331741087409281,-0.0174986608181636,2.4222930912517e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,39956,0.0466727974017632,0.00736779675268835,0.0322319157664941,0.0611136790370324,2.44357270025386e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',37557,0.0245350200423495,0.00387440207974396,0.0169411919660513,0.0321288481186476,2.48942228961511e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,37869,0.0323164910338612,0.00510988138035896,0.0223011235283577,0.0423318585393648,2.62428053490463e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39975,0.0233580633915347,0.00370887051644227,0.0160886771793079,0.0306274496037616,3.09841779606075e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40398,-0.0155281601151661,0.00246682137942637,-0.0203631300188418,-0.0106931902114904,3.15831290345012e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40531,0.023265660028669,0.00370427327305451,0.0160052844134821,0.0305260356438558,3.45573119299667e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,37557,0.0451854141792496,0.00719664034117169,0.0310799991105531,0.0592908292479461,3.52232528477473e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,37666,-0.0506594044453099,0.00808925090888347,-0.0665143362267215,-0.0348044726638983,3.90445097176898e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37709,0.0241894979335969,0.0038631159876049,0.0166177905978913,0.0317612052693025,3.92669237062178e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40039,0.0195118660736962,0.00312658435173392,0.0133837607442977,0.0256399714030947,4.47068493587101e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37567,0.0304537254026114,0.00490359485842298,0.0208426794801024,0.0400647713251205,5.44150045426031e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,40406,0.0151134014992393,0.00243482718485488,0.0103411402169238,0.0198856627815549,5.52785117786309e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37623,0.0456292730374712,0.00736185980095889,0.0312000278275918,0.0600585182473507,5.8867567138171e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,40412,0.0621916935933559,0.0100731666849719,0.0424482868908109,0.0819351002959008,6.81959138787329e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39956,0.026792308769868,0.00433950661795244,0.0182868757986812,0.0352977417410548,6.82228465603439e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,37852,0.0396237855738002,0.00642386210560528,0.0270330158468139,0.0522145553007866,7.10501819578768e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,40008,0.0397603851481257,0.00646451902526281,0.0270899278586106,0.0524308424376408,7.91002261586447e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40531,0.0333252185340378,0.00543658833376991,0.0226695053998488,0.0439809316682268,9.00412732774615e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,37666,0.0237950492466581,0.00388174657273931,0.016186825964089,0.0314032725292272,9.03889827443239e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40336,0.0246108132369547,0.00402485399842216,0.0167220994000473,0.0324995270738621,9.8996608294558e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,37593,0.0342173947817306,0.00559763081231999,0.0232460383895834,0.0451887511738777,1.00647351965112e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40478,-0.0181462706510006,0.00296971567957011,-0.023966913382958,-0.0123256279190431,1.01654467155093e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40291,0.0260667704006466,0.00428118788073089,0.0176756421544141,0.0344578986468791,1.16474720534862e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37477,0.0364007095832327,0.00597838009199552,0.0246830846029215,0.048118334563544,1.1701454698819e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,37637,0.0174226230941508,0.00286305174698189,0.0118110416700663,0.0230342045182353,1.19471544645722e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37666,-0.0156472102253237,0.0025766738772726,-0.020697491024778,-0.0105969294258694,1.29276264106918e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40531,0.0158375536136201,0.00261756756293555,0.0107071211902664,0.0209679860369738,1.47612206615413e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,40453,0.0161214268010777,0.00267041914082476,0.0108874052850611,0.0213554483170942,1.6043390231657e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,39892,0.0252964038714348,0.00419214034296282,0.0170798087992277,0.0335129989436419,1.63357367353485e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,40492,0.0160524393935972,0.00266296950837398,0.0108330191571842,0.0212718596300102,1.69613743891323e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,37623,0.0158763952857827,0.00264085971673684,0.0107003102409785,0.021052480330587,1.88294038956052e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40406,-0.0227669586094851,0.0037890766151713,-0.0301935487752209,-0.0153403684437494,1.9122837948314e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37896,0.0140012980647262,0.00233433637646637,0.00942599876685215,0.0185765973626003,2.04918185820352e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,39956,0.0201597463471353,0.00336418814032665,0.0135659375920951,0.0267535551021755,2.11274048880195e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37593,0.0302502023862736,0.00506255049768643,0.0203276034108082,0.040172801361739,2.35626452489668e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,40484,-0.0318419336994666,0.00533421144634872,-0.0422969881343101,-0.0213868792646231,2.43179384709736e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40493,0.028013445948584,0.00470020469137616,0.0188010447534867,0.0372258471436813,2.57445626143632e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37593,0.0323608587157761,0.0054382516985325,0.0217018853866524,0.0430198320448998,2.73963655354618e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37557,0.0296083142881886,0.00498661827662722,0.0198345424659992,0.0393820861103779,2.96628583889689e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37623,-0.0195664914786247,0.00330257656005332,-0.0260395415363292,-0.0130934414209201,3.20847077801869e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40354,0.022248516220104,0.00375640225678575,0.014885967796804,0.0296110646434041,3.22980325808391e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37896,0.0223574696644031,0.00377515544722027,0.0149581649878514,0.0297567743409549,3.25291158246664e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40300,0.0300966051187912,0.00510364717805252,0.0200934566498083,0.0400997535877742,3.77519538147157e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,40531,0.0293920544192602,0.00498500827632899,0.0196214381976553,0.039162670640865,3.79672368277507e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSN,Gelsolin,37923,-0.0100133613070607,0.00170639905710134,-0.0133579034589793,-0.00666881915514206,4.51111984042776e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39975,0.0248791968680382,0.00424440103991389,0.016560170829807,0.0331982229062694,4.67582037107652e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,40039,0.0449753821906463,0.00768178196963425,0.0299190895301631,0.0600316748511294,4.87153105208697e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37982,0.0134358871971069,0.00229903856938816,0.00892977160110607,0.0179420027931077,5.20937531265389e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,40417,0.0106840146476571,0.00182847184140464,0.00710020983850403,0.0142678194568102,5.22237228884292e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,38008,-0.0118152569012154,0.00202595248748317,-0.0157861237766824,-0.00784439002574842,5.60314045202176e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40406,0.0124406735654274,0.00213476602344414,0.00825653215947686,0.0166248149713779,5.72965294024218e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,37976,0.00767801088974759,0.00131869619281823,0.00509336635182387,0.0102626554276713,5.93160968062021e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TF,Serotransferrin,38008,0.0113684043255274,0.00195404489415832,0.00753847633297709,0.0151983323180777,6.0943139763284e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,40300,0.0972751608476629,0.0167492393838889,0.0644466516552407,0.130103670040085,6.45360848295309e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,37895,0.0184048067038611,0.00318068091181664,0.0121706721167005,0.0246389412910217,7.34978562644028e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39956,0.019902469000878,0.00344275554538698,0.0131546681319195,0.0266502698698365,7.56990272014779e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40375,0.0244368305905217,0.00423337150379129,0.0161394224430908,0.0327342387379526,7.9591765197435e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB1,Calbindin,40300,0.0217903423742856,0.00379149901776904,0.0143590042994583,0.0292216804491129,9.24243438962905e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40177,0.0209963191521644,0.00365599845768432,0.0138305621751032,0.0281620761292257,9.47442483913091e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,37895,0.027196035748634,0.00473513525917595,0.0179151706406491,0.0364769008566188,9.47719579759708e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37906,0.0293999358135602,0.00512039254618001,0.0193639664230474,0.039435905204073,9.573585617755e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37623,0.0318473531452653,0.00554935914572061,0.0209706092196529,0.0427240970708777,9.73784771741581e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,37709,0.0152153477408465,0.00265514017008454,0.0100112730074808,0.0204194224742122,1.02298547729621e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40484,0.0129314224070682,0.00225850586385933,0.00850475091390396,0.0173580939002325,1.04880945539256e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39975,0.0207547352747468,0.00362858407354548,0.0136427104905976,0.0278667600588959,1.0862114613675e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,37896,0.0299508070274627,0.00524122808879171,0.0196779999734309,0.0402236140814944,1.12385622866733e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,37896,0.0157631344257909,0.00276007361584529,0.0103533901387342,0.0211728787128477,1.1460541281214e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37557,0.0233779083985359,0.00409602143007405,0.0153497063955907,0.031406110401481,1.17154187277686e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,37709,0.027944740626005,0.00490243383142993,0.0183359703164023,0.0375535109356077,1.22233439743336e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40039,0.0306025387235723,0.00537762387781437,0.0200623959230561,0.0411426815240884,1.28781463666343e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,40531,-0.0082978204750439,0.00145973279009606,-0.0111588967436322,-0.00543674420645562,1.33488946258635e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37534,0.0209364262759173,0.0036921449176015,0.0136998222374184,0.0281730303144163,1.45366840796595e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37937,0.0202361909935386,0.00357502618599884,0.0132291396689808,0.0272432423180963,1.54069847606602e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40398,0.0138371411463865,0.00245746506466857,0.00902050961963606,0.0186537726731369,1.82551809319824e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40531,0.012664387596743,0.00225185808942757,0.00825074574146497,0.0170780294520211,1.89721055901165e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37709,0.0269523834094867,0.00480460858470864,0.0175353505834578,0.0363694162355157,2.06741176920202e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,37567,0.0329745534488979,0.00588343528786648,0.0214430202846796,0.0445060866131162,2.12892009227804e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40403,-0.0120985785578695,0.00216266937795729,-0.0163374105386658,-0.00785974657707325,2.25179165878034e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40327,0.0120500439950323,0.00215424521649019,0.00782772337071149,0.016272364619353,2.26044506252352e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40037,0.0293469905385543,0.0052474257014038,0.0190620361638029,0.0396319449133058,2.27393246339051e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37536,0.0309799048800178,0.00554393366674053,0.0201137948932064,0.0418460148668292,2.3418985129675e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,37896,0.0280229622975959,0.00501775439357121,0.0181881636861963,0.0378577609089955,2.38558893331127e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37937,0.119152796537804,0.0213742814904696,0.0772592048164836,0.161046388259124,2.52879885886713e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,39797,0.0130898709637988,0.0023488286733404,0.0084861667640516,0.0176935751635459,2.54698219369122e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,40171,0.0132456991473413,0.002378353937922,0.00858412542901418,0.0179072728656684,2.59998135224137e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,39956,0.02776406858168,0.00501170713533597,0.0179411225964215,0.0375870145669385,3.07670661491773e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37937,0.0164184615346821,0.00296581318265156,0.0106054676966851,0.0222314553726792,3.15407671998512e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37593,0.0221919854462147,0.00400967525323796,0.0143330219498683,0.0300509489425611,3.17897479012652e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39956,0.0413419904424415,0.00747114939212415,0.0266985376338782,0.0559854432510048,3.1889513671065e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARTN,Artemin,40039,0.0219813641501935,0.00397715098386172,0.0141861482218245,0.0297765800785624,3.31143742532066e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,37638,0.0699409375034089,0.0126633528757179,0.0451207658670019,0.0947611091398159,3.39380011343337e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37623,-0.0101293470714536,0.00183513218840728,-0.0137262061607318,-0.0065324879821753,3.46034249026424e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,40252,0.0328568601896869,0.00595648241794124,0.0211821546505221,0.0445315657288517,3.51944258145049e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37895,0.0182756921045664,0.00331445893776719,0.0117793525865427,0.0247720316225901,3.57383133531345e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37895,0.0220255244926086,0.00400544206426505,0.0141748580466491,0.0298761909385681,3.89143466021661e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40267,0.0113746123218708,0.00207038871288085,0.00731665044462432,0.0154325741991172,3.99110957756374e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,39956,0.0353219473036065,0.0064618721681009,0.0226566778541287,0.0479872167530842,4.6686207903919e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,37557,-0.0181389441846192,0.00331908195752775,-0.0246443448213736,-0.0116335435478649,4.71239309317855e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,40273,0.0290502237164561,0.00531712002857795,0.0186286684604433,0.0394717789724689,4.73819391191423e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRELP,Prolargin,40352,0.0113194246520171,0.00207270216790323,0.00725692840292679,0.0153819209011074,4.80044404854145e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40147,0.0566061912248333,0.0103659652885984,0.0362888992591805,0.0769234831904861,4.81268341234353e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40531,0.0119883116067232,0.00219739360842439,0.00768142013421144,0.0162952030792351,4.95022863144221e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,40336,-0.0238586218953305,0.00438012793663832,-0.0324436726511416,-0.0152735711395193,5.1983770920839e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37593,0.01842257720682,0.00339014846790652,0.0117778862097232,0.0250672682039167,5.60397272873863e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37896,0.0205357155508441,0.00381461422768638,0.0130590716645788,0.0280123594371094,7.43065305376341e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38008,0.00858659776782723,0.00160042419637192,0.00544976634293828,0.0117234291927162,8.21883139921002e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,38008,0.0124853171099961,0.00232888138169752,0.00792070960186897,0.0170499246181232,8.40822093109955e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,39891,0.0146368802867615,0.00273077905165011,0.0092845533455273,0.0199892072279957,8.44339818217158e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37562,0.0285464438907936,0.00533388796154349,0.0180920234861684,0.0390008642954188,8.85002330954126e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40300,-0.0126272168988193,0.00236052267765108,-0.0172538413470154,-0.00800059245062318,8.95059258118306e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,40300,0.0137140617561933,0.00256488873354404,0.00868687983844701,0.0187412436739396,9.07413671257812e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37985,0.0159602837747778,0.00298824521055098,0.0101033231620979,0.0218172443874577,9.39193769044737e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37623,0.0112260570651883,0.00210386491900921,0.00710248182393023,0.0153496323064463,9.66355163163718e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37567,0.049732828116796,0.00934273983912803,0.0314210580321051,0.0680445982014869,1.0366514421241e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,37982,-0.0117308620363535,0.00220970057649734,-0.0160618751662883,-0.00739984890641875,1.12092517662996e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40517,0.0261074751017978,0.00492760997530254,0.0164493595502048,0.0357655906533908,1.18491435534647e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39929,0.0327979581813591,0.0062015575947742,0.0206429052956016,0.0449530110671165,1.2488870560469e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37557,0.0480523643538116,0.00908687469673125,0.0302420899482183,0.0658626387594048,1.2557552198704e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,37536,0.0543878486534151,0.0103661735060955,0.034070148581468,0.0747055487253623,1.5729486030237e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,40223,0.0241452797740948,0.00460496860495939,0.0151195413083743,0.0331710182398152,1.59756826579047e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40354,0.0311021857407342,0.00593506845049995,0.0194694515777543,0.0427349199037141,1.62267829593915e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37895,0.0284810670359576,0.00543776282345067,0.0178230519019943,0.0391390821699209,1.65094106748026e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37993,0.0167185665634277,0.00319838706424406,0.0104497279175093,0.022987405209346,1.74667557349578e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,39975,0.0395590525962582,0.00758408170919378,0.0246942524462384,0.054423852746278,1.8511448614673e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40039,0.0195509437075699,0.00375281727559002,0.0121954218474135,0.0269064655677264,1.91585564236844e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40374,-0.0158749862832933,0.00306464633171295,-0.0218816930934507,-0.00986827947313592,2.24545567696034e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,37982,0.0316029094896479,0.00610092277467238,0.01964510085129,0.0435607181280058,2.25047597487001e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,40039,0.0259344961466115,0.00500895270174779,0.0161169488511858,0.0357520434420372,2.27519076205509e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39956,0.0212448407811089,0.00410465291824412,0.0131997210613504,0.0292899605008674,2.297766817352e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37953,0.00682398255857098,0.00132060571119738,0.00423559536462411,0.00941236975251785,2.40870091437116e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37895,0.0239904322289784,0.00464427314222336,0.0148876568702206,0.0330932075877362,2.43103661372121e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,40023,0.0196281394932285,0.00381087848251399,0.0121588176675011,0.0270974613189559,2.62884888678092e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37937,-0.0123273493991136,0.00239454223983061,-0.0170206521891815,-0.00763404660904556,2.66836853692419e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40037,0.0254551301970466,0.00495453246330113,0.0157442465689764,0.0351660138251168,2.81409338966301e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39956,0.0187626831844676,0.00365649932530155,0.0115959445068766,0.0259294218620587,2.91185117877395e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,40531,-0.0138674766455758,0.00270989142735628,-0.0191788638431942,-0.00855608944795755,3.13419038777435e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,40187,-0.0231603553786791,0.00453634075780556,-0.032051583263978,-0.0142691274933802,3.33743636848962e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,37895,0.0203277534890849,0.00401059518822854,0.0124669869201569,0.0281885200580128,4.06262533658844e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSPN,Persephin,40336,0.0449135821887904,0.00886420855339975,0.0275397334241269,0.062287430953454,4.08998873700016e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,40294,0.0356290839706502,0.00706873242456426,0.0217743684185043,0.0494837995227961,4.69735023191099e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37896,0.0118927266651222,0.00236975970160289,0.00724799764998058,0.0165374556802639,5.27320758204923e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,40065,0.0246879591442976,0.00492206917377531,0.015040703563698,0.0343352147248972,5.34017143799764e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37993,-0.0223054128646056,0.00445591054358668,-0.0310389975300355,-0.0135718281991757,5.63285740583554e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37896,0.0176683143831277,0.00353589308519021,0.0107379639361549,0.0245986648301005,5.90080352934851e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,37172,0.0551053324706165,0.0110550874127354,0.0334373611416552,0.0767733037995779,6.29032712486328e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37593,0.00915807809684895,0.00183778324971465,0.00555602292740825,0.0127601332662897,6.33306639267907e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7,Complement component C7,37673,-0.0140583777417829,0.00282609302380745,-0.0195975200684455,-0.00851923541512032,6.62407883298601e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,40300,-0.0388922561092921,0.00786528423232341,-0.054308213204646,-0.0234762990139382,7.70020773997822e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,39975,0.0248971342992672,0.00503529605154888,0.0150279540382314,0.034766314560303,7.71280419308674e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,37472,-0.0275490301754086,0.00557193420239166,-0.0384700212120962,-0.0166280391387209,7.73904080453917e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREH,Trehalase,37993,0.0328988929746842,0.00665693058145215,0.0198513090350379,0.0459464769143304,7.82292631639979e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37617,0.0126441969678526,0.00256271748763038,0.0076212706920971,0.0176671232436082,8.15881011689812e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,40177,0.0305889912275275,0.00620639903136403,0.018424449126054,0.042753533329001,8.36551151803741e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,37709,-0.0155563295281158,0.00316076400719235,-0.0217514269822129,-0.00936123207401883,8.68274723703164e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,40039,0.0366072713589184,0.00744127182103669,0.0220223785896865,0.0511921641281503,8.76544975851224e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37623,-0.0114712935623517,0.0023357439551721,-0.016049351714489,-0.00689323541021438,9.1609483669032e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,37536,0.0200863534541172,0.00409033278590938,0.0120693011937348,0.0281034057144995,9.18528192358954e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37955,0.0121448476565403,0.00248310660148866,0.00727795871762257,0.0170117365954581,1.01486203020125e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,40223,0.018885987544478,0.00386714769837919,0.0113063780556548,0.0264655970333012,1.05133951939819e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,37593,0.0203485042938814,0.00416782767163225,0.0121795620574822,0.0285174465302806,1.06098771635619e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,40354,-0.0294618613437326,0.00605275920587216,-0.041325269387242,-0.0175984533002232,1.14097882299954e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37895,0.0176252733045282,0.0036225058878795,0.0105251617642844,0.024725384844772,1.15467102701861e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37782,0.0268144138809936,0.00552028372638752,0.015994657777274,0.0376341699847131,1.20267999914504e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37666,0.0369441546425641,0.00760637710577188,0.0220356555152513,0.051852653769877,1.20544788214671e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40037,0.0271818313843604,0.00559944473405416,0.0162069197056142,0.0381567430631065,1.21934171607105e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37860,0.0135763454748999,0.00280425847590527,0.00807999886212554,0.0190726920876742,1.30410229005652e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40354,0.0121031227932422,0.00250093856488406,0.0072012832060695,0.017004962380415,1.31432273228912e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37477,-0.0131315762657032,0.00271376544264436,-0.0184505565332862,-0.00781259599812026,1.32071352292386e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37536,0.0269595601919759,0.00557437207968156,0.0160337909158,0.0378853294681518,1.33757050644553e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40354,0.0190589504316783,0.00394348888858492,0.0113297122100518,0.0267881886533047,1.35734343021498e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,37937,0.01692847562628,0.00350712371953406,0.0100545131359933,0.0238024381165668,1.40206749428971e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,40484,0.01956795955436,0.00405723981299898,0.011615769520882,0.0275201495878379,1.42732878697004e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,40484,0.0166494802123492,0.00345637528549694,0.00987498465277525,0.0234239757719232,1.47039159502031e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,40354,0.0360879462761866,0.00749590251519439,0.0213959773464056,0.0507799152059676,1.49033103388526e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,37557,0.0164978159354541,0.0034326681774946,0.00976978630756467,0.0232258455633435,1.5559461361778e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,37567,0.0224619990236423,0.00468248402990606,0.0132843303250264,0.0316396677222581,1.62810646868309e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,40398,0.0198605894564746,0.00415180865902399,0.0117230444847876,0.0279981344281617,1.73724148714162e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40039,0.0154284659111224,0.0032263763562609,0.00910476825285101,0.0217521635693937,1.75164064887097e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37937,0.0160778807265026,0.00336384802525717,0.00948473859699852,0.0226710228560066,1.77489145856245e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,40039,0.0172624479926212,0.00362755412959599,0.010152441898613,0.0243724540866293,1.96590073664632e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40391,0.0376548342014761,0.00791858131831523,0.0221344148175783,0.053175253585374,1.99934755166215e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,37985,0.0106555807191389,0.00224262787551975,0.00626003008312015,0.0150511313551576,2.04107756921747e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40429,0.0311618121530041,0.00656169004306305,0.0183008996686005,0.0440227246374077,2.06146209916643e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,40039,0.0163329573812694,0.00345532159410376,0.009560527056826,0.0231053877057127,2.29967164253612e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,37623,0.0288375150584825,0.00610598723974586,0.0168697800685806,0.0408052500483844,2.34989688145618e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,40466,-0.0129628881248875,0.0027583347729259,-0.0183692242798222,-0.0075565519699527,2.62925246578497e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40039,0.0249479060288942,0.00531401165872494,0.0145324431777933,0.0353633688799951,2.69218373048789e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37557,0.0282343443569259,0.00602236578451236,0.0164305074192817,0.0400381812945702,2.78331604808211e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40417,-0.0172777560720376,0.00370435267092387,-0.0245382873070484,-0.0100172248370268,3.12366570458703e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,40470,0.00902431717808712,0.00194303593547545,0.00521596674455524,0.012832667611619,3.43707735944882e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37557,0.0273817817105825,0.00590497385037524,0.0158080329638471,0.038955530457318,3.56796090335055e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37623,0.0156150006545197,0.00336976863705638,0.00901025412588923,0.0222197471831502,3.62369606211507e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39956,0.0349926505507415,0.00757218082831037,0.0201511761272532,0.0498341249742298,3.84578668173213e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40466,-0.0122317798238555,0.00265026002387201,-0.0174262894706446,-0.00703727017706636,3.95549133187294e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,37981,0.0150653454174445,0.00326998217854411,0.008656180347498,0.0214745104873909,4.11923616289039e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39975,0.0246516089362642,0.00537247841246113,0.0141215512478403,0.035181666624688,4.49940952278359e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37593,0.0144763712250953,0.00315672953433558,0.00828918133779761,0.0206635611123931,4.56260382172947e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37709,0.0282478804707912,0.00616525871190526,0.0161639733954569,0.0403317875461255,4.65232034851549e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37895,0.0207114495662597,0.00452253377950958,0.011847283358421,0.0295756157740985,4.7002167004311e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,40037,0.0135268236980859,0.00296158710993107,0.00772211296262101,0.0193315344335508,4.97537688923245e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,40495,0.0248657396316368,0.005445901140697,0.0141917733958706,0.0355397058674029,5.00921152357825e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39956,0.0123357413471222,0.00270463584336264,0.00703465509413146,0.017636827600113,5.13098207416056e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37955,0.0125750910791283,0.00277802747921237,0.00713015721987201,0.0180200249383845,6.04451363620482e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37557,0.0227818098573007,0.0050383676745272,0.0129066092152274,0.032657010499374,6.18932535660007e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37557,0.025471154631731,0.00564881911920659,0.0143994691580861,0.0365428401053759,6.56645940362368e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40336,-0.0155388414778114,0.00345436003845902,-0.0223093871531911,-0.00876829580243171,6.89758040273679e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,40354,0.0139889805640192,0.00311573719308581,0.00788213566557104,0.0200958254624674,7.1797321864849e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37937,0.021773135906449,0.00485787954788194,0.0122516919926004,0.0312945798202976,7.45473692896611e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39818,-0.0346999647562608,0.00774749305235896,-0.0498850511388844,-0.0195148783736373,7.55823599142369e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,37593,0.0139936437235847,0.00312667781392121,0.00786535520829915,0.0201219322388703,7.68510213059556e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,40327,0.0142963046136086,0.0031987703507607,0.00802671472611762,0.0205658945010996,7.9014357255689e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,39975,0.0123733691520266,0.00277354251771829,0.00693722581729871,0.0178095124867544,8.20690564180151e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39956,0.0566027252272753,0.0127099142925074,0.0316912932139607,0.0815141572405898,8.50995761972418e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,37567,0.0307880668886112,0.00692788976240528,0.0172094029542969,0.0443667308229256,8.8994336830427e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,40348,-0.0213900192859813,0.00481439634890886,-0.0308262361298427,-0.0119538024421199,8.9342090701954e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37709,0.0184951361399357,0.00417067359133689,0.0103206159009154,0.026669656378956,9.29993219148736e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40336,0.023949352984004,0.00541581673287016,0.0133343521875785,0.0345643537804296,9.83893349407293e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37985,-0.0129238896659402,0.00292623213015581,-0.0186593046410456,-0.00718847469083482,1.01060618822445e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39975,0.0172505972350457,0.00391106517376038,0.00958490949447532,0.024916284975616,1.03722590032776e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40039,0.0182013218227222,0.00413303772263889,0.01010056788635,0.0263020757590944,1.07049568059416e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40398,-0.0179528644584946,0.00408162516729462,-0.0259528497863921,-0.00995287913059716,1.09728182990615e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,37477,0.0141673701383601,0.00322167820859751,0.00785288084950897,0.0204818594272112,1.10366944790058e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37557,0.0351491857982746,0.00800467254181655,0.0194600276163142,0.0508383439802351,1.13671186752954e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40354,0.0123445749359996,0.00283604714811101,0.00678592252570205,0.0179032273462972,1.35286074435881e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,40327,-0.00754399668693662,0.00173540969043774,-0.0109453996801946,-0.00414259369367865,1.38808724650053e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40300,0.0174595403016057,0.00401636851899138,0.00958745800438257,0.0253316225988288,1.38811583928448e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,40223,-0.0164546250427118,0.00378939540780116,-0.0238818400420021,-0.0090274100434215,1.41889595876765e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37623,0.0124498546107346,0.00286817893716189,0.00682822389389727,0.0180714853275719,1.43100517684867e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37955,0.0135039269243599,0.00311237080699408,0.00740368014265148,0.0196041737060683,1.44309448221391e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,37896,0.0320076240262646,0.0073838393560274,0.0175352988884509,0.0464799491640783,1.46939349450181e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,37666,0.0148526050904135,0.00342850741463362,0.00813273055773159,0.0215724796230954,1.48790191357034e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,40231,0.0267720181977311,0.00618539437594993,0.0146486452208693,0.038895391174593,1.51214807199067e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLU,Clusterin,38008,0.0128202998742102,0.00296849828187693,0.00700204324173145,0.018638556506689,1.58007430332175e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,40037,-0.0495350894579577,0.0114740193559358,-0.0720241673955919,-0.0270460115203235,1.59030776720889e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37666,0.0303166430243002,0.00702546759482399,0.0165467265384451,0.0440865595101552,1.60582246349531e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37914,0.0147392226047008,0.00342302068117219,0.00803010206960332,0.0214483431397983,1.67476996797677e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37955,0.018711452974198,0.00435424212817693,0.0101771384029712,0.0272457675454248,1.74107604493718e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37709,0.0256855009199859,0.00597883012160318,0.0139669938816437,0.0374040079583281,1.75087774622125e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37709,0.0276768240528352,0.00644994511995819,0.0150349316177171,0.0403187164879532,1.79118340905917e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37895,0.0204015071279417,0.00475537439641785,0.0110809733109628,0.0297220409449207,1.79760107094376e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40037,0.0125677673146486,0.00295451586790039,0.00677691621356382,0.0183586184157333,2.11447872111721e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,37536,0.033331763476087,0.00784975278828996,0.0179462480110387,0.0487172789411353,2.18910113425812e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,37895,0.0194776089263906,0.00458938259650059,0.0104824190372494,0.0284727988155317,2.20985261312539e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,40336,0.0296269736804271,0.00698352442010383,0.0159392658170236,0.0433146815438306,2.22385173699633e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40336,0.0321977576658587,0.00759932932552516,0.0173030721878294,0.047092443143888,2.27883473722101e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,39797,0.0134135012303199,0.00317486773516664,0.00719076046939332,0.0196362419912465,2.40426204520106e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40300,-0.00896400049714873,0.00212408118568996,-0.0131271996211011,-0.0048008013731964,2.45468348644531e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37557,0.0134728695843038,0.00320514787304182,0.0071907797531418,0.0197549594154658,2.64551355364978e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,37593,0.0157331805321063,0.00376225776945383,0.0083591553039768,0.0231072057602358,2.9102792920852e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,37623,0.0315072243110496,0.00755951401148211,0.0166905768485447,0.0463238717735545,3.09396212711993e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,37477,0.0274865760564993,0.0066025443510944,0.0145455891283543,0.0404275629846443,3.16075144627452e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,40039,0.0247227386925928,0.00594041180926734,0.0130795315464288,0.0363659458387568,3.17459157452429e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,37623,0.0108380510460068,0.00260727563184067,0.00572779080759907,0.0159483112844145,3.24707997294136e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37709,0.016359901203781,0.00396017776525756,0.00859795278387622,0.0241218496236858,3.63242777723541e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37896,0.0203723744603,0.00493461052614339,0.010700537829059,0.0300442110915411,3.67395111427694e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37567,0.0143943530333024,0.00349596238851382,0.00754226675181532,0.0212464393147895,3.85480826856192e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37623,0.0134694511988834,0.00327457407087751,0.00705128601996349,0.0198876163778033,3.92337479503496e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,39956,0.0143546831433165,0.00349198094342698,0.00751040049419962,0.0211989657924334,3.96395299648135e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_A,,37955,0.0120325476983197,0.00293338639803599,0.00628311035816914,0.0177819850384702,4.12119839547607e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,40355,-0.0139911735407186,0.00341135630100423,-0.0206774318906869,-0.00730491519075035,4.12786459150641e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,40406,-0.0135309767357394,0.00330721694720116,-0.0200131219522537,-0.00704883151922513,4.30979556128974e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,40189,-0.0104139225212621,0.002549503665964,-0.0154109497065515,-0.00541689533597266,4.43549198689962e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,37895,-0.0147754823070689,0.00361946988941658,-0.0218696432903254,-0.00768132132381239,4.48650164652037e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37896,0.0289309197704728,0.00711642296902068,0.0149827307511923,0.0428791087897534,4.82285554272622e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37557,0.0178134189502903,0.00438877908424222,0.00921141194517558,0.0264154259554051,4.96001577261387e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37593,0.0118799695169063,0.00293057165759479,0.00613604906802048,0.0176238899657921,5.06813289706889e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37557,0.0165439639474479,0.00408207699028788,0.00854309304648368,0.0245448348484122,5.08938895728506e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37593,0.0110688784321775,0.00273427214940135,0.00570970501935084,0.0164280518450041,5.19090448095346e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40531,-0.0105570609316177,0.00261366059466984,-0.0156798356971705,-0.00543428616606476,5.38861057187108e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,40300,-0.0492141997505272,0.0121868581441038,-0.0731004417129706,-0.0253279577880838,5.40932074807268e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,40354,0.0205506949389476,0.00509085331340554,0.0105726224446728,0.0305287674332225,5.44418686673069e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37709,0.0162229837787981,0.00402084809853123,0.00834212150567689,0.0241038460519193,5.49748651615098e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40350,0.0130462321968396,0.00323997736475196,0.0066958765619258,0.0193965878317535,5.68414271212736e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39956,0.0177571365428162,0.0044216931658803,0.00909061793769077,0.0264236551479416,5.94950053793744e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40531,0.0105577433034411,0.00263293104353114,0.00539719845812006,0.0157182881487621,6.1023441886801e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37477,0.0148714194426779,0.00371243113643062,0.00759505441527389,0.0221477844700819,6.21398483939514e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40037,-0.00747799911913862,0.00186784244126927,-0.0111389703040264,-0.00381702793425085,6.26882717185194e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39954,0.016749136637733,0.00418721832117773,0.00854218872822468,0.0249560845472414,6.36195995531346e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,37593,0.0107065534333347,0.00267955870565043,0.00545461837025982,0.0159584884964095,6.48714872110879e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,40037,0.021772328102429,0.00546419362325844,0.0110625086008424,0.0324821476040155,6.79169951214051e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,37567,0.0111870483267461,0.00281561463064561,0.0056684436506807,0.0167056530028115,7.12877074274631e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40466,0.00967857617243779,0.00243745000171482,0.00490117416907674,0.0144559781757988,7.19509415443829e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37557,-0.0143337583838714,0.00362197427051163,-0.0214328279540742,-0.0072346888136686,7.61557450623462e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37623,0.0148478454289689,0.00375609290784566,0.00748590332959137,0.0222097875283464,7.75798258152383e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40223,-0.0127200413888934,0.00322078160827105,-0.0190327733411046,-0.00640730943668211,7.86995132984341e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40350,0.0175883916976433,0.00445435633420496,0.00885785328260163,0.0263189301126851,7.89542268203569e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,37937,0.0333292260731701,0.00850935929138784,0.0166508818620499,0.0500075702842903,9.01845837749667e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40531,0.0108469490256422,0.00278189911805537,0.00539442675425364,0.0162994712970307,9.69364593870749e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,37955,0.0104538923779056,0.00270178231167973,0.00515839904701333,0.0157493857087979,0.000109680217724863
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37896,0.0151052978908692,0.00390461129748969,0.00745225974778937,0.022758336033949,0.000109987814511386
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,40398,-0.0104936748918947,0.00271635084765886,-0.015817722553306,-0.0051696272304833,0.000112376245454265
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37896,0.0166382948971124,0.00430688817794933,0.00819679406833174,0.0250797957258931,0.000112444531791359
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,37557,-0.0145630965637044,0.00380030507804035,-0.0220116945166635,-0.00711449861074531,0.000127654511378561
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,39975,0.0138652276200842,0.00365014037956925,0.00671095247612843,0.0210195027640399,0.000146102081715452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37557,0.0161601081744627,0.00426125942595452,0.00780803969959184,0.0245121766493335,0.000149909507430158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,40300,0.00648073915656014,0.00170991591964807,0.00312930395404992,0.00983217435907036,0.000151148957508585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,40222,0.0178759988051417,0.00471732701747945,0.00863003785088199,0.0271219597594014,0.000151552515808535
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37477,0.0201979365873334,0.00534674974601343,0.00971830708514707,0.0306775660895197,0.000159045214099108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39956,0.0133540944955666,0.00353850710057441,0.00641862057844072,0.0202895684126924,0.000161291432417993
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,40484,0.00685934926295595,0.00182095476700621,0.00329027791962378,0.0104284206062881,0.000165880272961708
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,37929,0.0106410033999633,0.0028255910030377,0.00510284503400939,0.0161791617659172,0.000166629758829073
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,37709,0.0177305902706185,0.00472256118486505,0.00847437034828305,0.0269868101929541,0.000174469179063076
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,37593,0.00998067742119728,0.0026612713045649,0.00476458566425008,0.0151967691781445,0.000177351694260353
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40300,0.0137647718059937,0.0036791754504289,0.00655358792315311,0.0209759556888344,0.000183741731398571
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40432,0.0270608544313886,0.00723939990482053,0.0128716306179404,0.0412500782448368,0.000186138827793838
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37895,0.0151761140692825,0.00406769160821382,0.00720343851718344,0.0231487896213816,0.000191588923437782
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,40393,0.0496582109323585,0.0133149611784696,0.0235608870225582,0.0757555348421589,0.000192521198784334
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37567,0.0165854413481803,0.00445483078967019,0.00785397300042677,0.0253169096959339,0.000197674674911992
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37477,0.0257680043978487,0.00695409708510686,0.0121379741110393,0.0393980346846582,0.000211895788065371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37557,0.0281190413341739,0.00758973635865492,0.0132431580712102,0.0429949245971375,0.000212362741300227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,37937,0.0128327408333894,0.00346986132588261,0.00603181263465951,0.0196336690321193,0.000217872015524342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,40327,0.014461553599939,0.00392126945721521,0.00677586546379714,0.0221472417360808,0.000226797608887477
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37593,0.0222272984344231,0.00603213911478243,0.0104043057694496,0.0340502910993967,0.000229791033390653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37477,-0.00874349985997547,0.00237402313373736,-0.0133965852021007,-0.00409041451785025,0.000231448202495004
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,40300,0.006993536872702,0.00189973225395596,0.00327006165494831,0.0107170120904557,0.000232792625101277
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,40336,0.0182970985680451,0.00498577649123525,0.00852497664522401,0.0280692204908662,0.000243478153032066
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,40352,-0.0117842805630696,0.00321527023859653,-0.0180862102307188,-0.00548235089542037,0.000248048264307227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37937,0.0101750751952473,0.00278102416019191,0.00472426784127118,0.0156258825492235,0.000254413462619444
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MB,Myoglobin,40531,0.0159870254070316,0.00438566555820413,0.00739112091295148,0.0245829299011117,0.000267931795702722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,40039,0.0144286989729705,0.00396521437020111,0.00665687880737628,0.0222005191385646,0.000274775559579174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40531,-0.0102240244884624,0.00281919272444068,-0.0157496422283661,-0.00469840674855865,0.000288089293559708
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,37567,0.0140226935320001,0.00387216841519688,0.00643324343821425,0.021612143625786,0.000294111478650283
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37623,0.0110848399438017,0.00306243615474994,0.00508246508049184,0.0170872148071116,0.000296147607873871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40154,-0.0121540792200119,0.00337575866369069,-0.0187705662008457,-0.00553759223917816,0.000318707950794054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40531,0.00733173513683755,0.00204253812325032,0.00332836041526692,0.0113351098584082,0.000332270814375907
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,37805,0.0097485161829416,0.00271612606988074,0.00442490908597535,0.0150721232799079,0.000332978113485561
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,37666,-0.010295407150938,0.00287079781424166,-0.0159221708668516,-0.00466864343502432,0.000336674220498711
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37895,0.0199742146203383,0.00557986916857067,0.00903767104993981,0.0309107581907368,0.000345210993158913
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,40327,-0.0106758792666386,0.0029865138814337,-0.0165294464742486,-0.00482231205902853,0.000351675486860659
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLC,Galectin-10,40328,0.0209952390428779,0.00588133933591096,0.00946781394449239,0.0325226641412633,0.000358300596734635
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTTG1,Securin,37709,0.0132630940007902,0.00371918023746319,0.00597350073536235,0.020552687266218,0.000363562634864075
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,40354,-0.0222493253487946,0.00624216360702577,-0.0344839660185651,-0.0100146846790241,0.000365812314413533
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,40374,0.0104757997637959,0.00293955312445956,0.0047142756398552,0.0162373238877367,0.000366678978205754
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,40406,0.025239117136895,0.00708722750497284,0.0113481512271482,0.0391300830466418,0.000370222004208409
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,37536,0.0234183325766934,0.00658521550308505,0.0105113101906467,0.0363253549627401,0.000377588894529381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,37567,0.0154920424708761,0.00436287433506024,0.00694080877415801,0.0240432761675942,0.000385290925863708
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39956,0.0157781435770193,0.00445565577030828,0.00704505826721505,0.0245112288868235,0.000399556154269258
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40336,0.0475122261949911,0.0134230891736498,0.0212029714146375,0.0738214809753447,0.000401895176182232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,37709,0.0233239104913281,0.00659525642767063,0.0103972078930937,0.0362506130895626,0.000406900649938885
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39975,0.0179875354014284,0.00508671718894971,0.00801756971108697,0.0279575010917698,0.000407144699991877
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37937,0.0225789671324192,0.00638773177317822,0.0100590128569899,0.0350989214078485,0.000409544877289236
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37895,0.00900020931661117,0.00255378005959875,0.00399480039979762,0.0140056182334247,0.000426063281905776
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37896,0.00922480391373228,0.00262449516188576,0.0040807933964362,0.0143688144310284,0.000441388634696574
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37666,0.00842884399326756,0.00239968938246417,0.00372545280363779,0.0131322351828973,0.00044543956908617
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40511,0.0109338049625239,0.00311408774264624,0.0048301929869373,0.0170374169381106,0.000447517527275799
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40223,0.0190005298861903,0.00541831654945779,0.00838062944925304,0.0296204303231276,0.00045492401899001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40466,0.0225728592473394,0.006439224876284,0.00995197848982279,0.0351937400048561,0.000456954960184602
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37666,0.0125232273641074,0.00357249268166653,0.00552114170804104,0.0195253130201738,0.000457330975307491
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,37643,-0.0180120491604543,0.00513931258507937,-0.0280851018272099,-0.00793899649369874,0.000458537871442824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,37536,0.014170262638769,0.00404915945521713,0.0062339101065434,0.0221066151709946,0.000467582728988273
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,37477,0.0224196787583404,0.00642094873526255,0.0098346192372258,0.035004738279455,0.000481644795814045
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,38008,-0.0115117569674995,0.00330215317336334,-0.0179839771872917,-0.00503953674770736,0.000491601462712192
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37536,0.0339532590597061,0.00975682990282458,0.01482987245017,0.0530766456692423,0.000503144863234949
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37895,0.0120598401772423,0.00347123186640365,0.00525622571909112,0.0188634546353934,0.00051394554962726
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40374,0.00741093077409658,0.00214094888186015,0.00321467096565069,0.0116071905825425,0.000538549558370916
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37709,0.0169148153132724,0.00488724938575663,0.00733580651718937,0.0264938241093554,0.000539849360943013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,37955,0.011601404662919,0.00336107928718511,0.00501368926003623,0.0181891200658019,0.000558792264091085
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37955,0.0135206785025992,0.00392059114140307,0.00583631986544923,0.0212050371397492,0.000565151889427051
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,37937,0.0223557607048958,0.00649653847565274,0.00962254529261641,0.0350889761171751,0.000580937687849974
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37937,-0.0186661824271246,0.00544011656941259,-0.0293288109031733,-0.00800355395107593,0.000602696831878604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,39987,0.01462982547636,0.00426507465349395,0.00627027915551187,0.0229893717972082,0.000604826295445299
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37955,0.00826293739240685,0.00241188072304087,0.00353565117524674,0.012990223609567,0.000614519645025069
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,40269,0.0149026928839701,0.00435951084824935,0.0063580516214014,0.0234473341465389,0.000631417276617911
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40336,0.0139236194807483,0.00407335953662408,0.00593983478896505,0.0219074041725315,0.000631914193670032
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37666,0.0117964019392261,0.00345349447585816,0.00502755276654416,0.0185652511119081,0.00063789303586175
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,40336,0.0175824924193269,0.00514885939556182,0.00749072800402571,0.0276742568346281,0.000639808050169401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38008,-0.00598680921401611,0.00175600760873507,-0.00942858412713685,-0.00254503430089538,0.000653123383392788
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,40327,-0.0147141539277375,0.00431840865229575,-0.0231782348862372,-0.00625007296923786,0.000657695140266265
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37895,0.0109068883444296,0.00320166634987625,0.00463162229867212,0.017182154390187,0.000659631318303745
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37895,0.0290369582450697,0.00852688734854279,0.0123242590419258,0.0457496574482136,0.000662747326696436
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37593,0.0328535375521328,0.00967729371213974,0.0138860418763389,0.0518210332279267,0.000688542866634439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,37982,0.00680421576508994,0.00200452523919621,0.00287534629626537,0.0107330852339145,0.00068969654327344
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39975,0.0271023173009406,0.00799212295684554,0.0114377563055233,0.0427668782963578,0.000697789317782414
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40223,0.0068624250169768,0.00202374711726492,0.00289588066713757,0.010828969366816,0.000698217057335406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENG,Endoglin,40531,-0.00513679417466402,0.00152188411228315,-0.00811968703473899,-0.00215390131458904,0.000739134088916999
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40300,0.00791905529943624,0.00235328415134016,0.00330661836280953,0.012531492236063,0.000766952598213422
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40369,0.0171180219525228,0.00508833924495113,0.00714487703241855,0.027091166872627,0.000769563224553562
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,37593,0.00789444073694358,0.00235277755118253,0.00328299673662583,0.0125058847372613,0.000794831267197111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39929,0.0160573256135746,0.00478763598964255,0.00667355907387523,0.025441092153274,0.000798679610842178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,37557,-0.00964344818297509,0.00288187478542642,-0.0152919227624109,-0.00399497360353932,0.000821453345603089
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,37709,0.00691839519142568,0.0020681876403317,0.00286474741637555,0.0109720429664758,0.000824666792384016
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40374,0.00796193421288201,0.00238042501410612,0.00329630118523401,0.01262756724053,0.000825459902982448
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40037,0.00806927706840235,0.00242274592361838,0.00332069505811033,0.0128178590786944,0.000868500526250039
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37709,-0.00927091734317318,0.00278883432416,-0.0147370326185268,-0.00380480206781957,0.000888816511625782
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,37993,0.0130085040533296,0.00392003766932238,0.00532523022145778,0.0206917778852015,0.000907526816928406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,37567,0.0205487077310356,0.00621225404788967,0.00837268979717184,0.0327247256648994,0.000942950294096874
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37567,0.0208804515642675,0.00632040574110302,0.00849245631170556,0.0332684468168294,0.000956881638112265
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,40328,-0.00644501226450318,0.00195596124689147,-0.0102786963084105,-0.0026113282205959,0.000986157862278955
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37623,0.00966165515723179,0.00293693616866221,0.00390526026665385,0.0154180500478097,0.00100555581680452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37593,0.00927424341803335,0.00282144537624888,0.00374421048058554,0.0148042763554812,0.00101507009944143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37666,0.0158014942372824,0.00480882278277646,0.00637620158304056,0.0252267868915243,0.00101908178685284
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37567,0.0178806354140676,0.00544828492840659,0.00720199695439073,0.0285592738737446,0.00103385751453808
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,40484,0.00859785787892728,0.00262168221607989,0.00345936073541069,0.0137363550224439,0.00104205719149887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40417,0.00827408899538221,0.00252360900154268,0.00332781535235856,0.0132203626384059,0.00104519441945939
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37593,0.0190426290314561,0.0058084168577,0.00765813199036413,0.0304271260725482,0.00104648465928906
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,37567,0.0179838143262476,0.00549317443334608,0.00721719243688925,0.0287504362156059,0.00106368687522695
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37477,-0.0128291150149653,0.00392413774079489,-0.0205204249869233,-0.0051378050430073,0.00108100296413485
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,40245,0.0148695957786994,0.00455607285897373,0.00593969297511088,0.0237994985822879,0.00110206362579022
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37557,0.0144927725292158,0.00445456837664206,0.0057618185109974,0.0232237265474343,0.00114296385609106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37756,0.0130865260114434,0.00402278933743921,0.00520185891006255,0.0209711931128243,0.0011443897562104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,39956,0.017501086046472,0.00539716653251908,0.00692263964273458,0.0280795324502094,0.00118676752457658
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37593,0.0255466325233019,0.00788797858107699,0.010086194504391,0.0410070705422128,0.00120382768886894
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39956,0.0134221770423529,0.0041463978240937,0.0052952373071293,0.0215491167775766,0.00121017800014146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37623,0.0141675627760576,0.00438091415297482,0.00558097103622692,0.0227541545158882,0.00122400963353993
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,40354,0.00980466512323994,0.00303660230614064,0.00385292460320429,0.0157564056432756,0.00124551046112131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,37666,0.0097980237775106,0.00303956529988636,0.00384047578973333,0.0157555717652879,0.00126943858058092
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,37623,-0.0197417370279335,0.00612823334974769,-0.031753074393439,-0.00773039966242804,0.00127857970378466
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37774,0.00234277233917904,0.000728462144270772,0.000914986536408327,0.00377055814194975,0.00130277402767974
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,37557,0.0180136674570891,0.00560498062227779,0.00702790543742468,0.0289994294767536,0.00131276898647377
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37709,0.0200719229320092,0.00624975751238211,0.00782239820774023,0.0323214476562781,0.00132298200212585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,40531,-0.0066910383567615,0.00208466456830106,-0.0107769809106316,-0.00260509580289142,0.0013315874615485
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOC,Myocilin,40327,-0.0131382669225424,0.00409777369951368,-0.0211699033735892,-0.00510663047149558,0.00134768570262674
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37623,0.0166484190385694,0.00519890541885243,0.00645856441761862,0.0268382736595201,0.00136662216560557
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40039,0.0124548990096641,0.00389972107718281,0.00481144569838578,0.0200983523209424,0.00140696333202603
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,40271,0.00954764064030141,0.00299326158368388,0.003680847936281,0.0154144333443218,0.00142692646244434
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37567,0.0239295936875127,0.00753908787670408,0.00915298144917272,0.0387062059258527,0.00150664619539838
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37536,0.0341727514228781,0.0107779257929667,0.0130480168686634,0.0552974859770928,0.00152462663546948
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,40037,0.0144265826151361,0.00456966019087142,0.00547004864102813,0.0233831165892441,0.00159685294554427
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37557,0.0113665699812953,0.00360180185412323,0.00430703834721381,0.0184261016153769,0.00160420267672294
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37709,0.016786427258147,0.00531982489755634,0.0063595704589366,0.0272132840573574,0.00160610587939752
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,40039,0.00848458612119585,0.00269485639039784,0.00320266759601607,0.0137665046463756,0.00164455634705036
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37666,-0.00616774174961056,0.00196032389368992,-0.0100099765812428,-0.00232550691797831,0.00165724671537848
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39956,0.0155193857432753,0.00493806887224834,0.00584077075366859,0.0251980007328821,0.00167652761839435
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37955,0.0320888326458538,0.010221017790226,0.012055637777011,0.0521220275146967,0.00169604117344807
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,37557,-0.013392169899155,0.00426809140968837,-0.0217576290621442,-0.00502671073616585,0.0017063192121972
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40360,0.0138371013480884,0.00441405748353623,0.00518554868035738,0.0224886540158194,0.00172295582050265
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,37557,0.0121173294103482,0.00387255273401832,0.00452712605167225,0.0197075327690241,0.00175769761693593
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,40039,0.0131270399162699,0.00420143197707218,0.00489223324120848,0.0213618465913314,0.00178482444500875
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRL,Prolactin,40466,-0.021360910616043,0.00684145573539484,-0.0347701638574169,-0.00795165737466911,0.0017977837771172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,37896,0.0127393617677875,0.00408335506650025,0.00473598583744705,0.020742737698128,0.00181339971952185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37709,0.0198894675098209,0.00637654994765659,0.00739142961241403,0.0323875054072279,0.00181757328989826
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40037,-0.00945805427301096,0.00305198062840077,-0.0154399363046765,-0.00347617224134546,0.00194527910733102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,40336,0.0190391452219758,0.00614579116793599,0.00699339453282123,0.0310848959111303,0.00195226556602286
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37593,0.0097561507711959,0.00316787749641727,0.00354711087821805,0.0159651906641737,0.00207628317448702
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37567,0.0149145468392983,0.00485145331831746,0.00540569833539603,0.0244233953432005,0.00211470907925591
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40446,0.00817254736253333,0.00266302341261566,0.00295302147380663,0.01339207325126,0.00215209456728015
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37567,0.0200982174457264,0.00655740236867563,0.00724570880312213,0.0329507260883306,0.00218136765771752
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37896,0.00829368649023399,0.00270622760993104,0.00298948037476914,0.0135978926056988,0.00218344174635597
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40037,-0.0082939689335135,0.00271168632311003,-0.0136088741268092,-0.00297906374021785,0.00222749687600956
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39703,-0.0101872492525025,0.00333483576405805,-0.0167235273500563,-0.00365097115494874,0.00225600896811625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,40350,0.0122990530872393,0.00403167538069025,0.00439696934108636,0.0202011368333922,0.00228756238341247
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40154,0.0160749983240266,0.00528735001312828,0.0057117922982952,0.0264382043497581,0.00236751515687835
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37567,-0.0107225187970992,0.00353478683393239,-0.0176507009916067,-0.0037943366025917,0.00242265944436711
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,38008,-0.0204035298108394,0.0067264016469697,-0.0335872770389,-0.00721978258277882,0.00242312631577697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37593,0.0118626544620325,0.00392809626689404,0.00416358577892022,0.0195617231451449,0.00253301962332689
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRTN,Neurturin,40039,0.0133384234186759,0.00442474873887126,0.00466591589048825,0.0220109309468636,0.00257813715925297
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37993,0.0144525318036568,0.00481810045678069,0.0050090549083666,0.0238960086989469,0.00270796873787213
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,37895,0.0175507981032583,0.00586248252799757,0.00606033234838303,0.0290412638581335,0.00276074198311068
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,39956,0.0183793590866398,0.00614523201976537,0.00633470432789971,0.03042401384538,0.00278655275765385
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,37593,0.0131709949650936,0.0044150050842319,0.00451758499999908,0.0218244049301881,0.0028574335872702
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40531,-0.00876815074514396,0.00295001729009878,-0.0145501846337376,-0.00298611685655035,0.00296076125017192
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,40039,0.00863080697530714,0.00290410608228345,0.00293875905403159,0.0143228548965827,0.00296383749045331
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37955,0.0113534139614317,0.00382562603507701,0.00385518693268075,0.0188516409901826,0.00300536757026796
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,39929,0.00947821919616976,0.00320692290273804,0.0031926503068032,0.0157637880855363,0.00312583113160829
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,37477,-0.0121556697710798,0.00411324734806753,-0.0202176345732921,-0.00409370496886739,0.0031297626495404
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37452,0.0236736251651991,0.00802167548040549,0.00795114122360431,0.0393961091067938,0.00317099688228988
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,37761,0.0087542701496394,0.00296815133605304,0.00293669353097544,0.0145718467683034,0.00318943898308798
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37557,-0.00941017072850879,0.00319531562622785,-0.0156729893559154,-0.0031473521011022,0.00323533211822989
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39975,0.00924289495230457,0.0031406500024127,0.00308722094757568,0.0153985689570335,0.00325542116518404
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,37477,-0.00684673516037381,0.00232739542388824,-0.0114084301911948,-0.00228504012955286,0.00326883743730433
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REN,Renin,40354,0.0186906432002687,0.0063785645793688,0.00618865662470581,0.0311926297758315,0.00339195861442123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37985,0.0192376986060818,0.0065701883438752,0.00636012945208637,0.0321152677600772,0.00341687165219731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37536,-0.0170376131683261,0.00582493736116751,-0.0284544903962144,-0.00562073594043776,0.00345110145187778
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,40300,0.00740197806936773,0.00253429967419208,0.00243475070795125,0.0123692054307842,0.00349716626553211
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,37477,0.00959151844123806,0.00329308751506948,0.00313706691170187,0.0160459699707742,0.00359017101813478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37896,-0.0453391330455107,0.015580947281132,-0.0758777897165295,-0.014800476374492,0.00362127270996363
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,37557,-0.0122793530706563,0.00422268689731641,-0.0205558193893965,-0.00400288675191616,0.00364419577172728
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37993,-0.00848247929393635,0.00292577630691417,-0.0142170008554881,-0.00274795773238458,0.00374689133831303
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,40039,0.0181052941726583,0.00627094432497655,0.00581424329570422,0.0303963450496123,0.00389256125252689
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37557,0.010570505480762,0.00366512186223641,0.00338686663077865,0.0177541443307454,0.00393198077338364
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,40193,-0.00871643094760604,0.0030241560547012,-0.0146437768148204,-0.0027890850803917,0.00395356728352347
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37709,0.013757816863455,0.00477360364475778,0.00440155371972971,0.0231140800071802,0.00395717707645074
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,37536,0.0251069563644994,0.0087694473011839,0.00791883965417896,0.0422950730748198,0.00420312812524657
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40460,0.0103419198480222,0.00362044444346126,0.00324584873883812,0.0174379909572063,0.00428846656035344
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37567,0.0184936237991169,0.00653401684278063,0.00568695078726689,0.031300296810967,0.00465662539162755
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39956,0.0101420476077837,0.00358605912870664,0.00311337171551871,0.0171707235000487,0.00468724103497997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37895,0.0111770020999932,0.00395609254463479,0.00342306071250897,0.0189309434874773,0.00473114261472169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39956,0.014959935018098,0.00529868099892168,0.00457452026021154,0.0253453497759845,0.00475879142276919
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,37536,0.0119010046252425,0.00422121852908123,0.00362741630824331,0.0201745929422417,0.00481964426383176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37844,-0.00732966463181424,0.00260042293561254,-0.0124264935856148,-0.00223283567801367,0.00482978137184717
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37858,0.01346442969906,0.00478038448579179,0.00409487610690812,0.0228339832912119,0.00486058934686417
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37557,-0.0131614830051046,0.00468337467873155,-0.0223408973754185,-0.0039820686347908,0.00495754662498325
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37623,0.0106411895535801,0.0037922005287906,0.00320847651715056,0.0180739025900097,0.00502229983126019
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37982,-0.00648922813640504,0.0023175242032584,-0.0110315755747915,-0.00194688069801857,0.00511640718068164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,37638,0.0208833783496567,0.00745903562382757,0.00626366852695466,0.0355030881723587,0.00512177532751296
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,37347,0.00974619334376343,0.00348120809111659,0.00292302548517491,0.016569361202352,0.00512327594739895
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,40336,0.00817739984644461,0.00292552922758168,0.00244336256038452,0.0139114371325047,0.00519320095591693
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,40406,0.00685131176172876,0.00245112443754333,0.00204710786414384,0.0116555156593137,0.00519342397274592
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37666,0.00705970570989465,0.00253379166710382,0.00209347404237115,0.0120259373774181,0.00534023838196844
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,37758,0.0156822064056124,0.0056325540265747,0.00464240051352601,0.0267220122976988,0.00537342506384275
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37477,0.0137533173262079,0.00494842902046299,0.0040543964461004,0.0234522382063153,0.00545492347733785
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40039,-0.00952410132867302,0.00344203536831819,-0.0162704906505767,-0.00277771200676937,0.00566419729456717
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40354,-0.00702404146678286,0.00254675800945555,-0.0120156871653157,-0.00203239576824998,0.00582168133737048
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_DRA,,40283,0.00886235326042635,0.00321749190658343,0.00255606912352283,0.0151686373973299,0.00588617563683645
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,37895,0.00684226282933654,0.00248868323276746,0.00196444369311231,0.0117200819655608,0.00597932275289796
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37536,-0.00950555000043378,0.00346315097497015,-0.0162933259113753,-0.00271777408949228,0.00606360761315469
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37955,-0.00655346588311069,0.00239110936218312,-0.0112400402329896,-0.00186689153323178,0.00613771575030458
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,37557,0.0271799240854485,0.0099508705175571,0.00767621787103661,0.0466836302998604,0.00631480333888111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40288,0.0140756186525809,0.00516621598018223,0.00394983533142372,0.0242014019737381,0.00644596578898278
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,37937,-0.00645879270348003,0.00237086346778711,-0.0111056851003428,-0.0018119003066173,0.00645333746657617
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37567,-0.0076751995229736,0.00281769212894468,-0.0131978760957052,-0.00215252295024203,0.00645953603222935
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40391,0.0110899625687128,0.00407448428608627,0.0031039733679837,0.0190759517694419,0.00649964532128338
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40367,0.00657440392495437,0.00241601464875713,0.0018390152133904,0.0113097926365183,0.00651206042330125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37709,-0.00709807176060416,0.00261407299522311,-0.0122216548312415,-0.00197448868996686,0.00662954381112582
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37993,0.0143157589601862,0.00527595263342492,0.00397489179867335,0.024656626121699,0.00666813079600421
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,37895,0.00824055662932473,0.00304615199798057,0.00227009871328282,0.0142110145453666,0.00683421286593242
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40352,0.0064062028921033,0.00237720080784214,0.0017468893087327,0.0110655164754739,0.00704940340674268
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37567,0.0246390268464917,0.00915599073443994,0.00669328500698944,0.042584768685994,0.00713225251462256
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,40448,0.00747066956315888,0.00278377603602215,0.00201446853255547,0.0129268705937623,0.00728991015314005
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37895,0.0164344647490921,0.00614342976940451,0.00439334240105924,0.0284755870971249,0.00747910280774537
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,37982,-0.00613223686784439,0.00229389913126224,-0.0106282791651184,-0.0016361945705704,0.0075203444292818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELL,L-selectin,38008,0.00554416049130574,0.0020775920767548,0.00147208002086633,0.00961624096174516,0.00762698634061749
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37955,0.0165351469482253,0.00619967798060706,0.00438377810623546,0.0286865157902152,0.00766006566096782
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40037,0.0104096709285393,0.00390558990948917,0.00275471470594051,0.018064627151138,0.00769929582571268
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37968,0.0175422156974007,0.00658603761956071,0.00463358196306171,0.0304508494317397,0.00774134598220428
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37557,-0.00683822714910109,0.0025718191132971,-0.0118789926111634,-0.00179746168703877,0.00784899283453953
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37557,0.0211973331624218,0.00797548358651097,0.0055653853328603,0.0368292809919833,0.00787452711722406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37567,-0.00899032701210017,0.0033924914291231,-0.0156396102131815,-0.00234104381101889,0.00805725549023966
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37455,0.00601328829112524,0.00227352574493271,0.00155717783105714,0.0104693987511934,0.00818090146971429
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39956,0.0082961202899012,0.00314892568014326,0.0021242259568204,0.014468014622982,0.00843233156441619
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40300,-0.0148273082720308,0.00563044098930684,-0.0258629726110722,-0.00379164393298938,0.00846121503111544
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,40039,0.0150238694428716,0.00570821040684867,0.00383577704544823,0.026211961840295,0.00849736380582517
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,40336,0.00974853561729684,0.00371034351951835,0.00247626231904087,0.0170208089155528,0.00861242204574777
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,37623,-0.00421086515827584,0.00160290794100349,-0.00735256472264268,-0.001069165593909,0.00862369857478349
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37557,-0.0123091382391094,0.00469878695455059,-0.0215187606700285,-0.00309951580819024,0.00881236276206936
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,37567,0.00549878360590238,0.00210557991383142,0.00137184697479279,0.00962572023701196,0.00902409177189762
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37567,-0.00695035421866545,0.00267383947277277,-0.0121910795853001,-0.00170962885203083,0.00934939386992734
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40354,-0.0179608281457038,0.00691166444144226,-0.0315076904509306,-0.00441396584047696,0.00936841653923972
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,37993,0.0071635540556464,0.00276332088539403,0.0017474451202741,0.0125796629910187,0.00954192186330647
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSPN,Claspin,39920,0.00789664313088347,0.0030499766419981,0.00191868891256719,0.0138745973491998,0.0096321958022111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39956,0.00772428868201368,0.00298489414980914,0.00187389614838776,0.0135746812156396,0.0096683032812391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39975,0.0180348142396568,0.00697764270555212,0.00435863453677459,0.0317109939425389,0.00975662597846455
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37567,0.00849944377167634,0.00329312380084729,0.00204492112201565,0.014953966421337,0.00986316026843829
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37593,-0.00508970972949236,0.00197393409824326,-0.00895862056204915,-0.00122079889693558,0.00993496373826
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40039,0.0132097715369238,0.00512614403358904,0.0031625292310893,0.0232570138427583,0.00997700009996298
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37536,0.00753852856546853,0.00293535108078528,0.00178524044712938,0.0132918166838077,0.010234213647738
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIM,Vimentin,40037,0.0271310736929058,0.0105842812330275,0.00638588247617185,0.0478762649096398,0.0103764515828399
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37557,-0.00733292384356593,0.00286100439560199,-0.0129404924589458,-0.00172535522818602,0.0103864958352521
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37593,0.00495501977487283,0.00193623253651324,0.00116000400330688,0.00875003554643878,0.0105053417562827
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,37955,-0.00826689511036709,0.00325140029271683,-0.0146396396840921,-0.00189415053664211,0.0110152946792205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40037,0.0113237608674455,0.00445546950069896,0.00259104064607549,0.0200564810888154,0.0110460856327893
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,40223,-0.00756734258354759,0.00299346996892799,-0.0134345437226464,-0.00170014144444874,0.011482746515627
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37896,-0.0156477532462092,0.00620735033127171,-0.0278141598955018,-0.00348134659691665,0.0117188924865099
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37709,0.0120785545064842,0.00479572305234266,0.00267893732389259,0.0214781716890758,0.0117935896981238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40511,0.00815968918042848,0.00325838917667907,0.0017732463941375,0.0145461319667195,0.0122823680801732
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,37623,0.00641837530783912,0.0025665840149737,0.00138787063849066,0.0114488799771876,0.0124052447887252
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,40039,0.0113653999546909,0.00456081421257597,0.00242620409804197,0.0203045958113398,0.0127140811092306
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37477,0.0129654940150057,0.00521469708863016,0.0027446877212906,0.0231863003087208,0.0129190038401871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37985,-0.0073089046701502,0.00295566252378441,-0.0131020032167676,-0.00151580612353276,0.0134162996632502
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37536,0.0162758165884351,0.00666048763184427,0.00322126083002035,0.0293303723468499,0.0145531513474522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39952,0.00615906156589569,0.00252473165643698,0.00121058751927922,0.0111075356125122,0.0147190813113296
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37477,0.0198944321433878,0.00815710396514512,0.0039065083717034,0.0358823559150723,0.0147449496394776
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,40354,0.0258075968726095,0.0105842236744322,0.00506251847072245,0.0465526752744966,0.0147670673014172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40039,0.00636751812659112,0.00261218206600678,0.00124764127721783,0.0114873949759644,0.0147952363407899
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37993,-0.0100372543122553,0.0041387597214726,-0.0181492233663416,-0.00192528525816897,0.0153136137819265
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,40039,0.0103074843747204,0.0042883669785406,0.00190228509678083,0.01871268365266,0.0162464863264608
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,37557,0.0156741124372777,0.0065213920708028,0.00289218397850419,0.0284560408960511,0.0162531333706882
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,40414,0.00717471740183886,0.00298950631983377,0.00131528501496466,0.013034149788713,0.0164079195320518
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,37536,-0.00783126351525277,0.00327313829153172,-0.0142466145666549,-0.00141591246385059,0.016744143052842
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37962,-0.0226189285155824,0.0094792303124456,-0.0411982199279758,-0.00403963710318903,0.0170391826659904
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,40531,-0.00626852166888286,0.00262858647124247,-0.0114205511525181,-0.00111649218524762,0.0171022490041089
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37709,0.00773375716774695,0.00324871059894831,0.00136628439380825,0.0141012299416856,0.0173002943423638
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40039,0.0135823953619406,0.00571684395449296,0.00237738121113442,0.0247874095127468,0.0175203312883185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39975,0.0267617235724279,0.0113191974862261,0.00457609649942473,0.0489473506454311,0.018077514847197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37477,0.018891445751109,0.00799880028429066,0.00321379719389934,0.0345690943083187,0.0182018211411242
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37477,-0.00948752168780491,0.00401859169365792,-0.0173639614073744,-0.00161108196823538,0.0182449420980746
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37623,-0.00564370112593926,0.00239195026793631,-0.0103319236510944,-0.0009554786007841,0.0183162658309286
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,37993,0.0190627126931559,0.00808870380123507,0.00320885324273516,0.0349165721435766,0.0184518998173878
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40301,-0.014551524978091,0.00618016729095427,-0.0266646528683614,-0.00243839708782066,0.0185571800086699
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40037,0.00732946953261678,0.00313007101905115,0.00119453033527652,0.013464408729957,0.01921224366551
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,40039,0.016600495776108,0.0071032003674673,0.00267822305587206,0.0305227684963439,0.0194494614667468
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37557,0.0125952072449448,0.00539384799401644,0.00202326517667261,0.0231671493132171,0.0195528939985227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,40531,0.00835875653340118,0.0035863418229702,0.00132952656037958,0.0153879865064228,0.019780459858195
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39956,0.0101480939930348,0.00436004987424929,0.0016023962395062,0.0186937917465634,0.0199505237117811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,40365,0.00587716404063467,0.00252709064399958,0.000924066378395492,0.0108302617028739,0.0200489786038024
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,37557,0.0136824407149376,0.00588707225814791,0.0021437790889677,0.0252211023409075,0.0201326490719961
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39956,0.00891775203167669,0.00385191221491865,0.00136800409043614,0.0164674999729172,0.0206177507293153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37896,0.0171045292667194,0.00740037866421162,0.00259978708486465,0.0316092714485742,0.020831083459347
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,40037,0.0112633199018454,0.00487435328682163,0.00170958745967496,0.0208170523440157,0.0208606990514746
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39956,0.0139338718986911,0.00603915862167077,0.00209712100021641,0.0257706227971658,0.0210537820926748
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,37536,0.0121228301811945,0.00525721143692368,0.00181869576482404,0.0224269645975649,0.0211293714685055
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40485,-0.00932424639291227,0.00404454765679467,-0.0172515598002298,-0.00139693298559472,0.0211576286657114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37557,-0.00879317330121567,0.00381629701949844,-0.0162731154594326,-0.00131323114299873,0.0212319577975243
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37557,-0.00694360913448945,0.00301527897274207,-0.0128535559210639,-0.00103366234791499,0.021305224607666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37982,0.00722733499480686,0.00313969459066464,0.00107353359710417,0.0133811363925095,0.0213546314203336
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37895,0.0118651232521221,0.00517084968760128,0.00173025786442362,0.0219999886398206,0.0217703796431033
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,40401,0.00823431744700403,0.00359724575447261,0.00118371576823772,0.0152849191257703,0.0220887761153564
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37985,-0.00510894324174068,0.00223685140711138,-0.00949317199967898,-0.000724714483802381,0.0223876147995158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39975,0.00764522196397436,0.00335877631364312,0.00106202038923384,0.0142284235387149,0.0228480384975782
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,37593,0.00968509512292136,0.00426245432540655,0.00133068464512451,0.0180395056007182,0.023091277537807
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39956,0.0066073583201204,0.00291177991124548,0.000900269694079264,0.0123144469461615,0.0232709436641535
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAG,S-arrestin,37536,-0.010915790058273,0.00481692482889116,-0.0203569627228997,-0.00147461739364638,0.0234595321682191
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37976,0.00378166279255617,0.00166887767915178,0.000510662541418689,0.00705266304369365,0.0234676333995199
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37557,-0.00830689527348581,0.0036722074905875,-0.0155044219550373,-0.00110936859193431,0.0237076218472847
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NENF,Neudesin,37895,0.0219999536990886,0.00973219652016717,0.00292484851956094,0.0410750588786162,0.023804100102017
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40336,0.00806045577015856,0.00358205685248232,0.0010396243392932,0.0150812872010239,0.0244479045448553
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC1,Hamartin,37593,0.0153865192899415,0.00685635080732056,0.00194807170759323,0.0288249668722898,0.0248408338757155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37672,-0.0132634687763149,0.00592786590900455,-0.0248820859579638,-0.00164485159466595,0.0252717181414744
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,40406,0.00799017574975828,0.00357161381001696,0.000989812682125051,0.0149905388173915,0.0252913921415236
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,37985,0.00584879635123223,0.00261568933081947,0.000722045262826063,0.0109755474396384,0.0253651255463876
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40395,-0.0127777765128612,0.00571862118404867,-0.0239862740335966,-0.00156927899212584,0.0254695422578063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,40354,-0.00756729025904143,0.00339207861102215,-0.0142157643366448,-0.000918816181438013,0.0257035564475774
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,40039,-0.00640421538203724,0.00288229712662211,-0.0120535177502166,-0.000754913013857903,0.0263034426786703
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,40430,0.00877113899977669,0.00395196949159968,0.00102527879624132,0.0165169992033121,0.0264711392922641
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,40370,-0.00395847557057537,0.00179489199325442,-0.00747646387735404,-0.000440487263796699,0.0274394672556068
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,39975,0.0332815008039651,0.0151007405884735,0.00368404925055704,0.0628789523573732,0.0275414431990612
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,37536,0.0108953906110518,0.0049449284062758,0.00120333093475127,0.0205874502873524,0.0275876980411192
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37593,0.00529509980489695,0.00240422086888205,0.000582826901888127,0.0100073727079058,0.0276530828532239
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37477,0.028012377409808,0.0127423719981679,0.00303732829339888,0.052987426526217,0.027940672111233
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40354,0.00343251390203152,0.00156309841349801,0.00036884101157542,0.00649618679248763,0.0281086318559699
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37709,0.0149654088084275,0.0068312876344405,0.00157608504492414,0.0283547325719309,0.0284897244432019
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37557,0.00947567261386256,0.00435338931877514,0.000943029549063277,0.0180083156786618,0.0295267517528906
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,37557,-0.0080254058449934,0.00369955987137373,-0.0152765431928859,-0.000774268497100879,0.0300788446480984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,37477,0.0104799972350779,0.00485601968555279,0.000962198651394424,0.0199977958187614,0.0309347342720993
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37593,0.0132248200397339,0.0061389553790122,0.00119246749687001,0.0252571725825978,0.0312390066489685
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,39720,-0.00607036906137194,0.00281942737670731,-0.0115964467197183,-0.000544291403025618,0.031330336496917
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40039,0.0074551949339644,0.00347129183471816,0.00065146293791681,0.014258926930012,0.031755222049119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,36174,0.0201371359261898,0.00938615760226406,0.00174026702575227,0.0385340048266274,0.0319407350210846
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,40037,0.0116907668392985,0.00545093386476654,0.00100693646435612,0.022374597214241,0.0319900678212033
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,37955,0.00735626347333231,0.00342990774717945,0.000633644288860596,0.014078882657804,0.0319913577710151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,40039,0.00942545968683193,0.00441010909211538,0.000781645866285789,0.0180692735073781,0.0325940271289489
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37593,-0.0120075457356398,0.00561981169996297,-0.0230223766675672,-0.000992714803712325,0.0326452454418578
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,39948,-0.0169628009881166,0.00795234729430667,-0.0325494016849577,-0.00137620029127554,0.0329358106157627
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,37709,0.00848609420845657,0.00398044269258885,0.000684426530982417,0.0162877618859307,0.0330295065832883
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,40300,-0.0144682553010671,0.00680765182570901,-0.0278112528794567,-0.00112525772267739,0.0335775901127755
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37557,-0.0113284281114782,0.00538974617255136,-0.0218923306096789,-0.000764525613277549,0.0355856146243261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37477,-0.0108718863177781,0.00518186334882278,-0.0210283384814708,-0.000715434154085474,0.0359186153520714
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37709,0.017295605767394,0.00824831091266136,0.00112891637857769,0.0334622951562102,0.0360243038164419
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37536,-0.0103923745694754,0.00496827705245149,-0.0201301975922804,-0.000654551546670512,0.0364804565681116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37536,-0.00627027914070996,0.00299785673034095,-0.0121460783321782,-0.000394479949241706,0.0364946797376787
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37593,0.008064222961632,0.00385955542717419,0.000499494324370584,0.0156289515988934,0.0366893337225328
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40279,0.00650355738242595,0.00311304383262386,0.000401991470483193,0.0126051232943687,0.036711835033977
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,37593,0.0059822175294622,0.00286935935454505,0.000358273194553903,0.0116061618643705,0.037101108923161
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,37593,0.0166478978486273,0.00799520966675542,0.000977286901786705,0.032318508795468,0.0373403939341575
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37709,0.0111248210497518,0.00534943650988924,0.000639925490368913,0.0216097166091347,0.0375791266978874
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRNN,Cornulin,39852,0.0123183236836795,0.00594132041513403,0.000673335670016845,0.0239633116973422,0.0381580742543163
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37567,0.0067107485304592,0.00324859258002218,0.000343507073615732,0.0130779899873027,0.0388726061551592
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,37526,0.0162046120540483,0.00789454105156423,0.000731311592982386,0.0316779125151142,0.0401278421149881
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39975,0.0140685651861043,0.00686621168875904,0.000610790276136568,0.027526340096072,0.0404831995846121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,37567,0.00640418967519695,0.00314133843961855,0.000247166333544583,0.0125612130168493,0.0415018023180459
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37593,0.00811639786118029,0.00398142987335443,0.000312795309405598,0.015920000412955,0.0415135796693947
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37477,-0.00923902263490045,0.00454036414642252,-0.0181381363618886,-0.000339908907912316,0.0418847882707535
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37895,0.0118733332155996,0.00584165833156057,0.000423682885740845,0.0233229835454583,0.04211986263061
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40484,-0.0111202092807906,0.00547324135081977,-0.0218477623283973,-0.000392656233183821,0.0421963317666723
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37993,-0.00385302972025431,0.00189750255156816,-0.0075721347213279,-0.000133924719180722,0.0423171734758818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40300,0.00815491752549118,0.00402414193241499,0.000267599337957803,0.0160422357130246,0.0427304407129408
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40419,0.00380353701479035,0.00187695550902483,0.000124704217101685,0.00748236981247902,0.0427363429291859
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,40039,0.00975285507333976,0.00481619259794778,0.000313117581362104,0.0191925925653174,0.0428829883710032
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37557,-0.00882860634559144,0.00436104146744739,-0.0173762476217883,-0.000280965069394559,0.0429465663974717
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,37557,0.011427251358669,0.00565150456218747,0.000350302416781557,0.0225042003005565,0.0431982912385052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37709,0.00683575875274337,0.00339236333186488,0.00018672662228821,0.0134847908831985,0.0439202673524356
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,37557,0.008645390992012,0.00429140436583167,0.000234238434981923,0.0170565435490421,0.0439687305623563
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39956,0.0145769226222789,0.0072439317798211,0.000378816333829564,0.0287750289107283,0.0442061844192529
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40466,-0.0229831582865023,0.0114714288452388,-0.0454671588231704,-0.00049915774983432,0.0451390563170552
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37593,0.0125077806470275,0.00627044602917101,0.000217706429852318,0.0247978548642027,0.046094106287987
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37557,-0.00681659258620005,0.00344200275358269,-0.0135629179832221,-7.02671891779725e-05,0.0476778365802436
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40037,0.0141726721191244,0.0071689911250383,0.00012144951404938,0.0282238947241995,0.0480659022162332
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,37567,0.00481130615463647,0.00244705327526787,1.50817351114501e-05,0.00960753057416149,0.0493008188534635
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40037,0.00564010308985766,0.00286889119504444,1.70763475705682e-05,0.0112631298321448,0.0493218513771317
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37623,0.0145525613536862,0.0074097034063854,2.95426771707973e-05,0.0290755800302016,0.0495525962300898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37477,0.0156965033157621,0.00800652398398138,3.71630715855636e-06,0.0313892903243656,0.0499628463476977
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,40466,0.00405616054494483,0.00207663416003171,-1.40424087173184e-05,0.00812636349860699,0.0508088024609089
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,37546,0.0120881735592433,0.00619493994823316,-5.39087392937235e-05,0.0242302558577803,0.0510429084458471
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,40223,0.00436409694067827,0.00224692256686216,-3.98712903715613e-05,0.0087680651717281,0.0521239981208377
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,37593,0.00603332640006739,0.00311554226706667,-7.31364433832881e-05,0.0121397892435181,0.0528248100763034
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,40204,-0.0220484735105015,0.0113941201529157,-0.0443809490102162,0.000284001989213217,0.0529990095542629
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39975,-0.00586969421650095,0.00303645411638187,-0.0118211442846094,8.17558516075251e-05,0.0532450960065663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37593,0.00639640391731929,0.00332012540201473,-0.000111041870629569,0.0129038497052682,0.0540566617229472
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37557,-0.00828046866535289,0.00430539760165613,-0.0167190479645989,0.000158110633893125,0.0544670148782791
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,40369,0.0113906038631659,0.00594794389233006,-0.000267366165801027,0.0230485738921328,0.0555041604606215
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,40039,0.0152806033012555,0.00803246731564871,-0.000463032637415955,0.031024239239927,0.0571431896083279
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37536,-0.0111706971241443,0.00588326466782544,-0.0227018958730821,0.000360501624793593,0.0576227240539559
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37593,-0.00506959593194576,0.00267153711859138,-0.0103058086843849,0.000166616820493339,0.0577663932666298
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37536,0.00850887907066927,0.00449496078501412,-0.000301244067958407,0.0173190022092969,0.0583823339818335
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,40300,-0.0054414028880259,0.00288968165032001,-0.0111051789226531,0.000222373146601307,0.0597124602136414
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37937,0.00672866442483767,0.00357620507460001,-0.000280697521378344,0.0137380263710537,0.0599241435551421
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,37424,0.00586417781440956,0.00314439404521114,-0.000298834514204271,0.0120271901430234,0.0622091859363716
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,40386,0.00658288597646761,0.00353625595760405,-0.000348175700436325,0.0135139476533715,0.0626861945794052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37567,0.00954168281361732,0.0051445969265449,-0.000541727162410684,0.0196250927896453,0.0636615378944031
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,37536,-0.00728662062049966,0.00396520217219337,-0.0150584168779987,0.000485175636999349,0.0661378900501931
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37982,-0.0103472890881128,0.00563247438100916,-0.0213869388748907,0.000692360698665174,0.0662204502096439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37557,0.0054155223923278,0.00294858023501165,-0.000363694868295028,0.0111947396529506,0.0662835896245156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,37557,-0.0090241861144165,0.00491442157464175,-0.0186564524007143,0.000608080171881327,0.066340938623715
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37567,-0.0108885186357482,0.00594285696480444,-0.0225365182867649,0.000759481015268473,0.0669438883258666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37955,0.0128982899326801,0.00704137714606527,-0.000902809273607837,0.026699389138968,0.0670054558208669
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37955,0.00552181999924349,0.0030371222571622,-0.00043093962479443,0.0114745796232814,0.0690695869928397
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,40304,0.00440836785814602,0.0024273767142957,-0.000349290501873551,0.0091660262181656,0.0693733457253459
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39975,0.00537394460077926,0.00296070297102234,-0.000429033222424534,0.011176922423983,0.0695292526800679
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,37955,0.00874760465176687,0.00482520862651841,-0.000709804256209206,0.018205013559743,0.0698699553741486
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,37477,-0.00683276095050907,0.00376938423255434,-0.0142207540463156,0.000555232145297437,0.0699011920316185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37557,-0.00327009864139629,0.00181673033903916,-0.00683089010591303,0.000290692823120458,0.0718850156312958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37536,0.0126621985274383,0.00704820547412712,-0.00115228420185084,0.0264766812567275,0.0724358948930214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,40223,-0.00548003186239053,0.00305333650151959,-0.0114645714053689,0.000504507680587856,0.0727097500130395
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,37520,0.0154145209162515,0.00859843448539347,-0.00143841067511974,0.0322674525076227,0.0730420280076461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40484,-0.00546149230490875,0.00305713821132027,-0.0114534831990965,0.000530498589278976,0.0740417311464988
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,40037,0.0115539170485925,0.00648773595744267,-0.00116204542799514,0.0242698795251801,0.0749505758077071
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,37666,-0.00860023076576485,0.00483278761936799,-0.0180724944997261,0.000872032968196417,0.0751711362292073
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,37593,0.0101454501488343,0.00570437420215668,-0.00103512328739278,0.0213260235850614,0.0753385388932329
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,37536,0.00794612764545904,0.00446890951094745,-0.000812934995997957,0.016705190286916,0.0754121332135027
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,37226,-0.0111462042702249,0.00627434181458653,-0.0234439142268145,0.00115150568636471,0.0756786405874961
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37955,0.0117414644357425,0.00661748142290426,-0.0012287991531498,0.0247117280246349,0.0760343909755462
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37937,-0.0104285347270377,0.00588409844182945,-0.0219613676730235,0.00110429821894798,0.0763631986482417
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37567,-0.00832625274596906,0.00470743649511374,-0.017552828276392,0.000900322784453868,0.0769597501936997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,40039,0.00974747510793678,0.00551973688700674,-0.00107120919059643,0.02056615940647,0.0774269794991478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,37477,0.00915617011888824,0.00518599030907898,-0.00100837088690657,0.019320711124683,0.0774933460865851
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40309,-0.00443444482159421,0.00252584158080526,-0.00938509431997252,0.000516204676784106,0.0791708062701597
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37559,0.00602099689507937,0.00343262057296033,-0.000706939427922871,0.0127489332180816,0.0794448704142612
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37993,0.00362939847513597,0.00207063146603988,-0.000429039198302194,0.00768783614857413,0.0796593333387498
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37593,0.00972900326208812,0.00555782945425693,-0.00116434246825545,0.0206223489924317,0.080054701450452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37567,0.0136764667483063,0.00781432942315372,-0.00163961892107496,0.0289925524176876,0.0801110023920165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,37557,-0.00747734240035489,0.00428067404123097,-0.0158674635211676,0.000912778720457801,0.0807010981818992
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,40311,0.0199319451749726,0.0114237522165432,-0.00245860916945212,0.0423224995193974,0.0810423772239183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37536,-0.0053884919649693,0.00308887091821585,-0.0114426789646724,0.000665695034733776,0.08109786707695
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39956,0.00869668687072918,0.00500030704755251,-0.00110391494247374,0.0184972886839321,0.0820140616142835
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,37477,-0.00662020396457073,0.00380695892021947,-0.0140818434482009,0.00084143551905943,0.0820628988284174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37557,0.00809430447441184,0.00468178413945301,-0.00108199243891606,0.0172706013877397,0.0838517736058531
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,40039,-0.00458568571853281,0.00265375964266702,-0.00978705461816018,0.000615683181094552,0.0840087698423558
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37477,-0.00397020855716392,0.00229962139374114,-0.00847746648889654,0.000537049374568713,0.0842880729251369
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39525,0.00441199132785539,0.0025566455892654,-0.000599034027104802,0.00942301668281558,0.0844227351932052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,37405,0.00677466002791125,0.00394209900939933,-0.000951854030511443,0.0145011740863339,0.0857218204154958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39975,0.0076335077732161,0.0044559998767411,-0.00110025198519646,0.0163672675316287,0.0867168207236304
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37567,0.00766475611123983,0.00447627824917801,-0.00110874925714907,0.0164382614796287,0.0868640126388844
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,37536,0.00531600588647313,0.00311677158501738,-0.000792866420160941,0.0114248781931072,0.0881039072087645
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40531,-0.00437638826512603,0.00258615440562449,-0.00944525090015003,0.000692474369897966,0.0906200153296951
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37593,-0.0184539231894131,0.0109077621175909,-0.0398331369398912,0.00292529056106496,0.0907048284706612
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37955,0.00553951134094765,0.003310926559439,-0.000949904715552789,0.0120289273974481,0.0943307689206477
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40354,-0.00383126791133244,0.00230548412197529,-0.008350016790404,0.000687480967739134,0.0965713405690783
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40039,0.0177861695505615,0.0107379926703503,-0.00326029608332512,0.0388326351844481,0.0976655208453946
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,40039,0.0215764956941365,0.0130424217533656,-0.00398665094246002,0.0471396423307331,0.0980802088932995
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,37896,-0.015868760540606,0.00959255860332923,-0.0346701754031313,0.00293265432191931,0.0980943456221158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNC,Tenascin,40398,-0.00698269755533851,0.00422477079868176,-0.0152632483207548,0.00129785321007774,0.0983914350139535
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37896,0.00725217596400747,0.00440244874060825,-0.00137662356758471,0.0158809754955996,0.0995187344764111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,40484,0.00673320509859672,0.00410494345334398,-0.00131248406995749,0.0147788942671509,0.100969190084566
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,37593,-0.0064027438723955,0.00390820536799962,-0.0140628263936747,0.00125733864888375,0.101386748616701
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37985,0.00498502896687323,0.00304384880370634,-0.000980914688391194,0.0109509726221377,0.101499463957781
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,40063,-0.00436685837785212,0.00266799378880849,-0.00959612620391677,0.000862409448212531,0.101701342705067
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,40484,0.00456955410586708,0.00281241221861217,-0.000942773842612776,0.0100818820543469,0.104228875460251
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTG,Protogenin,40484,-0.00365296069602887,0.00224852283648932,-0.00806006545554792,0.00075414406349019,0.104266479655642
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,37805,-0.0153489320142581,0.00956586600191469,-0.0340980293780109,0.00340016534949465,0.108616021409529
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37709,0.00974439289517177,0.00611929667779391,-0.00224942859330429,0.0217382143836478,0.111317785320662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37536,0.0081297628351531,0.00511564339642078,-0.00189689822183163,0.0181564238921378,0.112040186682011
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37557,0.00560800995252943,0.00353454141145522,-0.00131969121392281,0.0125357111189817,0.112620562103013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37878,0.00599960883144864,0.00378472782110808,-0.0014184576979232,0.0134176753608205,0.112940953636476
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37709,-0.00647021847767628,0.00409951827529655,-0.0145052742972575,0.00156483734190496,0.114523433754092
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37557,0.00553904512923147,0.0035131964993905,-0.00134682000957391,0.0124249102680369,0.114902586209087
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36969,0.00713456263174305,0.00452703234687837,-0.00173842076813856,0.0160075460316247,0.115053128978993
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,37477,-0.0044881326080234,0.00285929630933162,-0.0100923533743134,0.00111608815826657,0.116517744185186
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37477,0.00586678046779209,0.00373787445953328,-0.00145945347289314,0.0131930144084773,0.116544153898851
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGN,Cingulin,37567,0.00593217891802303,0.00378540394773833,-0.00148721281954411,0.0133515706555902,0.117110975698593
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40352,-0.00532547267120414,0.00341515150878298,-0.0120191696284188,0.0013682242860105,0.118929575639847
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,39975,0.0149622440090724,0.00961174233224219,-0.00387677096212228,0.0338012589802671,0.119570895033851
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,37709,0.0239349486809846,0.0153795749526786,-0.00620901822626537,0.0540789155882345,0.119665028460507
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,37593,0.00371683511368147,0.00239371445097313,-0.000974845210225878,0.00840851543758881,0.120507452838246
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,40350,0.0255592519867756,0.0164703729623133,-0.00672267901935846,0.0578411829929096,0.120722329860777
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,37567,0.0121587507102386,0.00783579868761413,-0.00319941471748507,0.0275169161379623,0.120759927320994
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37955,0.00523605797934044,0.00339463939126486,-0.00141743522753869,0.0118895511862196,0.122987966696587
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37593,0.0040211523218584,0.00261015459313816,-0.00109475068069239,0.00913705532440919,0.123443083216298
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39752,0.00895564530745994,0.00582832339290543,-0.0024678685426347,0.0203791591575546,0.124418547153764
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39975,-0.0166290730649099,0.010836934088562,-0.0378694638784914,0.00461131774867173,0.124931662145252
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,40466,-0.00411459242841051,0.00268199283418264,-0.00937129838340848,0.00114211352658746,0.125011306587214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,40484,0.00832545616061982,0.00543447246117353,-0.00232610986328029,0.0189770221845199,0.125549233929732
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39956,0.00418305663589039,0.00274583930541482,-0.00119878840272265,0.00956490167450343,0.127674956619492
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,37452,0.00481655781746943,0.00316232025429974,-0.00138158988095807,0.0110147055158969,0.127755810535741
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,39929,-0.00845980109478704,0.00555865250857936,-0.0193547600116026,0.00243515782202852,0.128050608636849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,37567,0.0079019282624397,0.00522294097084403,-0.00233503604041459,0.018138892565294,0.130322305915257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37536,0.00779300309743467,0.00515640433335079,-0.00231354939593287,0.0178995555908022,0.130729801952284
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37477,-0.00410398068644807,0.00271789792033438,-0.00943106061030346,0.00122309923740731,0.1310719225292
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37593,0.00398435254768189,0.0026462910487139,-0.00120237790779735,0.00917108300316114,0.132184533274029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40352,0.0393897218181717,0.0261623108310227,-0.0118884074106328,0.0906678510469762,0.132192240596482
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,39942,0.0116760003056884,0.00776773984163533,-0.00354876978391681,0.0269007703952937,0.132823337309489
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),37730,0.0236902989331488,0.0157807247973148,-0.0072399216695882,0.0546205195358858,0.133323114613872
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37536,0.0108890329428487,0.00729177623039493,-0.00340284846872536,0.0251809143544228,0.135374769081465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,37477,0.00563036177405646,0.00379448727818697,-0.00180683329118999,0.0130675568393029,0.137879082262722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,37593,0.00378909187236639,0.002555959251202,-0.00122058825998953,0.00879877200472231,0.138243529190952
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37536,0.00452471094522765,0.0030562243825047,-0.00146548884448157,0.0105149107349369,0.13876649157301
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,37567,0.00799066450313368,0.00541069564494391,-0.00261429896095638,0.0185956279672237,0.139745874485167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39956,0.0086189811043846,0.00584221286502426,-0.00283175611106294,0.0200697183198321,0.140153847619321
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40460,0.0084152483757985,0.00570698205876132,-0.00277043645937369,0.0196009332109707,0.140352383545045
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39975,0.00677725974386301,0.00460012183139234,-0.00223897904566597,0.015793498533392,0.140696281546676
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37709,0.0102307849083341,0.006995830921084,-0.00348104369699052,0.0239426135136588,0.14365213330451
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,37895,-0.0106156621107515,0.0072638922925457,-0.0248528910041411,0.00362156678263809,0.143921148279663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37593,0.00476589431851361,0.00326411272758785,-0.00163176662755857,0.0111635552645858,0.144289585725732
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,37477,0.00821449235820245,0.00563059903768095,-0.00282148175565221,0.0192504664720571,0.144616188641314
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37557,0.0156273340008819,0.0107500604229217,-0.00544278442804475,0.0366974524298085,0.146054188504354
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37993,0.0178392782145794,0.012345693785111,-0.00635828160423817,0.042036838033397,0.14848669769235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37536,-0.00371880448233044,0.00257376792587645,-0.00876338961704829,0.00132578065238741,0.148513503467574
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,40039,0.00789244820166306,0.00548580113054179,-0.00285972201419885,0.018644618417525,0.150254268716813
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40417,-0.00264310087031317,0.00184068481385481,-0.0062508431054686,0.000964641364842267,0.151040875624707
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40336,-0.00313483028937387,0.00218548767241122,-0.00741838612729986,0.00114872554855211,0.151482170458563
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,37896,0.0133843916456866,0.00933205354372281,-0.00490643330001016,0.0316752165913833,0.15152743678237
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40327,0.0040188161236225,0.00281227460117383,-0.00149324209467821,0.00953087434192322,0.153016170981615
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40398,0.00423902619384353,0.00297115459169816,-0.00158443680588487,0.0100624891935719,0.153678206247244
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37709,0.0072000415428913,0.00505703125220264,-0.00271173971142588,0.0171118227972085,0.154537046722657
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCN,Decorin,40037,-0.00289242135308922,0.00203927147403047,-0.00688939344218894,0.0011045507360105,0.156105644849827
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37593,0.0119312710963524,0.00842563648136048,-0.00458297640711413,0.0284455185998189,0.156779405370996
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37567,0.00427618174312848,0.00303003598374186,-0.00166268878500556,0.0102150522712625,0.158190405452835
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37709,0.0081834965057492,0.00580551496017473,-0.00319531281619326,0.0195623058276917,0.158679116112416
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,37937,0.00463867942186947,0.003293306314071,-0.00181620095370969,0.0110935597974486,0.159000957769337
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37593,0.0074038353718971,0.00526864380290221,-0.00292270648179123,0.0177303772255854,0.159966433987523
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,37955,0.00598895833270695,0.00426358165228981,-0.00236766170578107,0.014345578371195,0.160140123894908
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37557,-0.00998366658564878,0.0071587986229522,-0.0240149118866351,0.00404757871533752,0.163159879895201
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,37709,-0.00369571091919148,0.002654244947213,-0.00889803101572896,0.001506609177346,0.16383147067052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37536,0.00774128002188218,0.00557074668230984,-0.00317738347544511,0.0186599435192095,0.16466472504162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,40039,-0.00544859551881848,0.00392169291095376,-0.0131351136242878,0.00223792258665089,0.164746853538819
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37536,-0.00768083062694113,0.00554115917311159,-0.0185415026062398,0.00317984135235758,0.165727325065603
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37536,-0.00678245200740831,0.00489585265509967,-0.0163783232114037,0.00281341919658703,0.165970178292076
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,37477,0.00672536043845054,0.00489410152238097,-0.00286707854541617,0.0163177994223172,0.169410467119085
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,37567,-0.00465956742148377,0.00339129514720933,-0.0113065059100141,0.00198737106704653,0.169471764917081
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,37477,0.00768903099197751,0.00560863527867257,-0.00330389415422073,0.0186819561381757,0.170421253864439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,37955,0.0196370728381515,0.0144403525016696,-0.00866601806512085,0.0479401637414239,0.173892221224289
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSND,Barttin,37477,-0.00418834724143247,0.00308820769381796,-0.0102412343213157,0.00186453983845073,0.175046694852329
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,37593,-0.00408209066764315,0.00302773856580216,-0.0100164582566154,0.00185227692132909,0.177607369224526
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,37536,0.0055821960659885,0.00414190843596498,-0.00253594446850286,0.0137003366004799,0.177766880004666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40300,0.00254401439913112,0.00189181936133749,-0.00116395154909037,0.00625198034735261,0.178726880815563
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37557,0.0116599702015257,0.0086940879574605,-0.00538044219509686,0.0287003825981483,0.179898951506796
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCLN,Nicalin,40039,0.00638951086620389,0.00477568728269124,-0.00297083620787094,0.0157498579402787,0.180940442290846
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37477,0.00351083151734634,0.0026266325539392,-0.0016373682883745,0.00865903132306718,0.181367329396176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,37709,0.00661728489035856,0.00497346509330132,-0.00313070669251202,0.0163652764732291,0.183370541130329
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39690,0.00556496843050194,0.00420948152017419,-0.00268561534903948,0.0138155522100434,0.186185316826065
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37557,0.0054309204483801,0.0041094057632156,-0.00262351484752249,0.0134853557442827,0.186330146031539
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,40037,0.00572762431226286,0.0043659739383576,-0.00282968460691804,0.0142849332314438,0.18958069004921
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,37557,0.00873409519474873,0.00668009988938411,-0.00435890058844412,0.0218270909779416,0.191072772389549
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,40300,0.00177807167597646,0.00136023022263365,-0.000887979560385503,0.00444412291233841,0.191169070282915
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LXN,Latexin,40178,-0.00772750591371596,0.00592520165788623,-0.019340901163173,0.00388588933574105,0.192192661918833
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,37933,0.00272876602750471,0.00209269452798275,-0.00137291524734148,0.0068304473023509,0.192273384176731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCT,Secretin,37567,0.00538472546773125,0.0041385732741752,-0.00272687814965215,0.0134963290851146,0.193244787917328
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,40327,0.0041227282001203,0.00317208815018521,-0.00209456457424271,0.0103400209744833,0.193726440510972
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37937,0.00327455257360497,0.00253545161009082,-0.00169493258217305,0.00824403772938298,0.196550192507077
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37870,-0.00312341392444335,0.00242759911567654,-0.00788150819116936,0.00163468034228267,0.198246617866887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37709,0.00476003110224816,0.00370801915584132,-0.00250768644320084,0.0120277486476972,0.19926495269673
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37709,0.00725516699015627,0.00568091966873355,-0.00387943556056149,0.018389769540874,0.20158530517708
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37557,-0.00506836398069679,0.00397073448659931,-0.0128510035744314,0.00271427561303785,0.201826232959282
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,39956,-0.0037538454939597,0.00294618981350381,-0.00952837752842716,0.00202068654050776,0.202634441606383
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37567,0.00338785640218488,0.00265931551110626,-0.00182440199958338,0.00860011480395314,0.202700858748319
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37593,0.00321241844070668,0.0025258417316369,-0.00173823135330164,0.00816306823471501,0.203459249209043
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37593,0.00254349727967345,0.00201212491930425,-0.00140026756216289,0.00648726212150978,0.206221878610142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,40336,0.00392796052262784,0.00311919187904516,-0.00218565556030067,0.0100415766055564,0.207944874664023
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37567,0.00722813180279784,0.00574465437895067,-0.00403139077994547,0.0184876543855411,0.208328764703029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37536,0.00754049948095453,0.00601241103185993,-0.00424382614149094,0.0193248251034,0.209807828779271
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37477,0.00924398501812946,0.00739272755737341,-0.00524576099432242,0.0237337310305814,0.211170076183152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,37676,-0.00235478583118077,0.00188840916699666,-0.00605606779849422,0.00134649613613268,0.212431310403272
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37709,0.00565570899577958,0.00455242308384013,-0.00326704024854707,0.0145784582401062,0.214128929957895
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,37536,-0.00408065755073747,0.00328756991470633,-0.0105242945835619,0.00236297948208694,0.214539998579269
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40037,0.00705205098367973,0.00568345906441767,-0.0040875287825789,0.0181916307499384,0.214697344866544
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37692,0.0111733786620755,0.00906873319566529,-0.00660133840142844,0.0289480957255795,0.217942157929076
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37557,0.0037727195203949,0.00306229185654998,-0.00222937251844306,0.00977481155923287,0.217974121777143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,40179,-0.00728374064246255,0.00591633989413501,-0.0188797668349672,0.00431228555004207,0.218295368053797
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,40355,0.006886561213168,0.00560871393102912,-0.00410651809164907,0.0178796405179851,0.219528027755798
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,39975,0.0102618883092104,0.00838219322318921,-0.00616721040824043,0.0266909870266613,0.220877040566922
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPN,Asporin,37985,0.00299105030780991,0.00244373927514569,-0.00179867867147565,0.00778077928709547,0.220986899049205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,40216,0.00313016159563449,0.00255785082734117,-0.0018832260259542,0.00814354921722317,0.22106607430737
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37567,0.00863331579778535,0.00707317547473904,-0.00523010813270316,0.0224967397282739,0.222270279239735
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39956,0.00541938647864194,0.00444638131352864,-0.00329552089587419,0.0141342938531581,0.2229269644002
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37536,0.00603122705238881,0.00494942479520096,-0.00366964554620507,0.0157320996509827,0.223028915027571
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37539,0.00442181629197747,0.00363560931624851,-0.0027039779678696,0.0115476105518245,0.223910961348809
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37536,0.00632723075636,0.00522579297200677,-0.00391532346877327,0.0165697849814933,0.226005626641854
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37593,-0.00460880270539398,0.00383754019332014,-0.0121303814843015,0.0029127760735135,0.229781244286318
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40039,0.00340980714531576,0.00284792028966089,-0.00217211662241958,0.0089917309130511,0.231208921961522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRN1,Neuritin,37955,-0.00392947935106129,0.0032890286294878,-0.0103759754648574,0.00251701676273479,0.232216114936327
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37557,-0.00559565470187599,0.00472179814112373,-0.0148503790584785,0.00365906965472652,0.236011815073956
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,39866,0.00737238394118592,0.00624096517020692,-0.00485990779241963,0.0196046756747915,0.237506133493983
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37593,0.00436032785462865,0.0036912754080479,-0.00287457194514523,0.0115952276544025,0.237523856751209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37937,-0.00274788979911464,0.00233915153734754,-0.00733262681231581,0.00183684721408653,0.240120363038016
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37536,0.00603086938115345,0.00516276804548618,-0.00408815598799946,0.0161498947503063,0.242768964323879
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,37993,0.00945034807614397,0.00812554658213421,-0.0064757232248391,0.025376419377127,0.244833150672669
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,37567,0.00969542134915401,0.00834523173823877,-0.00666123285779397,0.026052075556102,0.245341210345902
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,39956,0.00498892999554146,0.00432023698418211,-0.00347873449345547,0.0134565944845384,0.248197688997625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37593,-0.00333392730474675,0.0028964100779511,-0.00901089105753091,0.00234303644803741,0.249730552208018
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37985,0.0108188270425598,0.00940894857687914,-0.00762271216812335,0.0292603662532429,0.250228274273695
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,37536,-0.00288201414458106,0.00250890179874522,-0.00779946167012169,0.00203543338095958,0.25069435130413
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37895,-0.00802916313535131,0.00699441903759413,-0.0217382244490358,0.00567989817833318,0.25101436663508
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37895,0.00464368264983025,0.00406646015907202,-0.00332657926195091,0.0126139445616114,0.253496321700044
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,39956,0.00536740777289504,0.00474958339488401,-0.00394177568107761,0.0146765912268677,0.258460125600106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37557,-0.00517802549369806,0.00459027074129514,-0.0141749561466365,0.00381890515924041,0.259322160972243
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,40336,-0.00593952069286286,0.00527698623765937,-0.0162824137186752,0.00440337233294951,0.260372339407639
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37557,0.00469333031359046,0.0041729167882738,-0.00348558659142619,0.0128722472186071,0.260731620494083
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,37593,0.00595904370086284,0.00531833413929185,-0.00446489121214919,0.0163829786138749,0.26253321781948
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,37593,0.00564104339249562,0.0050384493207124,-0.00423431727610068,0.0155164040610919,0.262905096539485
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37536,-0.00461447721041638,0.00414252713807108,-0.0127338304010357,0.00350487598020294,0.265330513526653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37536,-0.00317938081972718,0.0028551235176849,-0.00877542291438957,0.00241666127493522,0.265484020147975
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40531,0.00344898904817079,0.00310952173953725,-0.00264567356132222,0.0095436516576638,0.267373327009057
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37985,0.00494082893365811,0.00447196895051399,-0.00382423020934932,0.0137058880766655,0.269246749341054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,37557,-0.00397874182604234,0.00361293400782893,-0.011060092481387,0.00310260882930237,0.270808302478465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,37567,0.00601621254358487,0.00549422269392227,-0.00475246393650278,0.0167848890236725,0.273533659847802
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,37593,0.0100864581426625,0.00931504844257078,-0.00817103680477625,0.0283439530901012,0.278911178390668
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,40198,-0.00439050561464714,0.00405839984685955,-0.0123449693144919,0.00356395808519758,0.27934388444951
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37557,0.00458730924070367,0.00424641811743685,-0.00373567026947256,0.0129102887508799,0.280038580199734
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37557,-0.00399402032356002,0.00370319165274633,-0.0112522759629428,0.0032642353158228,0.280815100829757
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,37972,-0.0032425501588668,0.00300932114663162,-0.00914081960626478,0.00265571928853119,0.281275192739023
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37937,0.00543824696864487,0.00506574903278802,-0.00449062113561965,0.0153671150729094,0.283051408398325
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37477,0.00475129484943394,0.00443897598101002,-0.0039490980733457,0.0134516877722136,0.284477888960189
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,37955,-0.00420852295140436,0.00393291310955088,-0.0119170326461241,0.00349998674331536,0.284603424421033
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,37557,0.00489058520161612,0.00459335573271366,-0.00411239203450266,0.0138935624377349,0.287027448311463
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,38008,0.00291817539456216,0.00274095053959894,-0.00245408766305177,0.00829043845217608,0.287049607328927
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37477,0.00824493468958901,0.00775101574673047,-0.00694705617400271,0.0234369255531807,0.287473865455067
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,37623,0.00500653263437623,0.00471899136951336,-0.00424269044986994,0.0142557557186224,0.288739904348256
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37896,0.0122381797973185,0.0115696607613715,-0.0104383552949697,0.0349147148896067,0.290173811212769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,37477,0.00765067396612445,0.00729782725238611,-0.00665306744855232,0.0219544153808012,0.29449703721589
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,37593,0.00454253661988781,0.00433657587671945,-0.0039571520984823,0.0130422253382579,0.294891126384373
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37477,0.00248003135779446,0.0023852199707315,-0.00219499978483929,0.00715506250042821,0.298475579918302
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,40511,-0.000795599237909618,0.000772248673081908,-0.00230920663715016,0.000718008161330923,0.302914230979512
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,37937,0.0021243007915446,0.00208336355063509,-0.00195909176770018,0.00620769335078937,0.307912969342062
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,40039,0.00605997200803784,0.00594658675771099,-0.0055953380370757,0.0177152820531514,0.308186842084549
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,40484,-0.00412689161429776,0.00406641750790803,-0.0120970699297975,0.00384328670120199,0.31018235638019
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37567,0.00713479454066513,0.00704249245723741,-0.00666849067552019,0.0209380797568505,0.311028006977715
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,39873,0.0063487417892418,0.00627652607245487,-0.00595324931276975,0.0186507328912533,0.311790332922093
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESPL1,Separin,37477,-0.00521613756453511,0.00516217764841897,-0.0153340057554363,0.00490173062636606,0.3122971069214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,40219,0.00256145229569073,0.00253773155014065,-0.00241250154258494,0.0075354061339664,0.312823628677352
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40037,0.00759406873943675,0.00757862652638316,-0.00726003925227424,0.0224481767311477,0.316340990376773
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37557,0.00875509505613476,0.00874423668192151,-0.0083836088404314,0.0258937989527009,0.316728421167461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39975,-0.0027713373993244,0.00276811956935265,-0.0081968517552556,0.0026541769566068,0.31676387771017
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37895,0.0051553426895844,0.00515461814921026,-0.0049477088828677,0.0152583942620365,0.317260491104594
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,37536,-0.00712496658960251,0.00713841947527994,-0.0211162687611512,0.00686633558194618,0.318241849523306
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,40484,-0.00401173149042258,0.00402054680105167,-0.0118920032204838,0.00386854023963868,0.318387803854478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37982,0.00422916506214577,0.00425351661449515,-0.00410772750226472,0.0125660576265563,0.32010680378894
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37985,0.00562042310933438,0.00567415049381373,-0.00550091185854052,0.0167417580772093,0.321932255606722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37477,0.00495966817338063,0.00502587514047047,-0.0048910471019415,0.0148103834487028,0.323745895449359
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37557,-0.00494068324369345,0.00505052545419419,-0.0148397131339141,0.00495834664652716,0.327968092715568
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37536,0.00506255624644967,0.00520887283803539,-0.0051468345160997,0.015271947008999,0.331113229507211
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37557,0.0062614686055695,0.00644506652740089,-0.00637086178813624,0.0188937989992752,0.331310605550462
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,39306,0.00417813110879438,0.00430087639002792,-0.00425158661566035,0.0126078488332491,0.331334880774879
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40531,0.00195570208464016,0.0020162641961919,-0.00199617573989596,0.00590757990917629,0.332079422540091
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37955,-0.0025585626168543,0.0026436008413377,-0.0077400202658762,0.0026228950321676,0.33314540059741
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39975,0.00401064543001331,0.00416613503440624,-0.00415497923742293,0.0121762700974495,0.335724270118057
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,37593,0.00496718464182329,0.00523714097539459,-0.0052976116699501,0.0152319809535967,0.342916080165651
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40037,0.00279155717366859,0.00294496647385,-0.00298057711507741,0.00856369146241459,0.34319100762951
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37477,0.00481491024303997,0.00508331955199756,-0.00514839607887524,0.0147782165649552,0.343555453383641
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37593,-0.00390923103519525,0.00412779573302132,-0.011999710671917,0.00418124860152654,0.343630457845713
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38008,-0.00215564638227945,0.00229436393568147,-0.00665259969621512,0.00234130693165622,0.347470374826701
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,37567,0.00587462023829261,0.0062819043349915,-0.00643791225829073,0.018187152734876,0.349720230722182
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37477,-0.00271281781741816,0.00293026504957518,-0.00845613731458551,0.00303050167974918,0.354570905042929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37593,-0.00767424920332222,0.00833235491298859,-0.0240056648327799,0.00865716642613542,0.357057915210621
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37567,0.00292353481750922,0.00318908817864881,-0.00332707801264244,0.00917414764766089,0.359300667458725
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,40398,0.00474550533433349,0.00520281646480191,-0.00545201493667825,0.0149430256053452,0.361728204153818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37477,0.00275585633984405,0.003024322597118,-0.00317181595050723,0.00868352863019532,0.362190565692605
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37557,-0.00312967643810737,0.00343595348233849,-0.00986414526349082,0.00360479238727608,0.362385306765347
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39956,0.00416715589313418,0.00458722987606985,-0.00482381466396273,0.0131581264502311,0.363667659082249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37666,-0.00255655387457499,0.00281929732573813,-0.00808237663302172,0.00296926888387175,0.364526279960704
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,37567,0.00320499847136933,0.003542769576437,-0.0037388298984472,0.0101488268411858,0.365662672322037
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40037,-0.00273033153660026,0.00301851308863422,-0.00864661719032332,0.00318595411712281,0.365729137066746
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,40336,-0.00209311289595043,0.00232097613506025,-0.00664222612066853,0.00245600032876767,0.367163833448614
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40354,0.00253061641583239,0.00281995113984235,-0.00299648781825862,0.00805772064992339,0.36952056197034
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,37955,-0.00205356718703267,0.00229819719757831,-0.00655803369428617,0.00245089932022082,0.37157558707502
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEB,Nebulin,37557,0.00291591727094313,0.00327637041793782,-0.003505768748215,0.00933760329010126,0.373490811156744
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37709,0.00598410826739381,0.00672510124920578,-0.00719709018104952,0.0191653067158371,0.373580395254773
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37536,0.00584971646618172,0.00658900719050832,-0.00706473762721458,0.018764170559578,0.374664998652155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40039,0.00297680263351454,0.0033552196004016,-0.00359942778327259,0.00955303305030168,0.374976610417969
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37955,0.00372166260004166,0.00424221871341442,-0.00459308607825061,0.0120364112783339,0.380343912599509
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37557,-0.00385652357640561,0.00440942738506399,-0.012499001251131,0.0047859540983198,0.381802877333374
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,37477,-0.00282244049514986,0.00322862924613231,-0.00915055381756918,0.00350567282726946,0.382030049607364
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37895,0.00346772996339851,0.00399726577727013,-0.00436691096005094,0.011302370886848,0.385669635291576
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,40039,0.00318401350799502,0.00368007026278825,-0.00402892420706994,0.01039695122306,0.386939848317999
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40336,0.00361968871292973,0.00420930968830466,-0.00463055827614741,0.0118699357020069,0.389843616420929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,37567,0.00360796225394276,0.00420439552721382,-0.00463265297939632,0.0118485774872818,0.390830545499797
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,37623,0.00172939667972224,0.00201652060797129,-0.0022229837119015,0.00568177707134597,0.391121143964822
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37567,0.00383483130779134,0.00450491035839488,-0.00499479299466264,0.0126644556102453,0.394642784990965
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37557,-0.00276796585999521,0.00325596258181432,-0.00914965252035128,0.00361372080036085,0.39527271749398
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,37593,0.00443232946007156,0.00523575729834236,-0.00582975484467946,0.0146944137648226,0.397261502696828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,37557,-0.00280297729096111,0.003311294695559,-0.00929311489425675,0.00368716031233453,0.397295000425133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40223,0.00526771958354133,0.00622374151541217,-0.00693081378666653,0.0174662529537492,0.397347429982295
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPTC,Opticin,40300,0.00340869592718058,0.00403367924008531,-0.00449731538338663,0.0113147072377478,0.398090796520156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40531,-0.00181736514772159,0.00216146602346064,-0.00605383855370444,0.00241910825826125,0.400471319780824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,37593,0.00472507063627394,0.00562713447115527,-0.00630411292719039,0.0157542541997383,0.401095296287898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,39956,0.00266032043958899,0.00318250123099473,-0.00357738197316068,0.00889802285233866,0.403212083497737
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37567,-0.00312339462318938,0.00376691932799711,-0.0105065565060637,0.00425976725968495,0.40702659422898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37623,-0.00282496207953831,0.00350673218412013,-0.00969815716041375,0.00404823300133714,0.42049816246708
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39956,0.00469859701818626,0.00586479054534121,-0.00679639245068251,0.016193586487055,0.42305510929443
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,37536,0.00467582326893931,0.00584256007859951,-0.00677559448511573,0.0161272410229943,0.423549309030578
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,37709,0.00608567386575834,0.00767364853183356,-0.00895467725663544,0.0211260249881521,0.427756287601238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40379,-0.00216497033323787,0.00273365307106177,-0.00752293035251893,0.00319298968604319,0.428390153641074
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37536,-0.00451695183406045,0.00574414553883582,-0.0157754770901787,0.00674157342205777,0.431672325466363
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,40451,0.00301432044259507,0.00385626469088486,-0.00454395835153925,0.0105725992367294,0.434421015154748
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,40037,-0.00193392060979987,0.00247573852187748,-0.00678636811267974,0.00291852689307999,0.434726745052357
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37955,-0.00375760983626075,0.00482610725226303,-0.0132167800506963,0.00570156037817478,0.436228689240632
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37567,0.00257562735556171,0.00332305130242945,-0.00393755319720002,0.00908880790832344,0.438306940418852
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,37477,-0.00323150123620539,0.00417187565747263,-0.0114083775248517,0.00494537505244096,0.438594885171266
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37567,0.00224119483763623,0.00290907382534037,-0.0034605898600309,0.00794297953530336,0.441067487656388
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,40223,0.00902630745297381,0.0117474847222154,-0.0139987626025683,0.032051377508516,0.442284332194476
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37567,0.00295724847906694,0.00386840600260143,-0.00462482728603186,0.0105393242441657,0.444605867619098
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,40492,-0.00321711913623608,0.00425199616267175,-0.0115510316150727,0.00511679334260054,0.449292360999428
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37557,0.00367349745108102,0.00486541733570098,-0.0058627205268929,0.0132097154290549,0.450249310448208
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,37875,-0.00344261005649943,0.00460441986236539,-0.0124672729867356,0.00558205287373674,0.454669254834898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37895,0.00320470781734422,0.00430173057945585,-0.00522668411838926,0.0116360997530777,0.456296192052317
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37557,0.00419506194488053,0.00566286188917537,-0.00690414735790319,0.0152942712476642,0.458826504055755
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37536,-0.00274808503297692,0.00372438821272426,-0.0100478859299165,0.00455171586396263,0.460611464422915
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,37536,0.00602034181976823,0.00822479309583024,-0.010100252648059,0.0221409362875955,0.464197019464923
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,40327,-0.00256321673865114,0.00352687129030814,-0.00947588446765509,0.00434945099035281,0.467378884364697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37477,0.00396030466493442,0.00546000600886377,-0.00674130711243857,0.0146619164423074,0.46826280411767
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37477,-0.00306848703041453,0.00423085443077499,-0.0113609617147335,0.00522398765390446,0.468303025843239
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,37895,0.00381068282300014,0.005268160338039,-0.00651491143955631,0.0141362770855566,0.469482242167483
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37955,0.00210859768222324,0.00294863682720605,-0.00367073049910062,0.0078879258635471,0.47455385780618
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,37557,0.00255546548089592,0.00365134644690618,-0.00460117355504018,0.00971210451683203,0.48402132024828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,37536,0.00470374849319754,0.00674819927944359,-0.00852272209451189,0.017930219080907,0.485791660152748
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIT,Vitrin,37985,0.00228450088025351,0.00330257740441102,-0.00418855083239208,0.0087575525928991,0.489117056214402
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40328,0.00457325004394875,0.00664243300473787,-0.00844591864533748,0.017592418733235,0.491154198137172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,37709,0.00356188946932804,0.00517363748565074,-0.00657844000254741,0.0137022189412035,0.491169478581132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,40037,0.00658656150861875,0.00961121587356088,-0.0122514216035606,0.0254245446207981,0.493165134693596
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37593,0.00309977203282991,0.00454134724024915,-0.00580126855805843,0.0120008126237183,0.49489276478362
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,37477,0.00439743376780094,0.00645208746212287,-0.00824865765795988,0.0170435251935618,0.495534328906471
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,37477,0.00276022767692924,0.00405091557687616,-0.00517956685374803,0.0107000222076065,0.495640874357506
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37536,-0.00260001686219974,0.00383907006880674,-0.0101245941970609,0.00492456047266147,0.498258222676869
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,37557,0.00516652818246736,0.00764064513260413,-0.00980913627743673,0.0201421926423715,0.498931924637583
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37179,0.00295438580380278,0.00439847339192564,-0.00566662204437147,0.011575393651977,0.50179684905942
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38008,-0.00114521161982222,0.00170589095326141,-0.00448875788821459,0.00219833464857014,0.502023317073177
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37557,0.00230443102544491,0.00344808489273915,-0.00445381536432383,0.00906267741521365,0.503939837379082
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPGN,Epigen,37895,-0.00296286539065612,0.00444826128488455,-0.0116814575090298,0.0057557267277176,0.505376064538239
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37536,0.0050541201855933,0.00772136636151389,-0.0100797578829739,0.0201879982541605,0.512760703826748
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40531,0.00409170876006862,0.00626526324993981,-0.00818820720981341,0.0163716247299506,0.513715006317547
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37567,0.00387625692245465,0.0060118616017175,-0.00790699181691165,0.015659505661821,0.519088718166564
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,37557,-0.0030532428461813,0.00474025939757719,-0.0123441512654326,0.00623766557306999,0.51951614959023
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37993,-0.00170110209958402,0.00264702705475418,-0.00688927512690221,0.00348707092773417,0.520464524159122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37477,0.00366071950567893,0.00571800826097973,-0.00754657668584134,0.0148680156971992,0.522048089979454
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37593,-0.00272154684309842,0.00426198067082148,-0.0110750289579085,0.00563193527171168,0.52311782433601
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37567,0.00299978309346906,0.00473841618681744,-0.00628751263269311,0.0122870788196312,0.526694290697523
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,37709,-0.0019655699583048,0.00310686515202552,-0.00805502565627482,0.00412388573966522,0.526970675620521
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,40327,-0.00131244948690738,0.00211782722150468,-0.00546339084105655,0.00283849186724179,0.535454273450387
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,37567,0.00367999827234614,0.00596536085309282,-0.0080121089997158,0.0153721055444081,0.537315026591245
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,40327,0.00161089205718852,0.00262565545537125,-0.00353539263533913,0.00675717674971617,0.539541372439917
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37993,-0.00152579029933143,0.00248844110389939,-0.00640313486297423,0.00335155426431138,0.539786759626328
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,37536,-0.00503655363478349,0.00826715637298667,-0.0212401801258374,0.0111670728562704,0.542386266912935
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37593,0.00263611930954614,0.00436565907694916,-0.00592057248127421,0.0111928111003665,0.545966578744401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,40327,0.00479011072267114,0.00800866044409707,-0.0109068637477591,0.0204870851931014,0.549770836624086
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS2,Podocin,37593,-0.00559933573782107,0.00943660324709398,-0.0240950781021253,0.0128964066264831,0.552948136351273
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37709,-0.00444487672643038,0.00764376632548053,-0.0194266587243722,0.0105369052715115,0.560911059662523
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37567,-0.00236016042379282,0.00406264097148007,-0.0103229367278938,0.00560261588030812,0.561289252863109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,37477,0.0042262823078632,0.00728420164653806,-0.0100507529193514,0.0185033175350778,0.561790853602391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37557,0.00250079940239733,0.00434972155710157,-0.00602465484952175,0.0110262536543164,0.565346334509078
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40398,0.0022708094405667,0.00396024061825273,-0.00549126217120865,0.0100328810523421,0.566380699623003
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,37567,-0.00308582630465082,0.00538184960178241,-0.0136342515241444,0.0074625989148427,0.566399602217887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37955,0.00189730914069598,0.00331403033109481,-0.00459819030824985,0.00839280858964181,0.566987345463722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37709,0.00346045134165827,0.00605166522618299,-0.0084008125016604,0.0153217151849769,0.567454950093158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,37477,0.00484446159963395,0.00848352026054004,-0.0117832381110245,0.0214721613102924,0.567979808771508
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37567,0.00360180479011146,0.0063203369134589,-0.00878605556026799,0.0159896651404909,0.568771943786044
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37557,-0.00367170564961893,0.00647360562322321,-0.0163599726711364,0.00901656137189857,0.570600978618749
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37477,-0.00327596330680064,0.00577880683366491,-0.0146024247007839,0.00805049808718258,0.570796864829026
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37593,0.00214322337163993,0.00378464946091639,-0.00527468957175619,0.00956113631503604,0.571203772508739
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,37477,-0.00301075332679308,0.00549040573870796,-0.0137719485746607,0.00775044192107453,0.583449828910925
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37709,0.00406538052595275,0.00742393631246908,-0.0104855346464866,0.0186162956983921,0.583972755397167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,40466,-0.00181602937837385,0.00332431603325642,-0.00833168880355643,0.00469963004680873,0.584876540758045
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,37557,-0.00220495979110293,0.00405964758219972,-0.0101618690522144,0.00575194947000853,0.587042176020543
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,37623,0.00335005511675586,0.00626309786345431,-0.00892561669561458,0.0156257269291263,0.592736421668479
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,37593,0.00261114178130829,0.0048976049526203,-0.00698816392582749,0.0122104474884441,0.593941069478133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37709,-0.00215542247218586,0.00405743530268406,-0.0101079956654466,0.00579715072107489,0.595269823323204
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37709,0.00212961393323161,0.00404818882290809,-0.00580483615966826,0.0100640640261315,0.59885124831719
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,37567,-0.00203069558311168,0.00388187701588292,-0.00963917453424221,0.00557778336801884,0.600898137958405
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37536,0.00429403273546371,0.00821471568131833,-0.0118068099999202,0.0203948754708476,0.601174871967369
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40531,-0.00125299141609623,0.00241456945184598,-0.00598554754171435,0.00347956470952188,0.603817018741617
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40336,0.00252231609583453,0.00492072409941566,-0.00712230313902016,0.0121669353306892,0.608244974622874
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37477,0.00228514199245739,0.00445950961872704,-0.00645549686024761,0.0110257808451624,0.608365773873357
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40198,0.00152358235555881,0.00300034425369024,-0.00435709238167406,0.00740425709279168,0.611598959186978
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,37985,0.00116237009731934,0.00231780796823478,-0.00338053352042083,0.00570527371505951,0.616030652907533
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37567,0.00186550693912403,0.0037270776419173,-0.00543956523903388,0.00917057911728194,0.616711702772097
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,37955,-0.00198748636952661,0.00399154670897849,-0.00981091791912446,0.00583594518007123,0.618545813731142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,37593,0.00135574839705684,0.00272392214802881,-0.00398313901307963,0.00669463580719331,0.618690290080889
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,37557,0.0016207422694937,0.0032724355638088,-0.00479323143557155,0.00803471597455895,0.620417178193524
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40336,0.00149085857917942,0.0030379698595191,-0.00446356234547802,0.00744527950383686,0.623615908310984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37567,-0.0017151469526843,0.00349938914763982,-0.00857394968205835,0.00514365577668975,0.624051858471414
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,37593,0.00225805466682858,0.00463773814472674,-0.00683191209683584,0.011348021430493,0.626346493693882
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37567,0.0015823190990232,0.00325176930367672,-0.00479114873618317,0.00795578693422956,0.626548177056098
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,40198,-0.00135681849122912,0.00279404126337568,-0.00683313936744546,0.00411950238498721,0.627249417849108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37557,-0.00253284170169256,0.00521802892526101,-0.0127601783952041,0.00769449499181901,0.627399324961958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,37593,0.00209698848382438,0.00433950619012024,-0.00640844364881129,0.0106024206164601,0.628939029895162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,37650,0.00160268061039252,0.00332113599477969,-0.00490674593937567,0.00811210716016071,0.62940908514569
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37557,-0.0017432255523952,0.0036263761890878,-0.00885092288300728,0.00536447177821689,0.630732557814295
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37682,0.00218582450862625,0.00455555789730693,-0.00674306897009534,0.0111147179873478,0.631366956521119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,37692,0.00425273961073913,0.00886389582765057,-0.013120496211456,0.0216259754329342,0.63139018280918
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,37477,-0.00205239153727116,0.00430158759005005,-0.0104835032137693,0.00637872013922694,0.633281688320148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37709,0.00274020348277567,0.0057439654974567,-0.00851796889223946,0.0139983758577908,0.633328834938413
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,37955,0.00353422761605357,0.00740950988438734,-0.0109884117573456,0.0180568669894528,0.633380277701494
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37477,-0.00407588315341892,0.00859257252074615,-0.0209173252940814,0.0127655589872435,0.635258594364973
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,40223,0.000515245870641426,0.00108991607719501,-0.00162098964066079,0.00265148138194364,0.63640591825805
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,37895,0.00498687068096534,0.0105574981217432,-0.0157058256376512,0.0256795669995819,0.636682191178872
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,37477,-0.0028970189619993,0.00614368649563928,-0.0149386444934523,0.00914460656945369,0.637260151526468
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37687,0.00235494263761341,0.00501378687741147,-0.00747207964211307,0.0121819649173399,0.638581817478155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37477,0.00234413450457836,0.00505358297932956,-0.00756088813490757,0.0122491571440643,0.642758710240371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40354,0.00117038727162312,0.00252631960064351,-0.00378119914563816,0.00612197368888441,0.643171742657327
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37477,-0.00142708178394881,0.00310876893517176,-0.00752026889688545,0.00466610532898783,0.646205596887719
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37557,-0.00255297721539649,0.00563388999482134,-0.0135954016052463,0.00848944717445333,0.650450796490399
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37593,-0.00112829502691416,0.00250228599535141,-0.00603277557780292,0.0037761855239746,0.6520649525417
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,39597,0.00111831356273287,0.00249785907889515,-0.00377749023190162,0.00601411735736735,0.654369752573604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37709,-0.00296060190335191,0.00664051040707538,-0.0159760023012196,0.0100547984945158,0.655720460727611
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37536,-0.0023163697584848,0.00519889301484751,-0.0125062000675859,0.00787346055061632,0.655929292954307
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37593,-0.00117772176402953,0.00264449999731473,-0.0063609417587664,0.00400549823070734,0.656075899612273
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37985,-0.00117660303418541,0.00264575409224036,-0.00636228105497651,0.00400907498660569,0.656533795132634
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,37536,0.00198650301495624,0.00451705630138013,-0.0068669273357488,0.0108399333656613,0.660105001794135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,40262,-0.00135767656306893,0.00308793224355648,-0.00741002376043963,0.00469467063430178,0.66018087811522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,37477,-0.00178363856002149,0.00413524659497214,-0.00988872188616689,0.00632144476612391,0.666238629298283
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37993,-0.000961499477236723,0.00223898124715728,-0.00534990272166499,0.00342690376719155,0.667612686336062
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,37477,0.00449189630857279,0.0105181121086619,-0.0161236034244046,0.0251073960415502,0.669340514503651
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37495,0.00132154230018709,0.00310120538531895,-0.00475682025503805,0.00739990485541224,0.67001412679933
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTN,Titin,37557,-0.00247978469738803,0.00590586342155806,-0.0140552770036418,0.00909570760886577,0.67457619683769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40298,0.000837647995651809,0.0019960614247872,-0.00307463239693109,0.00474992838823471,0.674746545847084
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37536,0.00323980230518243,0.00777379413362364,-0.0119968341967199,0.0184764388070848,0.676861189088948
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCIN,Adseverin,37536,0.00274992654777904,0.00662571652503305,-0.0102364778412857,0.0157363309368438,0.67812062400471
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37709,0.00136091712533269,0.00330265121988344,-0.00511227926563885,0.00783411351630424,0.680296191329904
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,37709,-0.00221452649164933,0.00547275288324942,-0.0129411221428182,0.00851206915951952,0.685744412970161
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37557,0.00170799434234177,0.00426988651472732,-0.00666098322652379,0.0100769719112073,0.689156182041322
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37567,0.00151526134165058,0.00381217764175772,-0.00595660683619455,0.0089871295194957,0.691020586334653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,37536,-0.00340363333706412,0.00858528049507785,-0.0202307831074167,0.0134235164332885,0.691779647760662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37557,0.00175424948648572,0.00442681307688425,-0.00692230414420742,0.0104308031171789,0.69190626464784
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,40484,-0.00155913106700372,0.00400565248196572,-0.00941020993165653,0.00629194779764908,0.697109160419296
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,40327,0.00101017442100523,0.00259713348520255,-0.00408020720999177,0.00610055605200223,0.697312838502731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37557,0.00230456972412951,0.00593568032837423,-0.00932936371948399,0.013938503167743,0.697832126094142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,37709,0.00212097564762019,0.00554473078588363,-0.00874669669271172,0.0129886479879521,0.702081130023337
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37477,0.00219301624373431,0.00573569884068592,-0.0090489534840101,0.0134349859714787,0.702211657836332
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,37937,0.00235588411096561,0.00616854704774551,-0.0097344681026156,0.0144462363245468,0.702527610101181
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,37477,0.00105039159172286,0.00279068425783826,-0.00441934955364013,0.00652013273708584,0.706631526771671
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,38008,0.0010935421160021,0.00293156374816774,-0.00465232283040668,0.00683940706241088,0.709136799793677
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37477,0.00168724060438041,0.00455529356461296,-0.007241134782261,0.0106156159910218,0.711097059948888
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37623,0.00869489970727962,0.0235653799486587,-0.0374932449920913,0.0548830444066506,0.712156603079077
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37557,0.00107008892255865,0.00292198429907853,-0.00465700030363526,0.00679717814875256,0.714206873948022
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,37477,0.00260103637773203,0.00710503556525197,-0.0113248333301618,0.0165269060856259,0.714308705418732
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37985,0.000902283426375354,0.00247352535498818,-0.00394582626940147,0.00575039312215218,0.715284097812194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,37955,-0.00206344706707036,0.00572701132140001,-0.0132883892570144,0.00916149512287366,0.718627796585424
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,37593,0.00123889115311537,0.00349238204123552,-0.00560617764770626,0.00808395995393699,0.72278931306217
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37593,0.00299132996680785,0.00843696910252718,-0.0135451294741454,0.0195277894077611,0.722932200615075
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37536,-0.000956865608851179,0.00270588337832966,-0.00626039703037732,0.00434666581267496,0.723626298820534
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37593,0.000895624927188028,0.00253404404481071,-0.00407110140064097,0.00586235125501703,0.72376652039893
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37985,0.00122392919445093,0.00347438284971819,-0.00558586119099673,0.00803371957989859,0.724639468251333
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,37477,0.00193737738495657,0.00560879105525384,-0.00905585308334096,0.0129306078532541,0.729785725538762
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37567,-0.000987415837175773,0.00289670229101958,-0.00666495232757416,0.00469012065322261,0.733202511112631
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,37896,0.00796428433143344,0.0233650984705859,-0.0378313086709148,0.0537598773337817,0.733212472843477
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,37536,-0.00155239374141971,0.00457093298017178,-0.0105114223825564,0.00740663489971697,0.734145944278988
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,37572,0.00197701278619808,0.00618921399412972,-0.0101538466422962,0.0141078722146923,0.74940651090235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,40509,0.00118036188886859,0.003742668872693,-0.00615526910160969,0.00851599287934687,0.752477455750623
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37477,-0.00101489190479784,0.00327883163546122,-0.00744140191030184,0.00541161810070616,0.756924471883224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37709,-0.00234718987324764,0.00761201321703605,-0.0172667357786383,0.012572356032143,0.757818309983801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37536,0.00110686550344022,0.00362579278530021,-0.00599968835574819,0.00821341936262864,0.760161232575859
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37623,-0.00155316407930595,0.00535450466882072,-0.0120479932301946,0.00894166507158265,0.771769694153342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37896,-0.00131625825480632,0.00454569572975367,-0.0102258218851235,0.00759330537551086,0.772156226382902
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,39826,-0.00146707504505241,0.00528674689680687,-0.0118290989627939,0.00889494887268906,0.781399533141811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,37709,-0.00102895888457533,0.00377053962610642,-0.00841921655174391,0.00636129878259324,0.784938695836074
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37895,0.00209101050801829,0.00766497748929548,-0.0129323453710009,0.0171143663870374,0.785010683548684
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37593,0.00119931862464648,0.00440140069063214,-0.00742742672899252,0.00982606397828548,0.785252888035871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,37557,0.0012244819324324,0.00451213320419484,-0.00761929914778949,0.0100682630126543,0.786106598294124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37477,0.000998037294058483,0.00374523005507967,-0.00634261361389767,0.00833868820201463,0.789872053888028
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40281,-0.0042851310454316,0.0160865070771225,-0.0358146849165917,0.0272444228257285,0.78994968732959
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37536,0.00119043138436243,0.00452549662834424,-0.00767954200719227,0.0100604047759171,0.792516269016169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37896,0.00121742193711912,0.00464462399932172,-0.00788604110155145,0.0103208849757897,0.793237409719089
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37985,-0.000621650951834666,0.00237304066502324,-0.00527281065528021,0.00402950875161088,0.793353272709918
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37536,0.00140373153116963,0.00544110304107037,-0.00926083042932829,0.0120682934916676,0.796421326693576
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,37895,0.000859817049008187,0.00333839849165013,-0.00568344399462606,0.00740307809264243,0.796755270329939
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40123,-0.00401925442737082,0.0156304487993974,-0.0346549340741897,0.026616425219448,0.797072059774312
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37593,0.00181773377392189,0.0070798321600721,-0.0120587372598194,0.0156942048076632,0.797377222092046
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37557,-0.00118171124286034,0.00469695263927505,-0.0103877384158394,0.00802431593011876,0.801361122753507
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37567,-0.00110410735277469,0.00442105297798559,-0.00976937118962645,0.00756115648407707,0.802793456633019
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37709,-0.00122199500025117,0.00489745700110177,-0.0108210107224106,0.00837702072190829,0.802965355066301
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,37993,0.00109440737687236,0.00448872581961204,-0.00770349522956724,0.00989230998331197,0.807379747458907
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,40374,-0.000719793772174125,0.00298248838392224,-0.00656547100466172,0.00512588346031347,0.809294712512706
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,37536,0.00137282634156536,0.00572318889302242,-0.00984462388875857,0.0125902765718893,0.810434115883072
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37557,0.00103299424961293,0.00437607832854037,-0.00754411927432619,0.00961010777355206,0.813393844124438
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37993,-0.0008055097402591,0.0034708621739119,-0.00760839960112642,0.00599738012060822,0.816481165278663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37896,-0.00067874197111412,0.00295617165428583,-0.00647283841351435,0.00511535447128611,0.818404796063593
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37593,-0.00111956703870353,0.00493856578105468,-0.0107991559695707,0.00856002189216364,0.820661470318439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37536,-0.00140618686429083,0.006408143398386,-0.0139661479251274,0.0111537741965457,0.826312696557764
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,37993,-0.000997581303608823,0.00467548847646578,-0.0101615387174818,0.0081663761102641,0.831046206513319
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,37993,0.00108918741237106,0.00512734827631992,-0.00896041520921598,0.0111387900339581,0.831777090470769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,37477,-0.000708038478893981,0.00337495032473619,-0.00732294111537691,0.00590686415758895,0.833833090200056
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,39975,-0.00154668674091857,0.00755967895651075,-0.0163636574956796,0.0132702840138425,0.837889774309196
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37536,-0.0012989101091049,0.00640113120670038,-0.0138451272742376,0.0112473070560278,0.839201624951802
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37536,-0.00136748730864796,0.00681772176766114,-0.0147302219732638,0.0119952473559679,0.841031414288533
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37557,-0.00116123478560824,0.00604600718967112,-0.0130114088773636,0.0106889393061472,0.847693176091086
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,37937,0.000906293670235912,0.00481673116412331,-0.00853449941144577,0.0103470867519176,0.850757715006381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,40406,0.000454695244905821,0.00244851304206085,-0.00434439031753344,0.00525378080734508,0.852680347895963
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39956,0.00114669361867058,0.00619491827947148,-0.0109953462090935,0.0132887334464347,0.853151219270284
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37895,-0.000770743163211123,0.00419558155348782,-0.00899408300804725,0.007452596681625,0.854248806155065
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,40354,-0.000576911764245125,0.003195020749572,-0.00683915243340624,0.00568532890491599,0.856710632792293
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,40039,-0.000503814124629809,0.00280137173182264,-0.00599450271900218,0.00498687446974256,0.857276192992193
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,37993,0.000709711392380184,0.00399666416527686,-0.00712375037156246,0.00854317315632282,0.859058678124461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALLD,Palladin,37593,0.000658193234157873,0.00373492178050397,-0.0066622534556299,0.00797863992394565,0.860118499171035
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,37452,0.00130179264474964,0.00739499351970549,-0.0131923946538731,0.0157959799433724,0.860267598368318
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37567,0.000514052713775024,0.00300184193731574,-0.00536955748336383,0.00639766291091388,0.864033166899941
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,37593,0.000651945279832046,0.00386980930055853,-0.00693288094926268,0.00823677150892677,0.866216439108754
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,39956,-0.000763002052293031,0.00469866042128366,-0.009972376478009,0.00844637237342294,0.871003109320262
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37455,-0.000697243318492597,0.00438541059038118,-0.00929264807563972,0.00789816143865452,0.873677984078432
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,37452,-0.000554383082500746,0.00365703277994639,-0.00772216733119566,0.00661340116619417,0.879509765213327
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,37593,0.000362664035894426,0.00245539034155732,-0.00444990103355793,0.00517522910534678,0.882580871176351
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39975,0.000421713293887868,0.00290166506226218,-0.00526555022814601,0.00610897681592175,0.884448322885725
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37567,0.00100089211001941,0.00715689130795062,-0.0130266148535638,0.0150283990736026,0.888780559655029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39975,-0.000433261911114788,0.00318986020914692,-0.00668538792104276,0.00581886409881318,0.891961599384988
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37623,0.000483583685694731,0.00365026317626075,-0.00667093213977633,0.0076380995111658,0.894607353985175
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37557,0.00071201343827295,0.00547021236154541,-0.010009602790356,0.0114336296669019,0.896440305737001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,37536,-0.000542645740966465,0.0043587873236984,-0.00908586889541532,0.00800057741348239,0.900925541577349
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40223,-0.000310195585002321,0.00253074791637758,-0.00527046150110238,0.00465007033109774,0.902448606295545
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,37536,0.00105593024203236,0.00885711142458926,-0.0163040081501626,0.0184158686342273,0.905104196544709
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37557,-0.000413351265681762,0.00350337479697884,-0.00727996586776028,0.00645326333639676,0.906080087018102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37955,-0.000247514556277933,0.00212148976545779,-0.0044056344965752,0.00391060538401934,0.907123170501133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37623,-0.000640856248015777,0.0056389060493877,-0.0116931121048157,0.0104113996087841,0.909517744604849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40437,0.000226543973770239,0.00202866991878709,-0.00374964906705245,0.00420273701459293,0.911085529544883
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37477,-0.000411387866670045,0.00368875497240917,-0.00764134761259201,0.00681857187925192,0.911201874854172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40327,0.000318142260182764,0.00290534570788945,-0.00537633532728057,0.0060126198476461,0.912805420837089
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37683,-0.000499424598613995,0.00472529920200285,-0.00976101103453958,0.00876216183731159,0.915828619685958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,37477,-0.000700323128600762,0.00664259767310627,-0.0137198145678891,0.0123191683106875,0.916036945653616
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37982,-0.00132950813934767,0.0129571407487135,-0.026725504006826,0.0240664877281307,0.918275501105172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,37536,-0.000308676870030802,0.00305647981256845,-0.00629937730266497,0.00568202356260336,0.919559173519419
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37557,0.000368215572822279,0.00370478107460313,-0.00689315533339985,0.00762958647904441,0.9208307035906
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,37709,-0.000312575701984584,0.00319446297072519,-0.00657372312460596,0.0059485717206368,0.922053504230204
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40466,-0.000412809747443322,0.00423156496116574,-0.00870667707132818,0.00788105757644153,0.92228698707294
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37477,0.000552451160177623,0.00577349916001003,-0.010763607193442,0.0118685095137973,0.923770315330481
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37623,0.000365115363259802,0.00383005812417026,-0.00714179856011391,0.00787202928663351,0.924055010461182
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37536,-0.000403167124597463,0.00455668014866288,-0.0093342602159767,0.00852792596678178,0.92949791780001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37557,0.000415534415881072,0.0047494590165171,-0.00889340525649245,0.0097244740882546,0.930282659880058
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40484,0.000460566126230782,0.00527909176916747,-0.00988645374133746,0.010807585993799,0.93047910039811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37536,0.000607275470608372,0.00708963478766789,-0.0132884087132207,0.0145029596544374,0.931740550431052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37895,0.000300791084964317,0.00352810526202801,-0.00661429522861058,0.00721587739853921,0.932059378873586
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37895,-0.000321900486771774,0.00383849155143098,-0.00784534392757649,0.00720154295403295,0.933168041796181
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,37536,0.000524582434361984,0.00679828016622543,-0.0128000466914399,0.0138492115601638,0.938494266536135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,37477,-0.000409049714192869,0.00542019347506388,-0.0110326289253181,0.0102145294969323,0.939843728622392
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,37567,0.000326544863301356,0.0044005057675715,-0.00829844644113878,0.0089515361677415,0.940847434842853
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37567,0.00028425794672738,0.00387143320994335,-0.00730375114476159,0.00787226703821636,0.941469462517999
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,37536,-0.000419356957859176,0.0058665717780199,-0.0119178376427782,0.0110791237270598,0.943014879617298
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37895,0.000336699170769364,0.00486689624144281,-0.00920241746245854,0.00987581580399727,0.944846179546755
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37567,0.000316370914471835,0.00458778570595953,-0.00867568906920884,0.00930843089815251,0.945022994038764
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37557,0.000148898175040363,0.00230840292580342,-0.00437557155953433,0.00467336790961506,0.948570957114645
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,37937,-0.000345241415694498,0.0053541819084746,-0.0108394379563047,0.0101489551249157,0.948588427344433
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37567,0.00037215048458853,0.00605681697973233,-0.0114992107956868,0.0122435117648639,0.95100714979236
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37557,-0.000349127056564231,0.00634996226573146,-0.0127950530973979,0.0120967989842694,0.956154466263134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERVV_1,,37557,0.000238560577947807,0.00434927613352974,-0.00828602064377048,0.0087631417996661,0.956258292612748
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,37709,0.000192774933810754,0.00355535273428861,-0.00677571642539492,0.00716126629301643,0.956759872405926
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,37709,0.000203826460877663,0.00385696596903538,-0.00735582683843168,0.007763479760187,0.957855150636762
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37536,-0.000206713119713537,0.0039204626815133,-0.00789081997547961,0.00747739373605254,0.957950457832461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASN,Vasorin,40111,-0.000116532381546428,0.00245684453738133,-0.00493194767481384,0.00469888291172098,0.962169747155587
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,39975,-0.0005976831426623,0.0128106566296369,-0.0257065701367507,0.0245112038514261,0.96278867443374
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,40039,-0.000200710485171854,0.00446145971683171,-0.00894517153016201,0.0085437505598183,0.96411774756914
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,37477,0.000199795944655584,0.00469291885338417,-0.00899832500797739,0.00939791689728856,0.966041839259743
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,37593,-0.000171064377922297,0.00402204650414113,-0.00805427552603892,0.00771214677019433,0.966075507138693
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37567,-0.000268592989240932,0.00632326726930567,-0.0126621968370801,0.0121250108585982,0.966119147947659
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37557,0.000143054467761617,0.00340453400791953,-0.00652983218776065,0.00681594112328389,0.966484343239264
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEO1,Neogenin,37955,-7.85369467975677e-05,0.00191440163508142,-0.00383076415155715,0.00367369025796201,0.967277146837296
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37536,-0.000219255289971224,0.00547330759760648,-0.0109469381812799,0.0105084276013375,0.968046691132654
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37452,-0.000178554149608463,0.00462893119343081,-0.00925125928873286,0.00889415098951593,0.969231010364453
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40417,-9.31484087643254e-05,0.00248706530165825,-0.00496779640001449,0.00478149958248584,0.970124169817285
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,37593,-8.94562167568172e-05,0.00274123822093741,-0.00546228312979415,0.00528337069628051,0.973967344918567
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,37895,-0.000134337524932268,0.00412957303033078,-0.0082283006643806,0.00795962561451607,0.974049389564914
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37599,-6.58834307385751e-05,0.00307820709334446,-0.00609916933369372,0.00596740247221657,0.982924359028584
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37477,9.30943668592593e-05,0.00508389492164701,-0.00987133967956888,0.0100575284132874,0.985390535735869
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,37477,5.97475356795276e-05,0.00376896099441996,-0.0073274160133836,0.00744691108474265,0.987352290290259
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,39956,5.99681262847985e-05,0.00392888033893454,-0.0076406373380269,0.0077605735905965,0.987822227056787
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,37567,4.18353154379725e-05,0.00315392802431869,-0.00613986361222665,0.0062235342431026,0.989416962953124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,37557,1.34380246181217e-05,0.0031090780737218,-0.00608035499987661,0.00610723104911286,0.996551468251107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37709,1.36495779815887e-05,0.00368019929306685,-0.00719954103642944,0.00722684019239262,0.997040769719491
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37536,1.59071152929307e-05,0.0044630542862407,-0.00873167928573885,0.00876349351632471,0.997156258583625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,37557,-1.64929331414478e-05,0.00480600119642752,-0.00943625527813938,0.00940326941185649,0.99726192747135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37955,1.22149420921386e-05,0.00379648548980347,-0.00742889661792265,0.00745332650210693,0.997432910918595
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,40531,1.73384243859363e-05,0.00638326350734903,-0.0124938580500182,0.01252853489879,0.997832796812337
